Attached files

file filename
EX-31.2 - EX-31.2 - PSYCHIATRIC SOLUTIONS INCg22196exv31w2.htm
EX-32.1 - EX-32.1 - PSYCHIATRIC SOLUTIONS INCg22196exv32w1.htm
EX-31.1 - EX-31.1 - PSYCHIATRIC SOLUTIONS INCg22196exv31w1.htm
EX-21.1 - EX-21.1 - PSYCHIATRIC SOLUTIONS INCg22196exv21w1.htm
EX-23.1 - EX-23.1 - PSYCHIATRIC SOLUTIONS INCg22196exv23w1.htm
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
     
þ   Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    for the fiscal year ended December 31, 2009 or
     
o   Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for the transition period from                      to                     
Commission file number 0-20488
Psychiatric Solutions, Inc.
(Exact Name of Registrant as Specified in Its Charter)
     
Delaware
(State or Other Jurisdiction of Incorporation or
Organization)
  23-2491707
(I.R.S. Employer Identification No.)
6640 Carothers Parkway, Suite 500
Franklin, TN 37067
(Address of Principal Executive Offices, Including Zip Code)
(615) 312-5700
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
     
Title Of Each Class   Name of Each Exchange On Which Registered
     
Common Stock, $.01 par value   NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
     Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. þ Yes     o No
     Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. o Yes     þ No
     Note — Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act from their obligations under those Sections.
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ Yes     o No
     Indicated by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). o Yes     o No
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.     o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
             
Large accelerated filer þ   Accelerated filer o   Non-accelerated filer o (Do not check if a smaller reporting company)   Smaller Reporting Company o
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes     þ No
     As of June 30, 2009, the aggregate market value of the shares of common stock of the registrant held by non-affiliates of the registrant was approximately $1.0 billion. For purposes of calculating such aggregate market value, shares owned by directors, executive officers and 5% beneficial owners of the registrant have been excluded.
     As of February 22, 2010, 56,263,260 shares of the registrant’s common stock were outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
     Portions of the registrant’s definitive proxy statement for its 2010 annual meeting of stockholders to be held on May 18, 2010 are incorporated by reference into Part III of this Form 10-K.
 
 

 


 

INDEX
         
    PAGE  
    3  
    3  
    12  
    18  
    18  
    20  
    20  
    21  
    21  
    21  
    23  
    31  
    31  
    31  
    32  
    32  
    32  
    32  
    33  
    33  
    33  
    33  
    34  
    34  
    34  
       
 EX-21.1
 EX-23.1
 EX-31.1
 EX-31.2
 EX-32.1

2


Table of Contents

PART I
     Unless the context otherwise requires, all references in this Annual Report on Form 10-K to “Psychiatric Solutions,” “the Company,” “we,” “us” or “our” mean Psychiatric Solutions, Inc. and its consolidated subsidiaries.
Item 1. Business
Overview
     We are a leading provider of inpatient behavioral health care services in the United States. We operate 94 inpatient behavioral health care facilities with approximately 11,000 beds in 32 states, Puerto Rico, and the U.S. Virgin Islands. In 2009, we opened Rolling Hills Hospital, an 80-bed inpatient facility in Franklin, Tennessee, acquired a 131-bed inpatient behavioral health care facility located in Fargo, North Dakota, acquired a 90-bed inpatient behavioral health care facility located in Panama City, Florida, and sold our employee assistance program (“EAP”) business for approximately $68.5 million, net of fees and expenses. We generated revenue of approximately $1.8 billion and $1.7 billion for the years ended December 31, 2009 and 2008, respectively. We believe that our primary focus on the provision of inpatient behavioral health care services allows us to operate more efficiently and provide higher quality care than our competitors.
     Our inpatient behavioral health care facilities accounted for 93.0% of our revenue for the year ended December 31, 2009. These inpatient facilities offer a wide range of inpatient behavioral health care services for children, adolescents and adults. We offer these services through a combination of acute inpatient behavioral facilities and residential treatment centers (“RTCs”). Our acute inpatient behavioral facilities provide the most intensive level of care, including 24-hour skilled nursing observation and care, daily interventions and oversight by a psychiatrist and intensive, highly coordinated treatment by a physician-led team of mental health professionals. Our RTCs offer longer term treatment programs primarily for children and adolescents with chronic behavioral health problems. Our RTCs provide physician-led, multi-disciplinary treatments that address the overall medical, psychiatric, social and academic needs of the patients.
     Other behavioral health care services accounted for 7.0% of our revenue for the year ended December 31, 2009. This portion of our business primarily consists of our contract management business and a managed care plan in Puerto Rico. Our contract management business involves the development, organization and management of behavioral health and rehabilitation programs within medical/surgical hospitals.
     Psychiatric Solutions was incorporated in the State of Delaware in 1988. Our principal executive offices are located at 6640 Carothers Parkway, Suite 500, Franklin, Tennessee 37067. Our telephone number is (615) 312-5700. Information about Psychiatric Solutions and our filings with the Securities and Exchange Commission can be found at our website at www.psysolutions.com.
Our Industry
     According to the National Association of Psychiatric Health Systems’ 2008 Annual Survey, an estimated 26.2% of Americans ages 18 and older, or slightly more than one in four adults, suffer from a diagnosable mental disorder in a given year, and about 6%, or about one in seventeen, suffer from a serious mental illness.
     The behavioral health care industry is highly fragmented with only a few large national providers. During the 1990s, the behavioral health care industry experienced a significant contraction following a long period of growth. The reduction was largely driven by third-party payors who decreased reimbursement, implemented more stringent admission criteria and decreased the authorized length of stay. We believe this reduced capacity has resulted in an underserved patient population.
     Reduced capacity, mental health parity legislation, and increased demand for behavioral health care services have resulted in favorable industry fundamentals over the last several years. Behavioral health care providers have enjoyed increased reimbursement rates and admissions and stabilized lengths of stay. According to the National Association of Psychiatric Health Systems, inpatient admissions increased approximately 3.5% from 2006 to 2007, and total inpatient days of care increased 3.2% from 2006 to 2007. In order to meet strong demand, facilities have been adding beds resulting in a 2% increase in licensed beds within existing facilities from 2006 to 2007. Following a rapid decrease during the early 1990s, inpatient average length of stay stabilized between 9 and 11 days from 1997 to 2007. The inpatient average length of stay was 9.7 days and 9.6 days in 2007 and 2006, respectively. The average inpatient net revenue per day in 2007 was $616 for facilities with less than fifty beds, $685 for facilities with between fifty and one hundred beds and $615 for facilities with more than one hundred beds. The average residential net revenue per day in 2007 was $346 for facilities with less than fifty beds, $420 for facilities with between fifty and one hundred beds and $358 for facilities with more than one hundred beds. Total patient days of care decreased 3.3% from 2006 to 2007 for RTC facilities, while average length of stay increased 2.4% to 168 days in 2007 from 164 days in 2006.
Our Competitive Strengths
     We believe the following competitive strengths contribute to our strong market share in each of our markets and will enable us to continue to successfully grow our business and increase our profitability:

3


Table of Contents

    Singular focus on behavioral health care — We focus primarily on the provision of inpatient behavioral health care services. We believe this allows us to operate more efficiently and provide higher quality care than our competitors. In addition, we believe our focus and reputation have helped us to develop important relationships and extensive referral networks within our markets and to attract and retain qualified behavioral health care professionals.
 
    Strong and sustainable market position — Our inpatient facilities have an established presence in each of our markets, and many of our owned and leased inpatient facilities have the leading market share in their respective service areas. We believe that the relationships and referral networks we have established will further enhance our presence within our markets. In addition, many of the states in which we operate require a certificate of need to open a behavioral health care facility, which may be difficult to obtain and may further preclude new market participants.
 
    Demonstrated ability to identify and integrate acquisitions — We attribute part of our success in integrating acquired inpatient facilities to our due diligence review of these facilities prior to completing the acquisitions as well as our ability to retain key employees at the acquired facilities. We employ a disciplined acquisition strategy that is based on defined criteria including quality of service, return on invested capital and strategic benefits. We also have a comprehensive post-acquisition strategic plan to facilitate the integration of acquired facilities that includes improving facility operations, retaining and recruiting psychiatrists and expanding the breadth of services offered by the facilities.
 
    Diversified payor mix and revenue base — As we have grown our business, we have focused on diversifying our sources of revenue. For the year ended December 31, 2009, we received 28.7% of our revenue from Medicaid, 13.5% from Medicare, 37.5% from HMO/PPO, commercial and private payors, 14.9% from various state agencies and 5.4% from other payors. We receive Medicaid payments from more than 30 states. Substantially all of our Medicaid payments relate to the care of children and adolescents. We believe that children and adolescents are a patient class that is less susceptible to reductions in reimbursement rates. For the year ended December 31, 2009, no single inpatient facility represented more than 2.2% of our revenue.
 
    Experienced management team — Our senior management team has extensive experience in the health care industry. Joey A. Jacobs, our Chairman, President and Chief Executive Officer, has over 30 years of experience in various capacities in the health care industry. Our senior management operates as a cohesive, complementary group and has extensive operating knowledge of our industry and understanding of the regulatory environment in which we operate. Our senior managers employ conservative fiscal policies and have a successful track record in both operating our core business and integrating acquired assets.
 
    Consistent free cash flow and minimal maintenance capital requirements — We generate consistent free cash flow by profitably operating our business, actively managing our working capital and having low maintenance capital expenditure requirements. As the behavioral health care business does not require the procurement and replacement of expensive medical equipment, our maintenance capital expenditure requirements are less than that of other facility-based health care providers. Historically, our maintenance capital expenditures have amounted to approximately 2% to 3% of our revenue. In addition, our accounts receivable management is less complex than medical/surgical hospital providers because there are fewer billing codes for inpatient behavioral health care services.
Our Growth Strategy
     We have experienced significant growth in our operations as measured by the number of our facilities, admissions, patient days, revenue and net income. We intend to continue growing our business and increasing our profitability by improving the performance of our inpatient facilities and through strategic acquisitions. The principal elements of our growth strategy are to:
    Continue to Drive Same-Facility Growth — We increased our same-facility revenue by approximately 5.3% for the year ended December 31, 2009 compared to the year ended December 31, 2008. Same-facility revenue also increased by approximately 8.4%, 6.9%, and 9.0% for the years ended December 31, 2008, 2007, and 2006, respectively, compared to the immediately preceding years. Same-facility revenue refers to the comparison of the inpatient facilities we owned during a prior period with the comparable period in the subsequent period, adjusted for closures and combinations for comparability purposes. We intend to continue to increase our same-facility revenue by increasing our admissions and patient days and obtaining annual reimbursement rate increases. We plan to accomplish these goals by:
    continuing to provide high quality service;
 
    expanding bed capacity at our facilities to meet demand;
 
    expanding our services and developing new services to take advantage of increased demand in select markets where we operate;
 
    building and expanding relationships that enhance our presence in local and regional markets; and

4


Table of Contents

    developing formal marketing initiatives and expanding referral networks.
    Grow Through Strategic Acquisitions — Our industry is highly fragmented and we plan to selectively pursue the acquisition of additional inpatient behavioral health care facilities. There are approximately 500 freestanding acute and residential treatment facilities in the United States and the top two providers operate approximately one-third of these facilities. We believe there are a number of acquisition candidates available at attractive valuations. We believe our focus on inpatient behavioral health care provides us with a strategic advantage when assessing a potential acquisition. We employ a disciplined acquisition strategy that is based on defined criteria, including quality of service, return on invested capital and strategic benefits.
 
    Enhance Operating Efficiencies — Our management team has extensive experience in the operation of multi-facility health care services companies. We intend to focus on improving our profitability by maintaining appropriate staffing ratios, controlling contract labor costs and reducing supply costs through group purchasing. We believe that our focus on efficient operations increases our profitability and will attract qualified behavioral health care professionals and patients.
Services
Inpatient Behavioral Health Care Facilities
     We operate 86 owned and 8 leased inpatient behavioral health care facilities. These facilities offer a wide range of inpatient behavioral health care services for children, adolescents and adults. Our inpatient facilities work closely with mental health professionals, including: licensed professional counselors, therapists and social workers; psychiatrists; non-psychiatric physicians; emergency rooms; school systems; insurance and managed care organizations; company-sponsored EAPs; and law enforcement and community agencies that interact with individuals who may need treatment for mental illness or substance abuse. During the year ended December 31, 2009, our inpatient behavioral health care facilities produced approximately 93.0% of our revenue.
     Through the diversity of programming and levels of care available, a patient can receive a seamless treatment experience from acute care to residential long-term care to group home living to outpatient treatment. This seamless system provides the continuity of care needed to step the patient down and allow the patient to develop and use successful coping skills and treatment interventions to sustain long-term treatment success. Treatment modalities include comprehensive assessment, multi-disciplinary treatment planning including the patient and family, group, individual and family therapy services, medical and dental services, educational services, recreational services and discharge planning services. Specialized interventions such as skills training include basic daily living skills, social skills, work/school adaptation skills and symptom management skills. Collateral consultations are provided to significant others such as family members, teachers, employers and other professionals when needed to help the patient successfully reintegrate back into his or her world. Disorders treated and services offered at our inpatient facilities include:

    bipolar disorder
 
    major depression
 
    schizophrenia
 
    attention deficit/hyperactivity disorder
 
    impulse disorder
 
    oppositional and conduct disorders
 
    developmentally delayed disorders
 
    neurological disorders
 
    acute eating disorders
 
    reactive attachment disorder
 
    dual diagnosis
 
    chemical dependency
    rehabilitation care
 
    day treatment
 
    detoxification
 
    partial hospitalization
 
    therapeutic foster care
 
    intensive outpatient
 
    rapid adoption services
 
    independent living skills
 
    vocational training


     Acute inpatient hospitalization is the most intensive level of care offered and typically involves skilled nursing observation and care, daily oversight by a psychiatrist, and intensive, highly coordinated treatment by a physician-led team of mental health professionals. Every patient admitted to our acute inpatient facilities is assessed by a medical doctor within 24 hours of admission. Patients with non-complex medical conditions are monitored during their stay by the physician and nursing staff at the inpatient facility. Patients with more complex medical needs are referred to more appropriate facilities for diagnosis and stabilization prior to treatment. Patients admitted to our acute inpatient facilities also receive comprehensive nursing and psychological assessments within 24 to 72 hours of admission. Oversight and management of a patient’s medication is performed by licensed psychiatrists on staff at the facility, and individual, family, and group therapy is performed by licensed counselors as appropriate to the patient’s assessed needs. Education regarding a patient’s illnesses is also provided by trained mental health professionals.
     Our RTCs provide longer term treatment programs for children and adolescents with long-standing behavioral/mental health problems. Our RTCs provide twenty-four hour care which includes individualized therapy that usually consists of one-on-one sessions with a licensed counselor, as well as process and rehabilitation group therapy. Another key component of the treatment of children and adolescents in our inpatient facilities is family therapy. Participation of the child’s or adolescent’s immediate family is strongly encouraged in order to increase the chance of success once the resident is discharged. Medications for residents are managed by

5


Table of Contents

licensed psychiatrists while they remain at the inpatient facility. Our RTCs also provide academic programs conducted by certified teachers to child and adolescent residents. These programs are individualized for each resident upon admission. Upon discharge, academic reports are forwarded to the resident’s school. Specialized programs for children and adolescents in our RTCs include programs for sexually reactive children, sex offenders, reactive attachment disorders, and children and adolescents who are developmentally delayed with a behavioral component. Our RTCs often receive out-of-state referrals to their programs due to the lack of specialized programs for these disorders within a patient’s own state.
     Our inpatient facilities’ programs are designed to meet the needs of various referral sources to provide services to patients with multiple issues and specialized needs. We believe that our success rate with these difficult to treat cases has expanded our network of referrals. The services provided at each inpatient facility are continually assessed and monitored through an ongoing quality improvement program. The purpose of this program is to strive for the highest quality of care possible for individuals with behavioral health issues, and includes regular site visits to each inpatient facility in order to assess compliance with legal and regulatory standards, as well as adherence to our compliance program. Standardized performance measures based on a national outcomes measurement database comparing our inpatient facilities’ performance with national norms are also reported and reviewed and corrective steps are taken when necessary.
Other Behavioral Health Care Services
     Other behavioral health care services accounted for 7.0% of our revenue for the year ended December 31, 2009. This portion of our business primarily consists of our contract management business and a managed care plan in Puerto Rico.
     Through our contract management business we develop, organize and manage behavioral health and rehabilitation programs within third-party general medical/surgical hospitals. Our broad range of services can be customized into individual programs that meet specific inpatient facility and community requirements. Our contract management business is dedicated to providing high quality programs with integrity, innovation and sufficient flexibility to develop customized individual programs. We provide our customers with a variety of management options, including clinical and management infrastructure, personnel recruitment, staff orientation and supervision, corporate consultation and performance improvement plans. Under the management contracts, the hospital is the actual provider of the mental health services and utilizes its own facilities, support services, and generally its own nursing staff in connection with the operation of its programs. Our management contracts generally have an initial term of two to five years and are extended for successive one-year periods unless terminated by either party.
Seasonality of Services
     Due to the large number of children and adolescent patients served, our inpatient behavioral health care facilities typically experience lower patient volumes and revenue during the summer months, the year-end holidays and other periods when school is out of session.
Marketing
     Our local and regional marketing is led by clinical and business development representatives at each of our inpatient facilities. These individuals manage relationships among a variety of referral sources in their respective communities. Our national marketing efforts are focused on increasing the census at our RTCs from various state referral sources by developing relationships and identifying contracting opportunities in their respective territories.
Competition
     The inpatient behavioral health care industry is highly fragmented and is subject to continual changes in the method in which services are provided and the types of companies providing such services. We primarily compete with regional and local competitors. Some of our competitors are owned by governmental agencies and supported by tax revenue and others are owned by nonprofit corporations and may be supported to a large extent by endowments and charitable contributions.
     In addition, we compete for patients with other providers of mental health care services, including other inpatient behavioral health care facilities, medical/surgical hospitals, independent psychiatrists and psychologists. We also compete with hospitals, nursing homes, clinics, physicians’ offices and staffing companies for the services of registered nurses and other professionals. We attempt to differentiate ourselves from our competition through our singular focus on the provision of behavioral health care services, our reputation for the quality of our services, recruitment of first rate medical staff and accessibility to our facilities. In addition, we believe that the active development of our referral network and participation in selected managed care provider panels enable us to successfully compete for patients in need of our services.
Reimbursement
     Our inpatient owned and leased facilities receive payment for services from the federal government, primarily under the Medicare program; state governments, primarily under their respective Medicaid programs; private insurers, including managed care plans; and directly from patients. Most of our inpatient behavioral health facilities are certified as providers of Medicare and/or Medicaid

6


Table of Contents

services by the appropriate governmental authorities. The requirements for certification are subject to change, and, in order to remain qualified for such programs, it may be necessary for us to make changes from time to time in our inpatient facilities, equipment, personnel and services. If an inpatient facility loses its certification, it will be unable to receive payment under the Medicare or Medicaid programs. Although we intend to continue participating in such programs, there can be no assurance that we will continue to qualify for participation.
     Patient service revenue is recorded net of contractual adjustments at the time of billing by our patient accounting systems at the amount we expect to collect. This amount is calculated automatically by our patient accounting systems based on contractually determined rates, or amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas, or a combination thereof. Most payments are determined based on negotiated per-diem rates. An estimate of contractual allowances is manually recorded for unbilled services based upon these contractually negotiated rates.
     Any co-payments and deductibles due from patients are estimated at the time of admission based on the patient’s insurance plan, and payment of these amounts is requested prior to discharge. If the payment is not received prior to discharge or completion of service, collection efforts are made through our normal billing and collection process.
     Our consolidated day’s sales outstanding were 49 and 52 for the years ended December 31, 2009 and 2008, respectively.
Medicare
     Medicare provides insurance benefits to persons age 65 and over and some disabled persons. The Centers for Medicare and Medicaid Services (“CMS”) implemented a three-year transition period to reimbursement based on an inpatient services prospective payment system (“PPS”) from reimbursement based on a reasonable cost basis, starting with the cost reporting periods beginning on or after January 1, 2005. PPS was fully implemented for cost reporting periods beginning on or after January 1, 2008. Inpatient psychiatric facilities received a 2.19% increase in the Medicare prospective base rate beginning July 1, 2009.
     Under CMS regulations, the PPS base per diem is adjusted for specific patient and facility characteristics that increase the cost of patient care. Payment rates for individual inpatient facilities are adjusted to reflect geographic differences in wages and rural providers and teaching facilities receive an increased payment adjustment. Additionally, the base rate is adjusted by factors that influence the cost of an individual patient’s care, such as each patient’s diagnosis related group, certain other medical and psychiatric comorbidities (i.e., other coexisting conditions that may complicate treatment) and age. Because the cost of inpatient behavioral care tends to be greatest at admission and a few days thereafter, the per diem rate is adjusted for each day to reflect the number of days the patient has been in the facility. Medicare pays this per diem amount, as adjusted, regardless of whether it is more or less than a hospital’s actual costs. Please see www.cms.hhs.gov/InpatientPsychFacilPPS for additional information.
     Medicare generally deducts from the amount of its payments to hospitals an amount for patient “deductible or coinsurance,” or the amount that the patient is expected to pay. These deductible or coinsurance amounts that are not paid by the patient result in “bad debts.” Medicare will reimburse 70% of these bad debts to the extent that neither a Medicare patient, a guarantor or any secondary payor for that patient pays the Medicare coinsurance amount, provided that a reasonable collection effort or the patient’s indigence is documented.
Recovery Audit Contractors
     In 2005, CMS began using recovery audit contractors (“RACs”) to detect Medicare overpayments not identified through existing claims review mechanisms. The RAC program relies on private auditing firms examining Medicare claims filed by health care providers. The RAC program began as a demonstration project in three states (New York, California, and Florida), and was made permanent by the Tax Relief and Health Care Act of 2006. The Act required CMS to have RACs in place in all 50 states no later than 2010.
     RACs perform post-discharge audits of medical records to identify Medicare overpayments resulting from incorrect payment amounts, non-covered services, incorrectly coded services, and duplicate services. CMS has given RACs the authority to look back at claims up to three years old, provided that the claim was paid on or after October 1, 2007. Claims identified as overpayments will be subject to the Medicare appeals process.
     RACs are paid a contingency fee based on the overpayments they identify and collect. Therefore, we anticipate that RACs will review claims submitted by our facilities in an attempt to identify possible overpayments. Although we believe the claims for reimbursement submitted to the Medicare program are accurate, we cannot predict whether we will be subject to RAC audits in the future, or if audited, what the result of such audits might be.
Medicaid
     Medicaid, a joint federal-state program that is administered by the respective states, provides health care benefits to qualifying individuals who are unable to afford medical care. All Medicaid funding is generally conditioned upon financial appropriations to state Medicaid agencies by the state legislatures. Many states face pressures to control their budgets, which has led some state

7


Table of Contents

legislatures to reduce such appropriations.
     Some states may adopt health care reform measures that could modify the manner in which all health services are delivered and reimbursed, especially with respect to Medicaid recipients and other individuals funded by public resources. Most states have applied for and been granted federal waivers from current Medicaid regulations in order to allow them to serve some or all of their Medicaid participants through managed care providers. The majority of our Medicaid payments relate to the care of children and adolescents. We believe that children and adolescents are a patient class that is less susceptible to reductions in reimbursement rates.
Managed Care and Commercial Insurance Carriers
     Our inpatient facilities are also reimbursed for certain behavioral health care services by private payors including health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”), commercial insurance companies, employers and individual private payors. Our inpatient facilities offer discounts from established charges to certain large group purchasers of health care services. Generally, patients covered by HMOs, PPOs and other private insurers are responsible for payment of certain co-payments and deductibles.
     The Mental Health Parity Act of 1996 (“MHPA”) was a federal law that required annual or lifetime limits for mental health benefits be no lower than the dollar limits for medical/surgical benefits offered by a group health plan. MHPA applied to group health plans or health insurance coverage offered in connection with a group health plan that offered both mental health and medical/surgical benefits. However it did not require plans to offer mental health benefits. MHPA was scheduled to “sunset” on December 31, 2003; however, MHPA has been extended several times on a year to year basis, most recently through the end of 2009. The Mental Health and Addiction Equity Parity Act of 2008 (the “2008 MHPA”) was passed in October of 2008 and will take effect for plan years beginning after July 1, 2010. The 2008 MHPA will substantially increase the mental health benefits protection afforded by MHPA and will expand the coverage of MHPA to include substance abuse treatment. On February 2, 2010, CMS published interim final rules governing implementation of the 2008 MHPA. Among the changes in the interim final rules is an expansion of the parity requirements for aggregate lifetime and annual dollar limits to include protections for substance use disorder benefits. Approximately 45 states have also enacted some form of mental health parity laws.
Annual Cost Reports
     All facilities participating in the Medicare program and some Medicaid programs, whether paid on a reasonable cost basis or under a PPS, are required to meet certain financial reporting requirements. Federal regulations require submission of annual cost reports identifying costs associated with the services provided by each facility to Medicare beneficiaries and Medicaid recipients. Annual cost reports required under Medicare and some Medicaid programs are subject to routine governmental audits, which may result in adjustments to the amounts ultimately determined to be due to us under those reimbursement programs for periods prior to full implementation of PPS. These audits often require several years to reach the final determination of amounts earned under the programs. Nonetheless, once the Medicare fiscal intermediaries have issued a final Notice of Program Reimbursement (“NPR”) after an audit, any disallowances of claimed costs are due and payable within 30 days of receipt of the NPR. Providers have rights to appeal, and it is common to contest issues raised in audits of prior years’ cost reports.
Regulation and Other Factors
Licensure, Certification and Accreditation
     Health care facilities are required to comply with extensive regulation at the federal, state and local levels. Under these laws and regulations, health care facilities must meet requirements for state licensure as well as additional qualifications to participate in government programs, including the Medicare and Medicaid programs. These requirements relate to the adequacy of medical care, equipment, personnel, operating policies and procedures, fire prevention, maintenance of adequate records, hospital use, rate-setting, and compliance with building codes and environmental protection laws. Facilities are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensing and accreditation.
     All of the inpatient facilities operated by us are properly licensed under applicable state laws. Most of the inpatient facilities operated by us are certified under Medicare and/or Medicaid programs and accredited by The Joint Commission, a functional prerequisite to participation in the Medicare and Medicaid programs. Should any of our inpatient facilities lose its accreditation by The Joint Commission, or otherwise lose its certification under the Medicare and/or Medicaid programs, that inpatient facility may be unable to receive reimbursement from the Medicare and/or Medicaid programs. If a provider for whom we provide contract management services is excluded from any federal health care program, no services furnished by that provider would be reimbursed by any federal health care program. If one of our facilities is excluded from a federal health care program, that facility would not be eligible for reimbursement by any federal health care program. Additionally, many private third-party payors require Joint Commission accreditation and/or Medicare certification in order to contract with a facility.
     We believe that the inpatient facilities we own and operate are in substantial compliance with current applicable federal, state, local and independent review body regulations and standards. The requirements for licensure, certification and accreditation are subject to

8


Table of Contents

change and, in order to remain qualified, it may be necessary for us to affect changes in our inpatient facilities, equipment, personnel and services. Additionally, certain of the employed and contracted personnel working at our inpatient facilities are subject to state laws and regulations governing their particular area of professional practice.
Fraud and Abuse Laws
     Participation in the Medicare and/or Medicaid programs is heavily regulated by federal law and CMS regulation. If a hospital fails to substantially comply with the numerous federal laws governing that facility’s activities, the facility’s participation in the Medicare and/or Medicaid programs may be terminated and/or civil or criminal penalties may be imposed.
     The portion of the Social Security Act commonly known as the “Anti-Kickback Statute” prohibits the payment, receipt, offer or solicitation of anything of value with the intent of generating referrals or orders for services or items covered by a federal or state health care program. Violations of the Anti-Kickback Statute may be punished by criminal or civil penalties, exclusion from federal and state health care programs, imprisonment and damages up to three times the total dollar amount involved. While evidence of intent is a prerequisite to any finding that the Anti-Kickback Statute has been violated, the statute has been interpreted broadly by federal regulators and courts to prohibit the payment of anything of value if even one purpose of the payment is to influence the referral of Medicare or Medicaid business.
     The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) broadened the scope of the fraud and abuse laws by adding several criminal statutes that are not related to receipt of payments from a federal health care program. HIPAA created civil penalties for proscribed conduct, including upcoding and billing for medically unnecessary goods or services. HIPAA established new enforcement mechanisms to combat fraud and abuse. These new mechanisms include a bounty system, where a portion of any payments recovered is returned to the government agencies, as well as a whistleblower program. HIPAA also expanded the categories of persons that may be excluded from participation in federal and state health care programs.
     The Office of Inspector General (the “OIG”) of the Department of Health and Human Services (“HHS”) is responsible for identifying fraud and abuse activities in government programs. In order to fulfill its duties, the OIG performs audits, investigations and inspections.
     The OIG is authorized to publish regulations outlining activities and business relationships that would be deemed not to violate the Anti-Kickback Statute. These regulations are known as “safe harbor” provisions. The safe harbor provisions delineate standards that, if complied with, protect conduct that might otherwise be deemed to violate the Anti-Kickback Statute. While compliance with the safe harbor provisions effectively insulates a practice from being found in violation of the Anti-Kickback Statute, the failure of a particular activity to comply with the safe harbor provisions does not mean that the activity violates the Anti-Kickback Statute. Rather, failure to comply with the safe harbor provisions simply denies us the opportunity to avail ourselves of the affirmative defense of safe harbor compliance. We have a variety of financial relationships with physicians who refer patients to our owned and leased facilities, as well as to behavioral health and rehabilitation programs we manage, including employment contracts, professional service agreements with independent contractor agreements and medical/clinical director agreements. We use our best efforts to structure each of our arrangements, especially each of our business relationships with physicians, to fit as closely as possible within the applicable safe harbors. We cannot guarantee that these arrangements will not be scrutinized by government authorities or, if scrutinized, that they will be determined to be in compliance with the Anti-Kickback Statute or other applicable laws. If we violate the Anti-Kickback Statute, we would be subject to criminal and civil penalties and/or possible exclusion from participating in Medicare, Medicaid or other governmental health care programs.
     We provide unit management services to acute care hospitals. Some of our management agreements provide for fees payable to us that are not fixed fees, but may vary based on revenue, the level of services rendered or the number of patients treated in the unit. We believe that the management fees reflect fair market value for the services rendered and are not determined in a manner that takes into account the volume or value of any referrals. These management agreements satisfy many but not all of the requirements of the Personal Services and Management Contract Safe Harbor. We believe our management agreements comply with the Anti-Kickback Statute. As discussed above, the preamble to the Safe Harbor regulations specifically indicates that the failure of a particular business arrangement to comply with a Safe Harbor does not determine whether the arrangement violates the Anti-Kickback Statute.
     The Social Security Act also includes a provision commonly known as the “Stark Law.” This law prohibits physicians from referring Medicare and Medicaid patients to health care entities in which they or any of their immediate family members have an ownership or other financial interest for the furnishing of any “designated health services”. These types of referrals are commonly known as “self referrals.” A violation of the Stark Law may result in a denial of payment, require refunds to patients and the Medicare program, civil monetary penalties of up to $15,000 for each violation, civil monetary penalties of up to $100,000 for circumvention schemes, civil monetary penalties of up to $10,000 for each day that an entity fails to report required information, exclusion from the Medicare and Medicaid programs and other federal programs, and additionally could result in penalties for false claims. There are ownership and compensation arrangement exceptions for many customary financial arrangements between physicians and facilities, including employment contracts, personal services agreements, leases and recruitment agreements. We have structured our financial arrangements with physicians to comply with the statutory exceptions included in the Stark Law and subsequent regulations. However, future Stark Law regulations may interpret provisions of this law in a manner different from the manner in which we have interpreted them. We cannot predict the effect such future regulations will have on us.

9


Table of Contents

     Many states in which we operate also have adopted, or are considering adopting, laws similar to the Anti-Kickback Statute and/or the Stark Law. Some of these state laws, commonly known as “all payor” laws, apply even if the government is not the payor. These statutes typically provide criminal and civil penalties as remedies. While there is little precedent for the interpretation or enforcement of these state laws, we have attempted to structure our financial relationships with physicians and others in accordance with these laws. However, if a state determines that we have violated such a law, we may be subject to criminal and civil penalties.
Emergency Medical Treatment and Active Labor Act
     The Emergency Medical Treatment and Active Labor Act (“EMTALA”) is a federal law that requires any Medicare participating hospital to conduct an appropriate medical screening examination, within the capabilities of the facility, of every person who presents at the hospital seeking treatment on an urgent basis. If the patient is suffering from an emergency medical condition, the facility must either stabilize that condition or make an appropriate transfer of the patient to a facility that can stabilize the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of a patient’s ability to pay for treatment. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer a patient, or if the hospital delays appropriate treatment, in order to first inquire about the patient’s ability to pay. Penalties for violations of EMTALA include civil monetary penalties and exclusion from participation in the Medicare program. In addition, an injured patient, the patient’s family or a medical facility that suffers a financial loss as a direct result of another hospital’s violation of the law can bring a civil suit against the hospital.
     The regulations adopted to implement EMTALA do not provide an abundance of specific guidance. These regulations effectively limit the types of emergency services that a hospital subject to EMTALA is required to provide to those services that are within the capability of the hospital. Although we believe that our inpatient behavioral health care facilities comply with the EMTALA regulations, we cannot predict whether CMS will implement additional requirements in the future or the cost of compliance with any such regulations.
The Federal False Claims Act
     The federal False Claims Act prohibits providers from, among other things, knowingly submitting false claims for payment to the federal government. This law has been used not only by the federal government, but also by individuals who bring an action on behalf of the government under the law’s “qui tam” or “whistleblower” provisions. When a private party brings a qui tam action under the federal False Claims Act, the defendant will generally not be aware of the lawsuit until the government determines whether it will intervene in the litigation.
     Civil liability under the federal False Claims Act can be up to three times the actual damages sustained by the government plus civil penalties for each separate false claim. There are many potential bases for liability under the federal False Claims Act, including claims submitted pursuant to a referral found to violate the Anti-Kickback Statute or the Stark Law. Although liability under the federal False Claims Act arises when an entity knowingly submits a false claim for reimbursement to the federal government, or knowingly and improperly avoids or decreases an obligation to pay money to the federal government, the federal False Claims Act defines the term “knowingly” broadly. Although simple negligence will not give rise to liability under the federal False Claims Act, submitting a claim with reckless disregard to its truth or falsity can constitute the knowing submission of a false claim. Additionally, the Fraud Enforcement and Recovery Act of 2009 (“FERA”) substantially broadened the scope of the False Claims Act. Most notably, FERA expands the definition of “false claim” to include claims made to contractors for funds spent on the government’s behalf and the retention of government overpayments, expands whistleblower protections, eases restrictions on the flow of information between the government and qui tam relators, and increases funding for government investigation and prosecution of alleged false claims. From time to time, companies in the health care industry, including us, may be subject to actions under the federal False Claims Act.
HIPAA Transaction, Privacy and Security Requirements
     HIPAA requires health plans, health care clearinghouses and health care providers (“Covered Entities”) to use standard data formats and code sets when electronically transmitting information in connection with various transactions, including health claims and equivalent encounter information, health care payment and remittance advice and health claim status, and establishes standards to protect the confidentiality, availability and integrity of health information maintained by Covered Entities, regardless of format. In 2009, the Health Information Technology for Economic and Clinical Health Act (“HITECH”) amended HIPAA to include a requirement that Covered Entities, such as us, self-report breaches of unsecured protected health information to affected patients, the HHS, and in some cases, the media. HITECH also modifies the responsibilities of HIPAA “business associates,” such as our managed unit division, and substantially increases the civil monetary penalties for HIPAA violations. We believe our inpatient facilities and, where applicable, other operations are in substantial compliance with the HIPAA regulations.

10


Table of Contents

Other Medical Record Disclosure Laws
     Disclosure of health records relating to drug and alcohol treatment is regulated by the Federal Confidentiality of Alcohol and Drug Abuse Patient Records law. This law prohibits the disclosure and use of alcohol and drug abuse patient records that are maintained by any federally assisted alcohol and drug abuse programs. The privacy protections afforded substance abuse treatment records are much more stringent than the HIPAA privacy rules and in most cases permit disclosure only when the patient has specifically consented to disclosure. Violations of this law could result in criminal penalties, including fines of up to $500 for first offenses and up to $5,000 for each subsequent offense.
     Additionally, some states have laws specifically dealing with the disclosure of medical records related to treatment for substance abuse and/or mental health disorders. Both HIPAA and the Federal Confidentiality of Alcohol and Drug Abuse Patient Records law provide a baseline level of protection for disclosure of health records. As such, they supersede state laws that are more lenient on the same subject. However, the federal laws give way to any state law that provides more stringent protection of health records.
Certificates of Need (“CON”)
     The construction of new health care facilities, the acquisition or expansion of existing facilities, the transfer or change of ownership and the addition of new beds, services or equipment may be subject to laws in certain states that require prior approval by state regulatory agencies. These CON laws generally require that a state agency determine the public need for construction or acquisition of facilities or the addition of new services. Failure to obtain necessary state approval can result in the inability to expand facilities, add services, or complete an acquisition. Violations of these state laws may result in the imposition of civil sanctions or revocation of a facility’s license.
Corporate Practice of Medicine and Fee Splitting
     Some states have laws that prohibit unlicensed persons or business entities, including corporations or business organizations that own hospitals, from employing physicians. Some states also have adopted laws that prohibit direct and indirect payments or fee-splitting arrangements between physicians and unlicensed persons or business entities. Possible sanctions for violation of these restrictions include loss of a physician’s license, civil and criminal penalties and rescission of business arrangements. These laws vary from state to state, are often vague and have seldom been interpreted by the courts or regulatory agencies. Although we attempt to structure our arrangements with health care providers to comply with the relevant state laws and the few available regulatory interpretations, there can be no assurance that government officials charged with responsibility for enforcing these laws will not assert that we, or certain transactions in which we are involved, are in violation of such laws, or that such laws ultimately will be interpreted by the courts in a manner consistent with our interpretation.
Health Care Industry Investigations
     Significant media and public attention has focused in recent years on the hospital industry. Because the law in this area is complex and constantly evolving, ongoing or future governmental investigations or litigation may result in interpretations that are inconsistent with industry practices, including our practices. It is possible that governmental entities could initiate investigations of, or litigation against, inpatient facilities owned, leased, or managed by us in the future and that such matters could result in significant penalties as well as adverse publicity.
Risk Management
     As is typical in the health care industry, we are subject to claims and legal actions by patients in the ordinary course of business. To cover these claims, we maintain professional malpractice liability insurance and general liability insurance in amounts we believe to be sufficient for our operations, although it is possible that some claims may exceed the scope of the coverage in effect. At various times in the past, the cost of malpractice insurance and other liability insurance has fluctuated significantly. Therefore, there can be no assurance that such insurance will continue to be available at reasonable prices which would allow us to maintain adequate levels of coverage.
Conversion Legislation
     Many states have adopted legislation regarding the sale or other disposition of hospitals operated by not-for-profit entities. In other states that do not have such legislation, the attorneys general have demonstrated an interest in these transactions under their general obligations to protect charitable assets. These legislative and administrative efforts primarily focus on the appropriate valuation of the assets divested and the use of the proceeds of the sale by the not-for-profit seller. These reviews and, in some instances, approval processes can add additional time to the closing of a not-for-profit hospital acquisition. Future actions by state legislators or attorneys general may seriously delay or even prevent our ability to acquire certain hospitals.

11


Table of Contents

Regulatory Compliance Program
     We are committed to ethical business practices and to operating in accordance with all applicable laws and regulations. Our compliance program was established to ensure that all employees have a solid framework for business, legal, ethical, and employment practices. Our compliance program establishes mechanisms to aid in the identification and correction of any actual or perceived violations of any of our policies or procedures or any other applicable rules and regulations. We have appointed a Chief Compliance Officer as well as compliance coordinators at each inpatient facility. The Chief Compliance Officer heads our Compliance Committee, which consists of senior management personnel and two members of our board of directors. Employee training is a key component of the compliance program. All employees receive training during orientation and annually thereafter.
Insurance
     We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. Our operations have professional and general liability insurance in umbrella form for claims in excess of a $3.0 million self-insured retention with an insured excess limit of $75.0 million. The self-insured reserves for professional and general liability risks are calculated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates.
Employees
     As of December 31, 2009, we employed approximately 23,000 employees, of whom approximately 16,000 are full-time employees. Approximately 22,000 employees staff our owned and leased inpatient behavioral health care facilities, approximately 1,100 employees staff our other behavioral health care businesses and approximately 200 employees are in corporate management including finance, accounting, legal, operations management, development, reimbursement, compliance, risk management, information systems, internal audit and human resources. We consider our employee relations to be in good standing.
Available Information
     We make available free of charge through our website, which you can find at www.psysolutions.com, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission.
Segments
     See Note 13 to our Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K for financial information about our segments, as defined by U.S. generally accepted accounting principles.
Executive Officers
     Information regarding our executive officers is set forth in Part III, Item 10 of this Annual Report on Form 10-K and is incorporated herein by reference.
Item 1A.   Risk Factors
     The following are some of the risks and uncertainties that could cause our actual financial condition, results of operations, business and prospects to differ materially from those contemplated by the forward-looking statements contained in this Annual Report on Form 10-K or our other filings with the SEC. These risks, as well as the risks described in “Reimbursement,” “Regulation and Other Factors,” and “Forward-Looking Statements” should be carefully considered before making an investment decision regarding us. The risks and uncertainties described below are not the only ones we face and there may be additional risks that we are not presently aware of or that we currently consider not likely to have a significant impact. If any of the following risks actually occurred, our business, financial condition and operating results could suffer, and the trading price of our common stock could decline.
If we fail to comply with extensive laws and government regulations, we could suffer penalties, lose our licenses or be excluded from health care programs. Also, any changes to the laws and regulations governing our business, or the interpretation and enforcement of those laws or regulations, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
     The health care industry is required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things:
    licensure and certification;
 
    relationships with physicians and other referral sources;

12


Table of Contents

    quality of medical services;
 
    qualifications of medical and support personnel;
 
    confidentiality of health-related information and medical records;
 
    billing for services;
 
    cost reporting;
 
    operating policies and procedures; and
 
    addition of facilities and services.
     Among these laws are the Anti-Kickback Statute and the Stark Law. These laws impact the relationships that we may have with physicians and other referral sources. The OIG has enacted safe harbor regulations that outline practices that are deemed protected from prosecution under the Anti-Kickback Statute. Our current financial relationships with physicians and other referral sources may not qualify for safe harbor protection under the Anti-Kickback Statute. Failure to meet a safe harbor does not mean that the arrangement automatically violates the Anti-Kickback Statute, but may subject the arrangement to greater scrutiny. Further, we cannot guarantee that practices that are outside of a safe harbor will not be found to violate the Anti-Kickback Statute.
     Additionally, we are subject to various routine and non-routine reviews, audits and investigations by the Medicare and Medicaid programs and other federal and state governmental agencies, which have various rights and remedies against us if they assert that we have overcharged the programs or failed to comply with program requirements.
     If we fail to comply with the Anti-Kickback Statute, the Stark Law or other applicable laws and regulations, we could be subjected to criminal penalties, civil penalties and exclusion of one or more of our inpatient facilities from participation in the Medicare, Medicaid and other federal and state health care programs. In addition, if we do not operate our inpatient facilities in accordance with applicable law, our inpatient facilities may lose their licenses or the ability to participate in third party reimbursement programs. If we become subject to material fines or, if other sanctions or other corrective actions are imposed on us, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected.
     While we believe we are in substantial compliance with all applicable laws, we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. In the future, different interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality, and could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows by:
    increasing our liability;
 
    increasing our administrative and other costs by requiring us to make changes in our inpatient facilities, equipment or personnel;
 
    increasing or decreasing mandated services;
 
    forcing us to restructure our relationships with referral sources and providers; or
 
    requiring us to implement additional or different programs and systems.
     A determination that we have violated these laws, or the public announcement that we are being investigated for possible violations of these laws, could have a material adverse effect on our business, financial condition, results of operations or prospects and our business reputation could suffer significantly. In addition, we are unable to predict whether other legislation or regulations at the federal or state level will be adopted or the effect such legislation or regulations will have on us.
Health care reform measures could adversely affect our business.
     The United States Congress is currently considering a variety of bills intended to significantly reform the U.S. health care system. All versions of the proposed legislation are intended, among other things, to increase access to health insurance and slow the rate of growth of health care spending. Any adopted reform measures could adversely impact the amount paid for services we provide to our patients who are covered by Medicare, Medicaid and other governmental agencies or third party payors. While we cannot predict what, if any, legislative or regulatory proposals will be adopted, adoption of such proposals could affect our reimbursement and materially harm our business, financial condition and results of operations.
The economic downturn and continued deficit spending by the federal government and state budget pressures may result in a reduction in payments and covered services. Lower reimbursement rates for our services would have an adverse effect on our business, financial condition and results of operations.

13


Table of Contents

     Approximately 57.1% of our revenue comes from the Medicare and Medicaid programs and various state agencies. Continued deficit spending due to adverse developments in the United States and global economies, bailout programs directed at specific industries and other governmental measures could lead to a reduction in federal government expenditures, including governmentally funded programs such as Medicare and Medicaid. In addition, state budget pressures may cause reductions in state spending. Given that Medicaid outlays are a significant component of state budgets, we expect continuing cost containment pressures on Medicaid outlays for our services. Reductions in expenditures for these programs could have a material adverse effect on our business and our consolidated financial condition, results of operations and cash flows.
     Many of the patients admitted to the units we manage for acute care hospitals are eligible for Medicare coverage. As a result, the providers rely upon payment from Medicare for the services. Many of the patients are also eligible for Medicaid payments. To the extent that a hospital deems revenue for a program we manage to be inadequate, it may seek to terminate its contract with us or not renew the contract. Similarly, we may not add new management contracts if prospective customers do not believe that such programs will generate sufficient revenue.
Government investigations may reduce our earnings. Companies within the health care industry continue to be the subject of federal and state investigations, which increases the risk that we may become subject to additional investigations in the future.
     Both federal and state government agencies as well as private payors are devoting increased attention and resources to anti-fraud initiatives against health care providers and have heightened and coordinated civil and criminal enforcement efforts as part of numerous ongoing investigations of health care organizations. These investigations relate to a wide variety of topics, including:
    cost reporting and billing practices;
 
    quality of care;
 
    financial relationships with referral sources;
 
    medical necessity of services provided; and
 
    treatment of indigent patients, including emergency medical screening and treatment requirements.
     The OIG and the U.S. Department of Justice have, from time to time, undertaken national enforcement initiatives that focus on specific billing practices or other suspected areas of abuse. Moreover, health care providers are subject to civil and criminal false claims laws, including the federal False Claims Act, which allows private parties to bring whistleblower lawsuits against private companies doing business with or receiving reimbursement under federal health care programs. Some states have adopted similar state whistleblower and false claims provisions. Publicity associated with the substantial amounts paid by other health care providers to settle these lawsuits may encourage our current and former employees and other health care providers to bring whistleblower lawsuits.
     In July 2008, we received a subpoena from the United States Department of Justice requesting certain information regarding one of our inpatient facilities in Chicago, Illinois. We have been cooperating, and will continue to cooperate, with the Department of Justice in connection with its investigation. A hold prohibiting admissions to this facility of patients in the custody of the Illinois Department of Children and Family Services remains in effect. We are uncertain when the hold will be removed. The outcome of the Department of Justice’s inquiry is uncertain, and adverse developments or outcomes can result in adverse publicity, significant expenses, monetary damages, penalties or injunctive relief against us that could significantly reduce our earnings and cash flows and harm our business.
The volatility and disruption of the capital and credit markets and adverse changes in the United States and global economies could impact our ability to access both available and affordable financing, and without such financing, we may be unable to achieve our objectives for strategic acquisitions and internal growth.
     The United States and global capital and credit markets have been experiencing extreme volatility and disruption at unprecedented levels. Significant declines in the United States housing market, including falling home prices, the increasing number of foreclosures and higher unemployment rates, have resulted in significant write-downs of asset values by financial institutions, including government-sponsored entities and major commercial and investment banks. These write-downs have caused many financial institutions to seek additional capital, to merge with larger and stronger institutions and, in some cases, to fail. Many lenders and institutional investors have reduced, and in some cases, ceased to provide funding to borrowers, including other financial institutions or have increased their rates significantly compared to the prior year.
     Our acquisition program requires capital resources. Likewise, the operation of existing inpatient facilities requires ongoing capital expenditures for renovation, expansion and the upgrade of equipment and technology. While we intend to finance strategic acquisitions and internal growth with cash flows from operations and borrowings under our revolving credit facility, we may require sources of capital in addition to those presently available to us. Due to the existing uncertainty in the capital and credit markets, as well as our level of indebtedness and restrictions set forth in our debt agreements, additional capital may not be available on terms acceptable to us or at all, and this may result in our inability to achieve objectives for strategic acquisitions and capital expenditures.

14


Table of Contents

Further, in the event we need additional funds, and we are unable to raise the necessary funds on acceptable terms, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected. If we are not able to obtain additional financing, then we may not be able to consummate acquisitions or undertake capital expenditures.
As a provider of health care services, we are subject to claims and legal actions by patients and others.
     We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. Facilities acquired by us may have unknown or contingent liabilities, including liabilities related to patient care and liabilities for failure to comply with health care laws and regulations, which could result in large claims and significant defense costs. Although we generally seek indemnification covering these matters from prior owners of facilities we acquire, material liabilities for past activities of acquired facilities may exist and such prior owners may not be able to satisfy their indemnification obligations. We are also susceptible to being named in claims brought related to patient care and other matters at inpatient facilities owned by third parties and managed by us.
     A stockholder lawsuit alleging violation of federal securities laws was filed during the third quarter of 2009. We believe the lawsuit is without merit and are defending it vigorously. We believe the ultimate outcome of the lawsuit will not have a material adverse effect on our results of operations, financial position or cash flows; however, there can be no assurance that an adverse determination will not have a material adverse effect on us.
     To protect ourselves from the cost of these claims, professional malpractice liability insurance and general liability insurance coverage is maintained in amounts and with self-insured retention common in the industry. We have professional and general liability insurance in umbrella form for claims in excess of a $3.0 million self-insured retention with an insured excess limit of $75.0 million for all of our inpatient facilities. The self-insured reserves for professional and general liability risks are calculated based on historical claims, demographic factors, industry trends, severity factors and other actuarial assumptions calculated by an independent third-party actuary. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates. There are no assurances that our insurance will cover all claims (e.g., claims for punitive damages) or that claims in excess of our insurance coverage will not arise. A successful lawsuit against us that is not covered by, or is in excess of, our insurance coverage may have a material adverse effect on our business, financial condition and results of operations. This insurance coverage may not continue to be available at a reasonable cost, especially given the significant increase in insurance premiums generally experienced in the health care industry.
We depend on our ability to attract and retain key management personnel.
     We are highly dependent on our senior management team, which has many years of experience addressing the broad range of concerns and issues relevant to our business. Our senior management team includes the talented managers of our divisions, who have extensive experience in all aspects of health care. The loss of key management or the inability to attract, retain and motivate sufficient numbers of qualified management personnel could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
The agreements governing our indebtedness contain various covenants that limit our discretion in the operation of our business and our failure to satisfy requirements in these agreements could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
     Our senior secured credit facilities and the indentures governing the 73/4% Senior Subordinated Notes due 2015 (the “73/4% Notes”) contain, among other things, covenants that may restrict our ability and our subsidiary guarantors’ ability to finance future operations or capital needs or to engage in other business activities. These debt instruments restrict, among other things, our ability and the ability of our subsidiaries to:
    incur additional indebtedness and issue preferred stock;
 
    redeem or repurchase stock, pay dividends or make other distributions;
 
    make certain restricted payments and investments;
 
    create liens;
 
    sell assets, including the capital stock of our restricted subsidiaries;
 
    merge or consolidate with other entities; and
 
    engage in transactions with affiliates.

15


Table of Contents

     In addition, our senior secured credit facilities require us to meet specified financial ratios and tests that may require that we take action to reduce our debt or act in a manner contrary to our business objectives. Events beyond our control, including changes in general business and economic conditions, may affect our ability to meet the specified financial ratios and tests. We cannot assure you that we will meet the specified ratios and tests or that the lenders under our senior secured credit facilities will waive any failure to meet the specified ratios or tests. A breach of any of these covenants would result in a default under our senior secured credit facilities and any resulting acceleration thereunder may result in a default under the indentures governing the 73/4% Notes. If an event of default under our senior secured credit facilities occurs, the lenders could elect to declare all amounts outstanding thereunder, together with accrued interest, to be immediately due and payable, and terminate their commitments to make further extensions of credit (including our ability to borrow under our revolving credit facility). Any breach or default under our debt agreements could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
Our substantial indebtedness could adversely affect our financial condition and our ability to fulfill other obligations.
     As of December 31, 2009, our total outstanding indebtedness was approximately $1.2 billion. Our indebtedness could have a material adverse effect on our business and consolidated financial position, results of operations and cash flows and impair our ability to fulfill other obligations in several ways, including:
    increasing our vulnerability to general adverse economic and industry conditions;
 
    requiring that a portion of our cash flow from operations be used for the payment of interest on our debt, thereby reducing our ability to use our cash flow to fund working capital, capital expenditures, acquisitions and general corporate requirements;
 
    limiting our ability to obtain additional financing to fund future capital expenditures, acquisitions, working capital and general corporate requirements; and
 
    placing us at a competitive disadvantage to our competitors that have less indebtedness.
     In the event we incur additional indebtedness, the risks described above could increase.
Acquired businesses expose us to increased operating risks.
     Acquisitions of inpatient facilities and other businesses may strain our resources, including management, information systems, regulatory compliance and other areas. Acquisitions expose us to additional business and operating risk and uncertainties, including:
    our ability to effectively manage the expanded activities;
 
    our ability to realize our investment in the increased number of inpatient facilities and other businesses;
 
    our exposure to unknown liabilities; and
 
    our ability to meet contractual obligations.
     If we are unable to manage the acquired businesses efficiently or effectively, or are unable to attract and retain additional qualified management personnel to run the expanded operations, it could have a material adverse effect on our business, financial condition and results of operations.
If we fail to integrate or improve, where necessary, the operations of existing and acquired inpatient facilities, we may be unable to achieve our growth strategy, which could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
     We may be unable to maintain or increase the profitability of, or operating cash flows at, existing behavioral health care facilities and acquired inpatient facilities, fully integrate the operations of an acquired facility or business in an efficient and cost-effective manner or otherwise achieve the intended benefit of our growth strategy. To the extent that we are unable to enroll in third party payor plans in a timely manner following an acquisition, we may experience a decrease in cash flow or profitability. The failure to effectively integrate any acquired businesses could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
     Hospital acquisitions generally require a longer period to complete than acquisitions in many other industries and are subject to additional regulatory uncertainty. Many states have adopted legislation regarding the sale or other disposition of facilities operated by not-for-profit entities. In other states that do not have specific legislation, the attorneys general have demonstrated an interest in these transactions under their general obligations to protect charitable assets from waste. These legislative and administrative efforts focus primarily on the appropriate valuation of the assets divested and the use of the proceeds of the sale by the non-profit seller. In addition, the acquisition of facilities in certain states requires advance regulatory approval under “certificate of need” or state licensure regulatory regimes. These state-level procedures could seriously delay or even prevent us from acquiring inpatient facilities, even after significant transaction costs have been incurred, and prevent us from achieving our growth strategy, which could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.

16


Table of Contents

We depend on our relationships with physicians and other health care professionals who provide services at our inpatient facilities.
     Our business depends upon the efforts and success of the physicians and other health care professionals who provide health care services at our inpatient facilities and the strength of the relationships with these physicians and other health care professionals.
     Our business and consolidated financial condition, results of operations and cash flows could be adversely affected if a significant number of physicians or a group of physicians:
    terminate their relationship with, or reduce their use of, our inpatient facilities;
 
    fail to maintain acceptable quality of care or to otherwise adhere to professional standards;
 
    suffer damage to their reputation; or
 
    exit the market entirely.
Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and stock price.
     Each year we are required to document and test our internal control procedures in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, which requires annual management assessments of the effectiveness of our internal controls over financial reporting and a report by our independent registered public accounting firm addressing the effectiveness of internal control over financial reporting. During the course of our annual testing we may identify deficiencies that we may not be able to remediate in time to meet the deadline imposed by the Sarbanes-Oxley Act for compliance with the requirements of Section 404. In addition, if we fail to maintain the adequacy of our internal controls, as such standards are modified, supplemented or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act. Failure to achieve and maintain an effective internal control environment could have a material adverse effect on our business and stock price.
We may be required to spend substantial amounts to comply with legislative and regulatory initiatives relating to privacy and security of patient health information and standards for electronic transactions.
     There are currently numerous legislative and regulatory initiatives at the federal and state levels addressing patient privacy and security concerns. In particular, federal regulations issued under HITECH require our facilities to comply with additional standards to protect the privacy, security and integrity of health care information. These regulations may require extensive administrative requirements, technical and physical information security requirements, restrictions on the use and disclosure of individually identifiable patient health and related financial information and have provided patients with additional rights with respect to their health information. Compliance with these regulations requires substantial expenditures, which could negatively impact our financial results. In addition, our management has spent, and may spend in the future, substantial time and effort on compliance measures.
Forward-Looking Statements
     This Annual Report on Form 10-K and other materials we have filed or may file with the Securities and Exchange Commission (the “SEC”), as well as information included in oral statements or other written statements made, or to be made, by our senior management, contain, or will contain, disclosures that are forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “intend,” “plan,” “estimate,” “project,” “continue,” “should” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties, including those set forth below, which could significantly affect our current plans and expectations and future financial condition and results.
     We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in our filings and reports.
     While it is not possible to identify all these factors, we continue to face many risks and uncertainties that could cause actual results to differ from those forward-looking statements, including:
    risks inherent to the health care industry, including the impact of unforeseen changes in regulation and the potential adverse impact of government investigations, liabilities and other claims asserted against us;
 
    uncertainty as to changes in U.S. general economic activity and the impact of these changes on our business;

17


Table of Contents

    economic downturn resulting in efforts by federal and state health care programs and managed care companies to reduce reimbursement rates for our services;
 
    health care reform proposals that, if adopted, could adversely impact reimbursement rates for our services;
 
    potential competition that alters or impedes our acquisition strategy by decreasing our ability to acquire additional inpatient facilities on favorable terms;
 
    our ability to comply with applicable licensure and accreditation requirements;
 
    our ability to comply with extensive laws and government regulations related to billing, physician relationships, adequacy of medical care and licensure;
 
    our ability to retain key employees who are instrumental to our operations;
 
    our ability to successfully integrate and improve the operations of acquired inpatient facilities;
 
    our ability to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act;
 
    our substantial indebtedness and adverse changes in credit markets impacting our ability to receive timely additional financing on terms acceptable to us to fund our acquisition strategy and capital expenditure needs;
 
    our ability to maintain favorable and continuing relationships with physicians and other health care professionals who use our inpatient facilities;
 
    our ability to ensure confidential information is not inappropriately disclosed and that we are in compliance with federal and state health information privacy standards;
 
    our ability to comply with federal and state governmental regulation covering health care-related products and services on-line, including the regulation of medical devices and the practice of medicine and pharmacology;
 
    our ability to obtain adequate levels of general and professional liability insurance;
 
    future trends for pricing, margins, revenue and profitability that remain difficult to predict in the industries that we serve;
 
    fluctuations in the market value of our common stock;
 
    negative press coverage of us or our industry that may affect public opinion; and
 
    those risks and uncertainties described from time to time in our filings with the SEC.
     We caution you that the factors listed above, as well as the risk factors included in this Annual Report on Form 10-K, may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict such new risk factors nor can we assess the impact, if any, of such new risk factors on our businesses or the extent to which any factor or combination of factors may cause actual results to differ materially from those expressed or implied by any forward-looking statements.
Item 1B.   Unresolved Staff Comments.
     We have no unresolved SEC staff comments.
Item 2.   Properties.
     We operate 94 owned or leased inpatient behavioral health care facilities with approximately 11,000 licensed beds in 32 states, Puerto Rico, and the U.S. Virgin Islands. The following table sets forth the name, location, number of licensed beds and the acquisition date for each of our owned and leased inpatient behavioral health care facilities.
                     
                    Date
Facility   Location   Beds   Own/Lease   Acquired/Opened
Cypress Creek Hospital
  Houston, TX     96     Own   9/01
West Oaks Hospital
  Houston, TX     160     Own   9/01
Texas NeuroRehab Center
  Austin, TX     151     Own   11/01
Holly Hill Hospital
  Raleigh, NC     152     Own   12/01
Riveredge Hospital
  Forest Park, IL     224     Own   7/02

18


Table of Contents

                     
                    Date
Facility   Location   Beds   Own/Lease   Acquired/Opened
Jefferson Trail Treatment Center for Children
  Charlottesville, VA     100     Lease   4/03
Cedar Springs Hospital
  Colorado Springs, CO     110     Own   4/03
Laurel Ridge Treatment Center
  San Antonio, TX     252     Own   4/03
San Marcos Treatment Center
  San Marcos, TX     265     Own   4/03
Shadow Mountain Behavioral Health System
  Tulsa, OK     209     Own   4/03
Laurel Oaks Behavioral Health Center
  Dothan, AL     115     Own   6/03
Hill Crest Behavioral Health Services
  Birmingham, AL     205     Own   6/03
Gulf Coast Treatment Center
  Fort Walton Beach, FL     168     Own   6/03
Manatee Palms Youth Services
  Bradenton, FL     60     Own   6/03
Havenwyck Hospital
  Auburn Hills, MI     184     Own   6/03
Heartland Behavioral Health Services
  Nevada, MO     159     Own   6/03
Brynn Marr Hospital
  Jacksonville, NC     88     Own   6/03
Benchmark Behavioral Health System
  Woods Cross, UT     151     Own   6/03
Macon Behavioral Health Treatment Center
  Macon, GA     155     Own   6/03
Manatee Adolescent Treatment Services
  Bradenton, FL     85     Own   6/03
Gulf Coast RTCs
  Crestview, FL     254†     Lease   6/03
Alliance Health Center
  Meridian, MS     194     Own   11/03
Calvary Center
  Phoenix, AZ     50     Lease   12/03
Brentwood Hospital
  Shreveport, LA     200     Own   3/04
Brentwood Behavioral Healthcare of Mississippi
  Flowood, MS     107     Own   3/04
Palmetto Lowcountry Behavioral Health
  North Charleston, SC     112     Own   5/04
Palmetto Pee Dee Behavioral Health
  Florence, SC     59     Own   5/04
Fort Lauderdale Hospital
  Fort Lauderdale, FL     100     Lease   6/04
Millwood Hospital
  Arlington, TX     120     Lease   6/04
Pride Institute
  Eden Prairie, MN     42     Own   6/04
Summit Oaks Hospital
  Summit, NJ     126     Own   6/04
North Spring Behavioral Healthcare
  Leesburg, VA     77     Own   6/04
Peak Behavioral Health Services
  Santa Teresa, NM     84     Own   6/04
Alhambra Hospital
  Rosemead, CA     97     Own   7/05
Belmont Pines Hospital
  Youngstown, OH     102     Own   7/05
Brooke Glen Behavioral Hospital
  Fort Washington, PA     146     Own   7/05
Columbus Behavioral Center
  Columbus, IN     61     Own   7/05
Cumberland Hospital
  New Kent, VA     136     Own   7/05
Fairfax Hospital
  Kirkland, WA     133     Own   7/05
Fox Run Hospital
  St. Clairsville, OH     100     Own   7/05
Fremont Hospital
  Fremont, CA     96     Own   7/05
Heritage Oaks Hospital
  Sacramento, CA     76     Own   7/05
Intermountain Hospital
  Boise, ID     125     Own   7/05
Meadows Hospital
  Bloomington, IN     78     Own   7/05
Mesilla Valley Hospital
  Las Cruces, NM     168     Own   7/05
Montevista Hospital
  Las Vegas, NV     101     Own   7/05
Pinnacle Pointe Hospital
  Little Rock, AR     124     Own   7/05
Sierra Vista Hospital
  Sacramento, CA     72     Own   7/05
Streamwood Behavioral Health
  Streamwood, IL     371     Own   7/05
Valle Vista Hospital
  Greenwood, IN     102     Own   7/05
West Hills Hospital
  Reno, NV     95     Own   7/05
Willow Springs Center
  Reno, NV     76     Own   7/05
Canyon Ridge Hospital
  Chino, CA     106     Own   8/05
Atlantic Shores Hospital
  Fort Lauderdale, FL     72     Own   1/06
Wellstone Regional Hospital
  Jeffersonville, IN     100     Own   1/06
Diamond Grove Center
  Louisville, MS     55     Own   5/06
Hickory Trail Hospital
  DeSoto, TX     86     Own   7/06
National Deaf Academy
  Mount Dora, FL     132     Own   7/06
Windmoor Healthcare
  Clearwater, FL     100     Own   9/06
University Behavioral Center
  Orlando, FL     104     Own   9/06
Sandy Pines Hospital
  Tequesta, FL     80     Own   9/06
Cumberland Hall
  Hopkinsville, KY     64     Own   12/06
Panamericano
  Cidra, Puerto Rico     240     Own   12/06
The Pines Residential Treatment Center
  Portsmouth, VA     424     Own   12/06

19


Table of Contents

                     
                    Date
Facility   Location   Beds   Own/Lease   Acquired/Opened
Palmetto Summerville
  Summerville, SC     60     Lease   12/06
Three Rivers Residential Treatment — Midlands Campus
  West Columbia, SC     59     Own   12/06
Virgin Islands Behavioral Services
  St. Croix, U.S. Virgin Islands     30     Own   12/06
Virginia Beach Psychiatric Center
  Virginia Beach, VA     100     Own   12/06
Three Rivers Behavioral Health
  West Columbia, SC     118     Own   01/07
Copper Hills Youth Center
  West Jordan, UT     153     Own   05/07
MeadowWood Behavioral Health System
  New Castle, DE     58     Own   05/07
High Point Treatment Center
  Cooper City, FL     68     Own   05/07
Focus by the Sea
  St. Simons, GA     101     Own   05/07
Arrowhead Behavioral Health
  Maumee, OH     42     Own   05/07
Friends Hospital
  Philadelphia, PA     219     Own   05/07
Kingwood Pines Hospital
  Kingwood, TX     78     Own   05/07
Windsor-Laurelwood Center
  Willoughby, OH     160     Lease   05/07
Lighthouse Care Center of Augusta
  Augusta, GA     106     Own   05/07
Lighthouse Care Center of Conway
  Conway, SC     108     Own   05/07
Michiana Behavioral Health Center
  Plymouth, IN     80     Own   05/07
Poplar Springs Hospital
  Petersburg, VA     199     Own   05/07
River Park Hospital
  Huntington, WV     187     Own   05/07
Lighthouse Care Center of Berkley
  Summerville, SC     *     Own   05/07
Austin Lakes Hospital
  Austin, TX     48     Lease   08/07
The Hughes Center for Exceptional Children
  Danville, VA     56     Own   09/07
The Brook — Dupont
  Louisville, KY     66     Own   03/08
River Point Behavioral Health
  Jacksonville, FL     99     Own   03/08
The Brook — KMI
  Louisville, KY     106     Own   03/08
The Vines
  Ocala, FL     88     Own   03/08
Wekiva Springs
  Jacksonville, FL     68     Own   03/08
Lincoln Prairie Behavioral Health Center
  Springfield, IL     80     Own   05/08
Rolling Hills Hospital
  Franklin, TN     80     Own   01/09
Prairie St. John’s
  Fargo, ND     131     Own   09/09
Emerald Coast Behavioral Hospital
  Panama City, FL     90     Own   09/09
 
*   We acquired a non-operating facility, Lighthouse Berkley, in the acquisition of Horizon Health. Currently no patients are being served at this facility.
 
  Operated beds.
     In addition, our principal executive offices are located in approximately 65,000 square feet of leased space in Franklin, Tennessee. We do not anticipate that we will experience any difficulty in renewing our lease upon its expiration in February 2012, or obtaining different space on comparable terms if such lease is not renewed. We believe our executive offices and our hospital properties and equipment are generally well maintained, in good operating condition and adequate for our present needs.
Item 3.   Legal Proceedings.
     A stockholder lawsuit alleging violations of federal securities laws was filed during the third quarter of 2009. We believe the lawsuit is without merit and are defending it vigorously.
     We are subject to various claims and legal actions that arise in the ordinary course of our business. In the opinion of management, we are not currently a party to any proceeding that would have a material adverse effect on our financial condition or results of operations.
Item 4.   Submission of Matters to a Vote of Security Holders.
     None.

20


Table of Contents

PART II
Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
     Our common stock trades on The NASDAQ Global Select Market under the symbol “PSYS”. The table below sets forth, for the calendar quarters indicated, the high and low sales prices per share for our common stock as reported on The NASDAQ Global Select Market.
                 
    High   Low
2008
               
First Quarter
  $ 34.31     $ 27.17  
Second Quarter
  $ 39.62     $ 30.45  
Third Quarter
  $ 40.90     $ 32.89  
Fourth Quarter
  $ 39.00     $ 22.86  
 
               
2009
               
First Quarter
  $ 28.74     $ 12.49  
Second Quarter
  $ 23.25     $ 13.03  
Third Quarter
  $ 30.14     $ 20.98  
Fourth Quarter
  $ 27.99     $ 17.63  
     At the close of business on February 22, 2009, there were approximately 191 holders of record of our common stock.
     We currently intend to retain future earnings for use in the expansion and operation of our business. Our Credit Agreement, as amended, prohibits us from paying dividends on our common stock. Also, the indenture governing our 73/4% Notes provides certain financial conditions that must be met in order for us to pay dividends. Subject to the terms of applicable contracts, the payment of any future cash dividends will be determined by our Board of Directors in light of conditions then-existing, including our earnings, financial condition and capital requirements, restrictions in financing agreements, business opportunities and conditions, and other factors.
     Item 6. Selected Financial Data.
     The selected financial data presented below for the years ended December 31, 2009, 2008 and 2007, and at December 31, 2009 and 2008, are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. The selected financial data for the years ended December 31, 2006 and 2005, and at December 31, 2007, 2006 and 2005, are derived from our audited consolidated financial statements not included herein. The audited consolidated financial statements for the years ended December 31, 2006 and 2005 and at December 31, 2007, 2006 and 2005 have been reclassified for discontinued operations. The selected financial data presented below should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and with our consolidated financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K.

21


Table of Contents

Psychiatric Solutions, Inc.
Selected Financial Data
As of and for the Years Ended December 31,
                                         
    2009     2008     2007     2006     2005  
    (In thousands, except per share amounts and operating data)  
Income Statement Data:
                                       
Revenue
  $ 1,805,361     $ 1,696,116     $ 1,414,700     $ 991,724     $ 689,408  
Costs and expenses:
                                       
Salaries, wages and employee benefits
    1,005,204       938,363       787,301       559,715       377,762  
Other operating expenses
    452,356       438,499       365,258       255,206       193,851  
Provision for doubtful accounts
    36,414       34,334       27,343       19,364       13,678  
Depreciation and amortization
    44,778       38,843       30,113       20,001       14,335  
Interest expense
    71,549       75,982       73,887       39,967       26,169  
Other expenses
                8,179             21,871  
 
                             
Total costs and expenses
    1,610,301       1,526,021       1,292,081       894,253       647,666  
 
                             
Income from continuing operations before income taxes
    195,060       170,095       122,619       97,471       41,742  
Provision for income taxes
    74,889       64,457       46,200       36,785       16,080  
 
                             
Income from continuing operations
  $ 120,171     $ 105,638     $ 76,419     $ 60,686     $ 25,662  
 
                             
Net income attributable to PSI stockholders
  $ 117,617     $ 104,953     $ 76,208     $ 60,632     $ 27,154  
 
                             
Basic earnings per share from continuing operations attributable to PSI stockholders
  $ 2.16     $ 1.89     $ 1.40     $ 1.15     $ 0.57  
 
                             
Basic earnings per share attributable to PSI stockholders
  $ 2.12     $ 1.89     $ 1.40     $ 1.15     $ 0.61  
 
                             
Shares used in computing basic earnings per share
    55,564       55,408       54,258       52,953       44,792  
Diluted earnings per share from continuing operations attributable to PSI stockholders
  $ 2.14     $ 1.87     $ 1.37     $ 1.12     $ 0.55  
 
                             
Diluted earnings per share attributable to PSI stockholders
  $ 2.10     $ 1.87     $ 1.37     $ 1.12     $ 0.59  
 
                             
Shares used in computing diluted earnings per share
    56,116       56,267       55,447       54,169       46,296  
 
                                       
Balance Sheet Data:
                                       
Cash
  $ 6,815     $ 51,271     $ 39,970     $ 18,520     $ 54,533  
Working capital
    177,918       233,906       161,681       103,287       138,843  
Property and equipment, net
    931,730       820,453       678,012       529,658       368,977  
Total assets
    2,507,240       2,505,990       2,179,505       1,581,746       1,176,131  
Total debt
    1,187,079       1,314,397       1,172,024       743,307       482,389  
Stockholders’ equity
    1,030,335       889,885       754,742       627,779       539,712  
 
                                       
Operating Data:
                                       
Number of facilities at period end
    94       91       86       70       55  
Number of licensed beds
    11,290       10,520       9,931       8,114       6,396  
Admissions
    177,967       163,616       138,454       106,451       76,795  
Patient days
    2,881,063       2,749,658       2,406,368       1,875,635       1,413,231  
Average length of stay
    16       17       17       18       18  

22


Table of Contents

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
     The following discussion and analysis should be read in conjunction with the selected financial data and the accompanying consolidated financial statements and related notes thereto included in this Annual Report on Form 10-K.
Overview
     Our business strategy is to acquire inpatient behavioral health care facilities and improve operating results within our inpatient facilities and our other behavioral health care operations. From 2001 to 2004, we acquired 34 inpatient behavioral health care facilities. During 2005, we acquired 20 inpatient behavioral health care facilities in the acquisition of Ardent Health Services, Inc. and one other inpatient facility. During 2006, we acquired 19 inpatient behavioral health care facilities, including nine inpatient facilities with the acquisition of the capital stock of Alternative Behavioral Services, Inc. on December 1, 2006. During 2007, we acquired 16 inpatient behavioral health care facilities, including 15 inpatient facilities in the acquisition of Horizon Health Corporation (“Horizon Health”). During 2008, we acquired five inpatient behavioral health care facilities from United Medical Corporation (“UMC”) and opened Lincoln Prairie Behavioral Health Center, an 80-bed inpatient facility in Springfield, Illinois. During 2009, we opened Rolling Hills Hospital, an 80-bed inpatient facility in Franklin, Tennessee, acquired two inpatient behavioral health care facilities, and completed the sale of our EAP business.
     We strive to improve the operating results of our inpatient behavioral health care operations by providing the highest quality service, expanding referral networks and marketing initiatives and meeting increased demand for behavioral health care services by expanding our services and developing new services. We also attempt to improve operating results by maintaining appropriate staffing ratios, controlling contract labor costs and reducing supply costs through group purchasing. Our same-facility revenue from owned and leased inpatient facilities increased 5.3% for the year ended December 31, 2009 compared to the year ended December 31, 2008, primarily as a result of increases in same-facility patient days and same-facility revenue per patient day. Same-facility patient days increased 3.5% and same-facility revenue per patient day increased 1.8% in 2009 compared to 2008. Same-facility growth refers to the comparison of each inpatient facility owned during 2008 with the comparable period in 2009, adjusted for closures and combinations for comparability purposes.
     Income from continuing operations before income taxes increased to $195.1 million, or 10.8% of revenue, for the year ended December 31, 2009 compared to $170.1 million, or 10.0% of revenue, for the same period of 2008. This increase in income from continuing operations before income taxes for the year ended December 31, 2009 compared to the same period of 2008 was primarily the result of same-facility revenue growth at our behavioral health care facilities of 5.3% for 2009 as compared to 2008 and a reduction in interest expense as a percentage of revenue to 4.0% in 2009 compared to 4.5% in 2008.
Sources of Revenue
Patient Service Revenue
     Patient service revenue is generated by our inpatient facilities for services provided to patients on an inpatient and outpatient basis within the inpatient behavioral health care facility setting. Patient service revenue is recorded at our established billing rates less contractual adjustments. Contractual adjustments are recorded to state our patient service revenue at the amount we expect to collect for the services provided based on amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas or amounts due from other third-party payors at contractually determined rates. Patient service revenue comprised approximately 93.0% of our total revenue in 2009.
Other Revenue
     Other behavioral health care services accounted for 7.0% of our revenue for the year ended December 31, 2009. This portion of our business primarily consists of our contract management business and a managed care plan in Puerto Rico. Our contract management business involves the development, organization and management of behavioral health and rehabilitation programs within medical/surgical hospitals. Services provided are recorded as revenue at contractually determined rates in the period the services are rendered, provided that collectability of such amounts is reasonably assured.
Results of Operations
     The following table illustrates our consolidated results of operations from continuing operations for the years ended December 31, 2009, 2008 and 2007 (dollars in thousands):

23


Table of Contents

                                                 
    Results of Operations, Consolidated Psychiatric Solutions  
    For the Year Ended December 31,  
    2009     2008     2007  
    Amount     %     Amount     %     Amount     %  
Revenue
  $ 1,805,361       100.0 %   $ 1,696,116       100.0 %   $ 1,414,700       100.0 %
Salaries, wages, and employee benefits (including share-based compensation of $17,505, $19,913 and $16,104 in 2009, 2008 and 2007, respectively)
    1,005,204       55.7 %     938,363       55.3 %     787,301       55.7 %
Professional fees
    166,785       9.2 %     162,491       9.6 %     135,803       9.6 %
Supplies
    92,572       5.1 %     92,393       5.5 %     77,738       5.5 %
Provision for doubtful accounts
    36,414       2.0 %     34,334       2.0 %     27,343       1.9 %
Other operating expenses
    192,999       10.7 %     183,615       10.8 %     151,717       10.7 %
Depreciation and amortization
    44,778       2.5 %     38,843       2.3 %     30,113       2.1 %
Interest expense, net
    71,549       4.0 %     75,982       4.5 %     73,887       5.2 %
Other expenses:
                                               
Loss on refinancing long-term debt
          0.0 %           0.0 %     8,179       0.6 %
 
                                   
Income from continuing operations before income taxes
    195,060       10.8 %     170,095       10.0 %     122,619       8.7 %
Provision for income taxes
    74,889       4.1 %     64,457       3.8 %     46,200       3.3 %
 
                                   
Income from continuing operations
    120,171       6.7 %     105,638       6.2 %     76,419       5.4 %
Less: Net income attributable to noncontrolling interest
    (93 )     0.0 %     (604 )     0.0 %     (285 )     0.0 %
 
                                   
Income from continuing operations attributable to PSI stockholders
  $ 120,078       6.7 %   $ 105,034       6.2 %   $ 76,134       5.4 %
 
                                   
Year Ended December 31, 2009 Compared To Year Ended December 31, 2008
     The following table compares key total facility statistics and same-facility statistics for 2009 and 2008 for owned and leased inpatient facilities:
                         
    Year Ended December 31,   %
    2009   2008   Change
Total facility results:
                       
Revenue (in thousands)
  $ 1,678,449     $ 1,571,141       6.8 %
Number of facilities at period end
    94       91       3.3 %
Admissions
    177,967       163,616       8.8 %
Patient days
    2,881,063       2,749,658       4.8 %
Average length of stay
    16.2       16.8       -3.6 %
Revenue per patient day
  $ 583     $ 571       2.1 %
 
                       
Same-facility results:
                       
Revenue (in thousands)
  $ 1,654,258     $ 1,571,141       5.3 %
Number of facilities at period end
    91       91       0.0 %
Admissions
    174,874       163,616       6.9 %
Patient days
    2,845,536       2,749,658       3.5 %
Average length of stay
    16.3       16.8       -3.0 %
Revenue per patient day
  $ 581     $ 571       1.8 %
     Revenue. Revenue from continuing operations increased $109.2 million, or 6.4%, to $1.8 billion for the year ended December 31, 2009 compared to the year ended December 31, 2008. Revenue from owned and leased inpatient facilities increased $107.3 million, or 6.8%, to $1.7 billion in 2009 compared to 2008. The increase in revenue from owned and leased inpatient facilities relates primarily to same-facility growth in patient days of 3.5% and revenue per patient day of 1.8%. Other revenue was $126.9 million in 2009 compared to $125.0 million in 2008.
     Salaries, wages, and employee benefits. Salaries, wages and employee benefits (“SWB”) expense was $1.0 billion in 2009 compared to $938.4 million in 2008, an increase of $66.8 million, or 7.1%. SWB expense includes $17.5 million and $19.9 million of shared-based compensation expense for the years ended December 31, 2009 and 2008, respectively. Based on our stock option and

24


Table of Contents

restricted stock grants outstanding at December 31, 2009, we estimate remaining unrecognized share-based compensation expense to be approximately $31.3 million with a weighted-average remaining amortization period of 2.1 years. Excluding share-based compensation expense, SWB expense was $987.7 million, or 54.7% of total revenue, in 2009 compared to $918.5 million, or 54.2% of total revenue, in 2008. SWB expense for owned and leased inpatient facilities was $905.5 million in 2009, or 53.9% of revenue. Same-facility SWB expense for owned and leased inpatient facilities was $891.9 million in 2009, or 53.9% of revenue, compared to $842.5 million in 2008, or 53.6% of revenue. This increase in same-facility SWB expense for owned and leased inpatient facilities is primarily the result of a shift from utilization of contract labor included in professional fees to the utilization of employees and an increase in health insurance claims for health insurance coverage for our employees and their dependents. SWB expense for other operations was $48.5 million in 2009 compared to $49.0 million in 2008. SWB expense for our corporate office was $51.2 million, including $17.5 million in share-based compensation, for 2009 compared to $46.4 million, including $19.9 million in share-based compensation, for 2008. This increase in SWB for our corporate office primarily relates to the increase in corporate employees to support our operations and an increase in incentive compensation expense.
     Professional fees. Professional fees were $166.8 million in 2009, or 9.2% of total revenue, compared to $162.5 million in 2008, or 9.6% of total revenue. Professional fees for owned and leased inpatient facilities were $150.3 million in 2009, or 9.0% of revenue. Same-facility professional fees for owned and leased inpatient facilities were $148.3 million in 2009, or 9.0% of revenue, compared to $142.9 million in 2008, or 9.1% of revenue. Professional fees for other operations and our corporate office decreased to $16.5 million in 2009 compared to $19.5 million in 2008.
     Supplies. Supplies expense was $92.6 million in 2009, or 5.1% of total revenue, compared to $92.4 million in 2008, or 5.5% of total revenue. Supplies expense for owned and leased inpatient facilities was $91.9 million in 2009, or 5.5% of revenue. Same-facility supplies expense for owned and leased inpatient facilities was $90.6 million in 2009, or 5.5% of revenue, compared to $91.6 million in 2008, or 5.8% of revenue.
     Provision for doubtful accounts. The provision for doubtful accounts was $36.4 million in 2009, or 2.0% of total revenue, compared to $34.3 million in 2008, or 2.0% of total revenue. The provision for doubtful accounts at owned and leased inpatient facilities comprised substantially all of our provision for doubtful accounts.
     Other operating expenses. Other operating expenses consist primarily of rent, utilities, insurance, travel, and repairs and maintenance expenses. Other operating expenses were $193.0 million in 2009, or 10.7% of total revenue, compared to $183.6 million in 2008, or 10.8% of total revenue. Other operating expenses for owned and leased inpatient facilities were $133.4 million in 2009, or 7.9% of revenue. Same-facility other operating expenses for owned and leased inpatient facilities were $131.7 million in 2009, or 8.0% of revenue, compared to $131.8 million in 2008, or 8.4% of revenue. This decrease in other operating expenses as a percent of revenue is primarily a result of a normalization of professional and general liability reserve activity compared with 2008. Other operating expenses for other operations and our corporate office increased to $59.6 million in 2009 compared to $51.6 million in 2008. This increase in other operating expenses for other operations and our corporate office was primarily the result of claims expense from a new at-risk contract within our managed care plan in Puerto Rico.
     Depreciation and amortization. Depreciation and amortization expense increased to $44.8 million in 2009 compared to $38.8 million in 2008, primarily as a result of depreciation on expansion projects at existing inpatient facilities and facilities acquired/opened in 2008 and 2009.
     Interest expense, net. Interest expense, net of interest income, decreased to $71.5 million in 2009 compared to $76.0 million in 2008 primarily as a result of a reduction in interest rates on our variable rate debt.
     Income attributable to noncontrolling interest. We own controlling interests in two joint ventures that own two of our inpatient behavioral health care facilities. Income attributable to noncontrolling interest represents the pro rata portion of each joint venture’s net profit belonging to the noncontrolling partner.
     Loss from discontinued operations, net of taxes. The loss from discontinued operations, net of income tax effect, was $2.5 million for the year ended December 31, 2009 compared to $81,000 for the year ended December 31, 2008. During 2009, we completed the sale of our EAP business, elected to close and make The Oaks Treatment Center and Cumberland Hall of Chattanooga available for sale, and terminated one contract with a South Carolina juvenile justice agency. We also elected to close and make Nashville Rehabilitation Hospital available for sale and transferred its behavioral health services to Rolling Hills Hospital in the first quarter of 2009. During the year ended December 31, 2008, we elected to dispose of a leased inpatient facility and terminate two contracts with a Puerto Rican juvenile justice agency to manage inpatient facilities. Accordingly, these operations are included in discontinued operations.
Year Ended December 31, 2008 Compared To Year Ended December 31, 2007
     The following table compares key total facility statistics and same-facility statistics for 2008 and 2007 for owned and leased inpatient facilities.

25


Table of Contents

                         
    Year Ended December 31,     %  
    2008     2007     Change  
Total facility results:
                       
Revenue (in thousands)
  $ 1,571,141     $ 1,314,203       19.6 %
Number of facilities at period end
    91       86       5.8 %
Admissions
    163,616       138,454       18.2 %
Patient days
    2,749,658       2,406,368       14.3 %
Average length of stay
    16.8       17.4       -3.4 %
Revenue per patient day
  $ 571     $ 546       4.6 %
 
                       
Same-facility results:
                       
Revenue (in thousands)
  $ 1,419,904     $ 1,309,453       8.4 %
Number of facilities at period end
    86       86       0.0 %
Admissions
    144,563       137,830       4.9 %
Patient days
    2,472,292       2,399,812       3.0 %
Average length of stay
    17.1       17.4       -1.7 %
Revenue per patient day
  $ 574     $ 546       5.1 %
     Revenue. Revenue from continuing operations increased $281.4 million, or 19.9%, to $1.7 billion for the year ended December 31, 2008 compared to the year ended December 31, 2007. Revenue from owned and leased inpatient facilities increased $256.9 million, or 19.6%, to $1.6 billion in 2008 compared to 2007. The increase in revenue from owned and leased inpatient facilities relates primarily to the acquisitions of Horizon Health in 2007 and five inpatient facilities from UMC in 2008. The remainder of the increase in revenue from owned and leased inpatient facilities is primarily attributable to same-facility growth in patient days of 3.0% and revenue per patient day of 5.1%. Other revenue was $125.0 million in 2008 compared to $100.5 million in 2007, an increase of $24.5 million, resulting primarily from the management contract business purchased in the Horizon Health acquisition.
     Salaries, wages, and employee benefits. SWB expense was $938.4 million in 2008 compared to $787.3 million in 2007, an increase of $151.1 million, or 19.2%. SWB expense includes $19.9 million and $16.1 million of shared-based compensation expense for the years ended December 31, 2008 and 2007, respectively. Excluding share-based compensation expense, SWB expense was $918.5 million, or 54.2% of total revenue, in 2008 compared to $771.2 million, or 54.5% of total revenue, in 2007. SWB expense for owned and leased inpatient facilities was $843.0 million in 2008, or 53.7% of revenue. Same-facility SWB expense for owned and leased inpatient facilities was $759.3 million in 2008, or 53.5% of revenue, compared to $707.3 million in 2007, or 54.0% of revenue. SWB expense for other operations increased to $49.0 million in 2008 compared to $35.1 million in 2007, primarily as a result of the management contract business purchased in the Horizon Health acquisition. SWB expense for our corporate office was $46.4 million, including $19.9 million in share-based compensation, for 2008 compared to $41.5 million, including $16.1 million in share-based compensation, for 2007.
     Professional fees. Professional fees were $162.5 million in 2008, or 9.6% of total revenue, compared to $135.8 million in 2007, or 9.6% of total revenue. Professional fees for owned and leased inpatient facilities were $143.0 million in 2008, or 9.1% of revenue. Same-facility professional fees for owned and leased inpatient facilities were $128.2 million in 2008, or 9.0% of revenue, compared to $120.8 million in 2007, or 9.2% of revenue. Professional fees for other operations and our corporate office increased to $19.5 million in 2008 compared to $14.2 million in 2007, primarily due to the other operations acquired in the Horizon Health acquisition.
     Supplies. Supplies expense was $92.4 million in 2008, or 5.5% of total revenue, compared to $77.7 million in 2007, or 5.5% of total revenue. Supplies expense for owned and leased inpatient facilities was $91.6 million in 2008, or 5.8% of revenue. Same-facility supplies expense for owned and leased inpatient facilities was $81.2 million in 2008, or 5.7% of revenue, compared to $76.7 million in 2007, or 5.9% of revenue. Supplies expense for other operations as well as our corporate office consisted primarily of office supplies and is negligible to our supplies expense overall.
     Provision for doubtful accounts. The provision for doubtful accounts was $34.3 million in 2008, or 2.0% of total revenue, compared to $27.3 million in 2007, or 1.9% of total revenue. The provision for doubtful accounts at owned and leased inpatient facilities comprised substantially all of our provision for doubtful accounts.
     Other operating expenses. Other operating expenses consist primarily of rent, utilities, insurance, travel, and repairs and maintenance expenses. Other operating expenses were $183.6 million in 2008, or 10.8% of total revenue, compared to $151.7 million in 2007, or 10.7% of total revenue. Other operating expenses for owned and leased inpatient facilities were $132.0 million in 2008, or 8.4% of revenue. Same-facility other operating expenses for owned and leased inpatient facilities were $118.2 million in 2008, or 8.3% of revenue, compared to $104.3 million in 2007, or 8.0% of revenue. The increase in same-facility other operating expenses for owned and leased inpatient facilities was primarily the result of an increase in our self-insured reserves for professional and general liability risks, which is primarily due to the revised assessment of certain claims at amounts higher than originally anticipated and the

26


Table of Contents

actuarial implications of such revisions. Other operating expenses for other operations and our corporate office increased to $51.6 million in 2008 compared to $46.3 million in 2007, primarily due to the management contract business purchased in the Horizon Health acquisition.
     Depreciation and amortization. Depreciation and amortization expense increased to $38.8 million in 2008 compared to $30.1 million in 2007, primarily as a result of the acquisitions of inpatient facilities and capital expenditures during 2007 and 2008.
     Interest expense, net. Interest expense, net of interest income, increased to $76.0 million in 2008 compared to $73.9 million in 2007 primarily as a result of an increase in our long-term debt offset by a reduction in our overall effective interest rate. We borrowed $443.2 million in May 2007 to finance the Horizon Health acquisition and borrowed $149.3 million in 2008 to finance the acquisition of five inpatient behavioral health care facilities from UMC, acquisitions of EAP businesses that were later moved to discontinued operations, capital expenditures and other general corporate purposes. In February 2009, as part of an amendment to our revolving credit facility, the interest rate margins on borrowings based on LIBOR were increased to a range of 5.0% to 5.75% depending upon a certain leverage ratio. This interest rate margin was 1.5% at December 31, 2008. For further information on the February 2009 amendment to our revolving credit facility, see Liquidity and Capital Resources within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.
     Income attributable to noncontrolling interest. During 2008 and 2007, we owned a controlling interest in a joint venture that owned one of our inpatient behavioral health care facilities. Income attributable to noncontrolling interest represents the pro rata portion of each joint venture’s net profit belonging to the noncontrolling partner.
     Loss on refinancing of long-term debt. During 2007 we incurred a loss on refinancing long-term debt of $8.2 million that consisted primarily of the amount above par value we paid to repurchase our 105/8% Senior Subordinated Notes due 2013 (“105/8 Notes”), the write-off of capitalized financing costs associated with our 105/8% Notes and the amount paid to exit the related interest rate swap agreements.
     (Loss) income from discontinued operations, net of taxes. The loss from discontinued operations, net of income tax effect, was $81,000 for the year ended December 31, 2008 compared to income from discontinued operations, net of income tax effect, of $74,000 for the year ended December 31, 2007. During 2009, we completed the sale of our EAP business, elected to close and make The Oaks Treatment Center and Cumberland Hall of Chattanooga available for sale, and terminated one contract with a South Carolina juvenile justice agency. We also elected to close and make Nashville Rehabilitation Hospital available for sale. During the year ended December 31, 2008, we elected to dispose of a leased inpatient facility and recorded a $1.9 million write-down to fair value of the assets held-for-sale for this facility. Additionally, two contracts with a Puerto Rican juvenile justice agency to manage inpatient facilities were terminated in 2008. During the year ended December 31, 2007, we elected to dispose of one inpatient facility. Accordingly these operations are included in discontinued operations.
Liquidity and Capital Resources
     We currently have $295.7 million available for borrowings under our $300 million revolving credit facility. Additionally, our cash flow from continuing operating activities was $205.4 million for the year ended December 31, 2009 and we had $177.9 million of working capital at December 31, 2009. We believe that our cash flow from operations, revolving credit facility availability and working capital are sufficient to fund our known future cash requirements for operations and capital expenditures. We historically spend approximately 2% to 3% of our revenue on routine capital expenditures and currently have plans for construction projects with expected costs of approximately $57 million over the next year, which will add approximately 300 new beds to our inpatient facilities.
     As part of our long-term growth strategy we are actively seeking acquisitions that fit our corporate growth strategy and may acquire additional inpatient behavioral health care facilities and other operations as well as incur expenditures for the expansion of our inpatient facilities. Management continually assesses our capital needs and, should the need arise, we will seek additional financing, including debt or equity, to fund potential acquisitions, facility expansions, repayment of indebtedness or for other corporate purposes. In negotiating such financing, there can be no assurance that we will be able to raise additional capital on terms satisfactory to us. Failure to obtain additional financing on reasonable terms could have a negative effect on our plans to acquire additional inpatient psychiatric facilities or expand our facilities.
     Working capital at December 31, 2009 was $177.9 million, including cash and cash equivalents of $6.8 million, compared to working capital of $233.9 million, including cash and cash equivalents of $51.3 million, at December 31, 2008. The $44.5 million decrease in cash and cash equivalents is primarily a result of principal payments in excess of borrowings to reduce debt by $127.9 million, cash used for acquisitions of $32.9 million and capital expenditures of $150.0 million, offset by cash provided by continuing operations of $205.4 million and cash received on the sale of our EAP business of $68.5 million, net of fees and expenses. The net reduction in debt included a $229.3 million reduction in our revolving credit facility such that there was no balance outstanding at December 31, 2009, thereby increasing our borrowing availability to $295.7 million from $63.9 million at December 31, 2008.
     Working capital includes net current assets held for sale of discontinued operations totaling $19.3 million and $72.3 million at December 31, 2009 and 2008, respectively. At December 31, 2008, the net current assets held for sale included assets and liabilities of

27


Table of Contents

our EAP business that was sold in the fourth quarter of 2009 for approximately $68.5 million, net of fees and expenses. Excluding net current assets held for sale of discontinued operations, working capital was $158.6 million and $161.6 million at December 31, 2009 and 2008, respectively. This change in working capital is primarily attributable to increases in accounts receivable of $8.0 million and decreases in other accrued liabilities of $19.0 million to purchase a hospital building previously leased and current maturities under our revolving credit facility of $29.3 million, offset by decreases in cash of $44.5 million, income tax receivable of $6.3 million and deferred tax assets of $4.5 million, and an increase in accrued interest expense of $4.8 million.
     Cash provided by continuing operating activities was $205.4 million in 2009 compared to $139.3 million in 2008. The increase in cash flows from continuing operating activities was primarily the result of cash provided by improved operating results, improved collections on accounts receivable and a reduction in payments for income taxes and interest. Income tax payments decreased to $49.9 million in 2009 compared to $68.1 million in 2008, primarily as a result of applying income tax overpayments for 2008 to income taxes due for 2009. Interest payments decreased to $62.0 million in 2009 compared to $79.8 million in 2008, primarily due to decreasing interest rates on our variable rate debt and timing of interest payments. During 2009, the balance of accounts receivable increased $3.9 million, net of acquisitions, compared to an increase of $17.8 million, net of acquisitions, during 2008, primarily as a result of improved collections on our accounts receivables. The increase in the balance of accounts receivable, net of acquisitions, during 2008 was primarily the result of post-acquisition receivables generated in 2008 from the five facilities acquired from UMC in March 2008, for which no accounts receivable were purchased. Our consolidated days sales outstanding were 49 and 52 at December 31, 2009 and 2008, respectively.
     Billings for patient accounts receivable are generally submitted to the payor within three days of the patient’s discharge or completion of services. Interim billings may be utilized for patients with extended lengths of stay. We verify within a reasonable period of time that claims submitted to third-party payors have been received and are being processed by such payors. Follow-up regarding the status of each claim is made on a periodic basis until payment on the claim is received. Billing notices for self-pay accounts receivable are distributed on a periodic basis. Self-pay accounts receivable are turned over to collection agencies once internal collection efforts have been exhausted. Accounts receivable under our inpatient management contracts are billed at least monthly. Follow-up collection efforts are made on a periodic basis until payment is received. Our allowance for doubtful accounts for patient receivables primarily consists of patient accounts that are greater than 180 days past the patient’s discharge date. Our allowance for doubtful accounts for receivables due under our inpatient management contracts primarily consists of amounts that are specifically identified as potential collection issues. Accounts receivable are not written off until collection within a reasonable period of time is deemed unlikely.
     Cash used by continuing investing activities was $181.7 million in 2009 compared to $244.4 million in 2008. Cash used in investing activities in 2009 primarily consisted of $130.7 million paid for purchases of fixed assets, $32.9 million paid for acquisitions and $19.3 million paid for the acquisition of the real estate of previously leased facilities. Cash used for routine and expansion capital expenditures was approximately $53.3 million and $77.4 million, respectively, for the year ended December 31, 2009. We expect expansion expenditures to continue during 2010 as a result of planned capital expansion projects and the construction of new facilities, which are expected to add approximately 300 new beds to our inpatient facilities. We define expansion capital expenditures as those that increase the capacity of our facilities or otherwise enhance revenue. Routine or maintenance capital expenditures were 3.0% of our net revenue for 2009. Cash provided by discontinued investing activities in 2009 primarily consisted of $68.5 million in proceeds from the sale of our EAP business, net of fees and expenses. Cash used in continuing investing activities in 2008 consisted primarily of $121.2 million in cash paid for acquisitions and $121.9 million paid for purchases of fixed assets. Acquisitions in 2008 consisted primarily of five inpatient behavioral health care facilities acquired from UMC. Cash used in discontinued investing activities in 2008 consisted primarily of cash paid for acquisitions of EAP businesses.
     Cash used in financing activities was $136.8 million in 2009 compared to cash provided by financing activities of $155.7 million in 2008. Cash used in financing activities for 2009 consisted primarily of $229.3 million of net payments on our revolving credit facility, $9.9 million paid for loan and issuance costs and $5.1 million principal payments on long-term debt, offset by $106.5 million received from the issuance of $120 million of our 73/4% Notes at a discount of 11.25%. Cash provided by financing activities in 2008 primarily resulted from $149.3 million borrowed under our revolving credit facility used to finance the acquisition of five inpatient behavioral health care facilities from UMC and certain EAP acquisitions, capital expenditures and other general corporate purposes.
     We have filed a universal shelf registration statement on Form S-3 and an acquisition shelf registration statement on Form S-4. The universal shelf registration statement permits us to sell, in one or more public offerings, an indeterminate amount of our common stock, common stock warrants, preferred stock and debt securities, or any combination of such securities, at prices and on terms satisfactory to us. The acquisition shelf registration statement enables us to issue up to 5 million shares of our common stock in one or more business combination transactions, including acquisitions by us of other businesses, assets, properties or securities. To date, no securities have been issued pursuant to either registration statement.

28


Table of Contents

Obligations and Commitments
                                         
    Payments Due by Period (in thousands)
            Less than                     More than  
    Total     1 year     1-3 years     3-5 years     5 years  
Long-term debt (1):
                                       
Senior Credit Facility:
                                       
Senior secured term loan facility, expiring on July 1, 2012 and bearing interest of 2.0% at December 31, 2009
  $ 564,875     $ 3,750     $ 561,125     $     $  
7 3/4% Senior Subordinated Notes due July 15, 2015
    582,666                         582,666  
Mortgage loans on facilities, maturing in 2036, 2037 and 2038 bearing fixed interest rates of 5.7% to 7.6%
    32,850       450       988       1,118       30,294  
 
                             
 
    1,180,391       4,200       562,113       1,118       612,960  
 
                                       
Lease and other obligations
    86,786       14,872       20,988       14,410       36,516  
 
                             
Total contractual obligations
  $ 1,267,177     $ 19,072     $ 583,101     $ 15,528     $ 649,476  
 
                             
 
(1)   Excludes capital lease obligations and other obligations of $6.7 million, which are included in lease and other obligations.
     The fair value of our $470.0 million in principal amount of 73/4% Notes was approximately $453.6 million and $343.7 million as of December 31, 2009 and 2008, respectively. The fair value of our $120.0 million in principal amount of 73/4% Notes issued in May 2009 was approximately $111.6 million as of December 31, 2009. The fair value of our senior secured term loan facility was approximately $536.6 million as of December 31, 2009. The fair values of our revolving credit facility and senior secured term loan facility were approximately $195.5 million and $446.4 million, respectively, as of December 31, 2008. The carrying value of our other long-term debt, including current maturities, of $39.5 million and $40.6 million at December 31, 2009 and 2008, respectively, approximated fair value. We had $564.9 million of variable rate debt outstanding under our senior secured term loan facility as of December 31, 2009. At our December 31, 2009 borrowing level, a hypothetical 10% increase in interest rates would decrease our annual net income and cash flows by approximately $0.7 million.
Impact of Inflation and Economic Trends
     Although inflation has not had a material impact on our results of operations, the health care industry is very labor intensive and salaries and benefits are subject to inflationary pressures as are supply costs, which tend to escalate as vendors pass on the rising costs through price increases. Some of the freestanding owned, leased and managed inpatient behavioral health care facilities we operate are experiencing the effects of the tight labor market, including a shortage of nurses, which has caused and may continue to cause an increase in our SWB expense in excess of the inflation rate. Although we cannot predict our ability to cover future cost increases, management believes that through adherence to cost containment policies, labor management and reasonable price increases, the effects of inflation on future operating margins should be manageable. Our ability to pass on increased costs associated with providing health care to Medicare and Medicaid patients is limited due to various federal, state and local laws which have been enacted that, in certain cases, limit our ability to increase prices. In addition, as a result of increasing regulatory and competitive pressures and a continuing industry wide shift of patients into managed care plans, our ability to maintain margins through price increases to non-Medicare patients is limited.
     The behavioral health care industry is typically not directly impacted by periods of recession, erosions of consumer confidence or other general economic trends as most health care services are not considered a component of discretionary spending. However, our inpatient facilities may be indirectly negatively impacted to the extent such economic conditions result in decreased reimbursements by federal or state governments or managed care payors. Discussion concerning the current economic downturn is included in Part I, Item 1A under the caption “Risk Factors.” We are not aware of any economic trends that would prevent us from being able to remain in compliance with all of our debt covenants and to meet all required obligations and commitments in the near future.
Critical Accounting Policies
     Our consolidated financial statements have been prepared in accordance with GAAP. In preparing our financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses included in the financial statements. Estimates are based on historical experience and other information currently available, the results of which form the basis of such estimates. While we believe our estimation processes are reasonable, actual results could differ from our estimates. The following represent the estimates considered most critical to our operating performance and involve the most subjective and complex assumptions and assessments.
     Allowance for Doubtful Accounts
     Our ability to collect outstanding patient receivables from third-party payors is critical to our operating performance and cash flows.

29


Table of Contents

     The primary collection risk with regard to patient receivables lies with uninsured patient accounts or patient accounts for which primary insurance has paid, but the portion owed by the patient remains outstanding. We estimate the allowance for doubtful accounts primarily based upon the age of the accounts since the patient discharge date. We continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts. Significant changes in payor mix or business office operations could have a significant impact on our results of operations and cash flows.
     The primary collection risk with regard to receivables due under our inpatient management contracts is attributable to contractual disputes. We estimate the allowance for doubtful accounts for these receivables based primarily upon the specific identification of potential collection issues. As with our patient receivables, we continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts.
     Allowances for Contractual Discounts
     The Medicare and Medicaid regulations are complex and various managed care contracts may include multiple reimbursement mechanisms for different types of services provided in our inpatient facilities and cost settlement provisions requiring complex calculations and assumptions subject to interpretation. We estimate the allowance for contractual discounts on a payor-specific basis by comparing our established billing rates with the amount we determine to be reimbursable given our interpretation of the applicable regulations or contract terms. Most payments are determined based on negotiated per-diem rates. While the services authorized and provided and related reimbursement are often subject to interpretation that could result in payments that differ from our estimates, these differences are deemed immaterial. Additionally, updated regulations and contract renegotiations occur frequently necessitating continual review and assessment of the estimation process by our management. We periodically compare the contractual rates on our patient accounting systems with the Medicare and Medicaid reimbursement rates or the third-party payor contract for accuracy. We also monitor the adequacy of our contractual adjustments using financial measures such as comparing cash receipts to net patient revenue adjusted for bad debt expense.
     As of December 31, 2009, our patient accounts receivable balance for third-party payors was $235.0 million. A theoretical 1% change in the amounts due from third-party payors at December 31, 2009 could have an after tax effect of approximately $1.5 million on our financial position and results of operations.
     The following table presents the percentage by payor of our net revenue for the years ended December 31, 2009 and 2008 and related accounts receivable at year end:
                                 
    For the Year Ended December 31,  
    2009     2008  
    Net Revenue     Accounts Receivable     Net Revenue     Accounts Receivable  
Medicaid
    29 %     24 %     30 %     26 %
Commercial/HMO/Private Pay
    37 %     42 %     36 %     41 %
Medicare
    14 %     12 %     13 %     10 %
State agency
    15 %     16 %     15 %     17 %
Other
    5 %     6 %     6 %     6 %
 
                       
 
    100 %     100 %     100 %     100 %
 
                       
     The following table presents the percentage by aging category of our accounts receivable at December 31, 2009 and 2008:
                 
    At December 31,  
    2009     2008  
0 - 30 days
    64 %     64 %
31 - 60 days
    14 %     13 %
61 - 90 days
    8 %     8 %
91 - 120 days
    5 %     5 %
121 - 150 days
    3 %     4 %
151 - 180 days
    3 %     4 %
> 180 days
    3 %     2 %
 
           
Total
    100 %     100 %
 
           
     Our consolidated day’s sales outstanding were 49 and 52 for the years ended December 31, 2009 and 2008, respectively. Our consolidated collections as a percentage of net revenue less bad debt expense was 101.5% and 99.9% for the years ended December 31, 2009 and 2008, respectively.

30


Table of Contents

     Professional and General Liability
     We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. Our operations have professional and general liability insurance in umbrella form for claims in excess of $3.0 million with an insured excess limit of $75.0 million. The self-insured reserves for professional and general liability risks are estimated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often limits timely adjustments to the assumptions used in these estimates.
     Income Taxes
     As part of our process for preparing our consolidated financial statements, our management is required to compute income taxes in each of the jurisdictions in which we operate. This process involves estimating the current tax benefit or expense of future deductible and taxable temporary differences. The tax effects of future deductible and taxable temporary differences are recorded as deferred tax assets and liabilities which are components of our balance sheet. Management then assesses our ability to realize the deferred tax assets based on reversals of deferred tax liabilities and, if necessary, estimates of future taxable income. A valuation allowance for deferred tax assets is established when we believe that it is more likely than not that the deferred tax asset will not be realized. Management must also assess the impact of our acquisitions on the realization of deferred tax assets subject to a valuation allowance to determine if all or a portion of the valuation allowance will be offset by reversing taxable differences or future taxable income of the acquired entity. To the extent the valuation allowance can be reversed due to the estimated future taxable income of an acquired entity, then our valuation allowance is reduced accordingly as an adjustment to purchase price.
     In order to apply GAAP, we are required to make significant judgments regarding the recognition and measurement of each tax position. Changes in these judgments may materially affect the estimate of our effective tax rate and our operating results.
     Share-Based Compensation
     We record share-based compensation expense for the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of such awards. We utilize the Black-Scholes option pricing model to estimate the grant-date fair value of our stock options. The Black-Scholes model includes certain variables and assumptions that require judgment, such as the expected volatility of our stock price and the expected term of our stock options. Additionally, judgment is in the estimation of forfeitures over the vesting period of share-based awards.
Item 7A.   Quantitative and Qualitative Disclosures About Market Risk.
     Our interest expense is sensitive to changes in the general level of interest rates. With respect to our interest-bearing liabilities, approximately $615.5 million of our long-term debt outstanding at December 31, 2009 was subject to a weighted-average fixed interest rate of 8.0%. Our variable rate debt is comprised of our senior secured term loan facility, which had $564.9 million outstanding at December 31, 2009 and on which interest is generally payable at LIBOR plus 1.75%.
     A hypothetical 10% increase in interest rates would decrease our net income and cash flows by approximately $0.7 million on an annual basis based upon our borrowing level at December 31, 2009. In the event we draw on our revolving credit facility and/or interest rates change significantly, we expect management would take actions intended to further mitigate our exposure to such change by targeting a portion of our debt portfolio to be maintained at fixed rates and periodically entering into interest rate swap agreements. Information on quantitative and qualitative disclosure about market risk is included in Part II, Item 7 of this Annual Report on Form 10-K under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources.”
Item 8.   Financial Statements and Supplementary Data.
     Information with respect to this Item is contained in our consolidated financial statements indicated in the Index on Page F-1 of this Annual Report on Form 10-K.
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
     None.

31


Table of Contents

Item 9A. Controls and Procedures.
Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
     We carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, our Chief Executive Officer and Chief Accounting Officer concluded that our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us (including our consolidated subsidiaries) in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported on a timely basis.
Management’s Report on Internal Control Over Financial Reporting
     Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we have included a report of management’s assessment of the design and operating effectiveness of our internal controls as part of this report. Our independent registered public accounting firm also reported on the effectiveness of our internal control over financial reporting. Management’s report and the independent registered public accounting firm’s report are included in our 2009 consolidated financial statements beginning with the index on page F-1 of this report under the captions entitled “Management’s Report on Internal Control Over Financial Reporting” and “Report of Independent Registered Public Accounting Firm.”
Changes in Internal Control Over Financial Reporting
     There has been no change in our internal control over financial reporting during the fourth quarter ended December 31, 2009 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information.
     None.
PART III
Item 10. Directors and Executive Officers and Corporate Governance.
Directors
     The information relating to our directors set forth in the Company’s Proxy Statement relating to the 2009 Annual Meeting of Stockholders under the caption “Proposal 1: Election of Directors” and “Corporate Governance — Committees of the Board of Directors — Audit Committee” is incorporated herein by reference.
Executive Officers of the Registrant
     The executive officers of the Company are:
                 
Name   Age   Officer Since   Positions
Joey A. Jacobs
    56     April 1997   President and Chief Executive Officer
Ronald M. Fincher
    56     October 2008   Chief Operating Officer
Jack E. Polson
    43     August 2002   Executive Vice President, Chief Accounting Officer
Brent Turner
    44     February 2003   Executive Vice President, Finance and Administration
Christopher L. Howard
    43     September 2005   Executive Vice President, General Counsel and Secretary
     Joey A. Jacobs, President and Chief Executive Officer. Mr. Jacobs serves as President and Chief Executive Officer and was one of our co-founders in April 1997. Prior to our founding, Mr. Jacobs served for 21 years in various capacities with HCA Inc. (“HCA,” also formerly known as Hospital Corporation of America, Columbia and Columbia/HCA), most recently as President of the Tennessee Division. Mr. Jacobs’ background at HCA also includes serving as President of HCA’s Central Group, Vice President of the Western Group, Assistant Vice President of the Central Group and Assistant Vice President of the Salt Lake City Division.
     Ronald M. Fincher, Chief Operating Officer. Mr. Fincher has served as Chief Operating Officer since January 14, 2010, after being appointed Co-Chief Operating Officer on October 13, 2008. He had served the company as a Division President since April 2003. As a Division President, Mr. Fincher was responsible for managing the operations of several of our inpatient behavioral health care facilities. Prior to joining us, Mr. Fincher served as a Regional Vice President of Universal Health Services, Inc. from 2000 until 2003.
     Jack E. Polson, Executive Vice President, Chief Accounting Officer. Mr. Polson has served as an Executive Vice President since September 2006 and as Chief Accounting Officer since August 2002. Prior to being appointed Chief Accounting Officer, Mr. Polson had served as Controller since June 1997. From June 1995 until joining us, Mr. Polson served as Controller for Columbia Healthcare Network, a risk-bearing physician health organization. From May 1992 until June 1995, Mr. Polson served as an Internal Audit Supervisor for HCA.

32


Table of Contents

     Brent Turner, Executive Vice President, Finance and Administration. Mr. Turner has served as the Executive Vice President, Finance and Administration since August 2005 and previously had served as the Vice President, Treasurer and Investor Relations since February 2003. From April 2002 until joining us, Mr. Turner served as Executive Vice President and Chief Financial Officer of a privately-held owner and operator of schools for children with learning disabilities. From November 2001 until March 2002, Mr. Turner served as Senior Vice President of Business Development for The Brown Schools, Inc., a provider of educational and therapeutic services for at-risk youth. From 1996 until January 2001, Mr. Turner was employed by Corrections Corporation of America, a private prison operator, serving as Treasurer from 1998 to 2001.
     Christopher L. Howard, Executive Vice President, General Counsel and Secretary. Mr. Howard has served as the Executive Vice President, General Counsel and Secretary since September 2005. Prior to joining us, Mr. Howard was a member of Waller Lansden Dortch & Davis, LLP, a law firm based in Nashville, Tennessee.
Code of Ethics
     We adopted a Code of Ethics that applies to all of our directors, officers and employees. The Code of Ethics is available on our website at www.psysolutions.com. We will disclose any amendment to, other than technical, administrative or non-substantive amendments, or waiver of our Code of Ethics granted to a director or executive officer by filing a Current Report on Form 8-K disclosing the amendment or waiver within four business days. Upon the written request of any person, we will furnish, without charge, a copy of our Code of Ethics. Requests should be directed to Psychiatric Solutions, Inc., 6640 Carothers Parkway, Suite 500, Franklin, Tennessee 37067, Attention: Christopher L. Howard, Esq., Executive Vice President, General Counsel and Secretary.
Section 16(a) Compliance
     The information relating to Section 16(a) beneficial ownership reporting compliance set forth in our Proxy Statement relating to the 2010 Annual Meeting of Stockholders under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” is incorporated herein by reference.
Item 11. Executive Compensation.
     The information set forth in our Proxy Statement relating to the 2010 Annual Meeting of Stockholders under the caption “Compensation Discussion and Analysis” and “Executive Compensation” is incorporated herein by reference. The “Compensation Committee Report” also included in the Proxy Statement is expressly not incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
     The information set forth in our Proxy Statement relating to the 2010 Annual Meeting of Stockholders under the caption “Security Ownership of Certain Beneficial Owners and Management” and “Executive Compensation – Equity Compensation Plan Information” is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
     The information set forth in our Proxy Statement relating to the 2010 Annual Meeting of Stockholders under the caption “Corporate Governance – Standards of Independence for the Board of Directors” and “Certain Relationships and Related Transactions” is incorporated herein by reference.
Item 14. Principal Accountant Fees and Services.
     The information set forth in our Proxy Statement relating to the 2010 Annual Meeting of Stockholders under the caption “Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm” is incorporated herein by reference.

33


Table of Contents

PART IV
Item 15. Exhibits and Financial Statement Schedules.
(a) The following documents are filed as part of this Annual Report on Form 10-K:
1. Consolidated Financial Statements: The consolidated financial statements of Psychiatric Solutions are included as follows:
     
    Page
Report of Independent Registered Public Accounting Firm
  F-2
Management’s Report on Internal Control Over Financial Reporting
  F-3
Report of Independent Registered Public Accounting Firm
  F-4
Consolidated Balance Sheets
  F-5
Consolidated Statements of Income
  F-6
Consolidated Statements of Stockholders’ Equity
  F-7
Consolidated Statements of Cash Flows
  F-8
Notes to Consolidated Financial Statements
  F-10
2. Financial Statement Schedules.
All schedules are omitted because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes in this report.
3. Exhibits. The exhibits which are filed with this report or which are incorporated herein by reference are set forth in the Exhibit Index on pages 34 through 37.
(b) Exhibits.
     
Exhibit    
Number   Description
3.1
  Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 1998).
 
   
3.2
  Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2002).
 
   
3.3
  Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement, filed on January 22, 2003).
 
   
3.4
  Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric Solutions, Inc., filed with the Delaware Secretary of State on December 15, 2005 (incorporated by reference to Exhibit 3.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005).
 
   
3.5
  By-Laws (incorporated by reference to Exhibit 3 to the Company’s Current Report on Form 8-K filed on November 6, 2007).
 
   
4.1
  Reference is made to Exhibits 3.1 through 3.5.
 
   
4.2
  Common Stock Specimen Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
 
   
4.3
  Indenture, dated as of July 6, 2005, by and among Psychiatric Solutions, Inc., the Guarantors named therein and Wachovia Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on July 8, 2005).
 
   
4.4
  Form of Notes (included in Exhibit 4.3).

34


Table of Contents

     
Exhibit    
Number   Description
4.5
  Seventeenth Supplemental Indenture, dated as of May 31, 2007, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on June 1, 2007).
 
   
4.6
  Purchase Agreement, dated as of May 4, 2009, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, and Banc of America Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities Inc. and RBC Capital Markets Corporation. (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on May 8, 2009).
 
   
4.7
  Indenture, dated as of May 7, 2009, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed on May 8, 2009).
 
   
4.8
  Form of Notes (included in Exhibit 4.8) (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K, filed on May 8, 2009).
 
   
4.9
  Registration Rights Agreement, dated as of May 7, 2009, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, and Banc of America Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities Inc. and RBC Capital Markets Corporation (incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K, filed on May 8, 2009).
 
   
10.1†
  Employment Agreement, dated as of May 10, 2007, between Joey A. Jacobs and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10 to the Company’s Current Report on Form 8-K, filed on May 15, 2007).
 
   
10.2†
  Form of Indemnification Agreement executed by each director of Psychiatric Solutions, Inc. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004).
 
   
10.3
  ISDA Master Agreement, dated as of November 29, 2007, between Merrill Lynch Capital Services, Inc. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q, filed on May 6, 2008).
 
   
10.4
  Second Amended and Restated Credit Agreement, dated as of July 1, 2005, by and among Psychiatric Solutions, Inc., the subsidiaries named as guarantors thereto, Citicorp North America, Inc., as term loan facility administrative agent, co-syndication agent and documentation agent, Bank of America, N.A., as revolving loan facility administrative agent, collateral agent swing line lender and co-syndication agent, and the various other agents and lenders party thereto. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on July 8, 2005).
 
   
10.5
  Amendment No. 1 to Psychiatric Solutions, Inc.’s Second Amended and Restated Credit Agreement, dated as of December 1, 2006, by and between Psychiatric Solutions, Inc., BHC Holdings, Inc., Premier Behavioral Solutions, Inc., Alternative Behavioral Services, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, Citicorp North America, Inc., as Term Loan Facility Administrative Agent, Bank of America, N.A., as Revolving Credit Facility Administrative Agent, Citigroup Global Markets Inc. and Banc of America Securities LLC, as the Arrangers (incorporated by reference to Exhibit 10 to the Company’s Current Report on Form 8-K, filed on December 7, 2006).
 
   
10.6
  Amendment No. 2 to Second Amended and Restated Credit Agreement, dated as of December 1, 2006, by and among Psychiatric Solutions, Inc., BHC Holdings, Inc., Premier Behavioral Solutions, Inc., Alternative Behavioral Services, Inc., Horizon Health Corporation, ABS LINCS PR, Inc., First Hospital Panamericano, Inc., FHCHS of Puerto Rico, Inc., First Corrections — Puerto-Rico, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, Citicorp North America, Inc., as term loan facility administrative agent, Bank of America, N.A., as revolving credit facility administrative agent, Citigroup Global Markets Inc. and Merrill, Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and joint book-running managers (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on June 1, 2007).

35


Table of Contents

     
Exhibit    
Number   Description
10.7
  Incremental Facility Amendment, dated as of February 25, 2009, to the Second Amended and Restated Credit Agreement, as amended, by and among Psychiatric Solutions, Inc., BHC Holdings, Inc., Premier Behavioral Solutions, Inc., Alternative Behavioral Services, Inc., Horizon Health Corporation, Community Cornerstones, Inc., FHP — Puerto Rico, Inc., First Hospital Panamericano, Inc., FHCHS of Puerto Rico, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, the incremental revolving credit lenders party thereto, Citicorp North America, Inc., as term loan facility administrative agent, Bank of America, N.A., as revolving credit facility administrative agent, Barclays Bank PLC, as syndication agent, and General Electric Capital Corporation, JPMorgan Chase Bank, N.A. and Fifth Third Bank, as documentation agents, (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009).
 
   
10.8
  Amendment No. 4 to Second Amended and Restated Credit Agreement, as amended, dated as of September 25, 2009, by and among Psychiatric Solutions, Inc., BHC Holdings, Inc., Premier Behavioral Solutions, Inc., Alternative Behavioral Services, Inc., Horizon Health Corporation, Community Cornerstones, Inc., First Corrections Puerto Rico, Inc., First Hospital Panamericano, Inc., FHCHS of Puerto Rico, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, the incremental revolving credit lenders party thereto, Citicorp North America, Inc. as term loan facility administrative agent, and Bank of America, N.A., as revolving credit facility administrative agent. (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009).
 
   
10.9†
  Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended by an Amendment adopted on May 4, 2004 (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 9, 2004).
 
   
10.10†
  Second Amendment to the Psychiatric Solutions, Inc. Equity Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 22, 2005).
 
   
10.11†
  Third Amendment to the Psychiatric Solutions, Inc. Equity Incentive Plan (incorporated by reference to Appendix B of the Company’s Definitive Proxy Statement, filed on April 21, 2006).
 
   
10.12†
  Fourth Amendment to the Psychiatric Solutions, Inc. Equity Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 10, 2008).
 
   
10.13†
  Psychiatric Solutions, Inc. Executive Performance Incentive Plan (incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement, filed on April 21, 2006).
 
   
10.14†
  Form of Nonstatutory Stock Option Agreement under the 1997 Plan (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007).
 
   
10.15†
  Form of Restricted Stock Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2006).
 
   
10.16†
  Amended and Restated Psychiatric Solutions, Inc. Outside Directors’ Non-Qualified Stock Option Plan (incorporated by reference to Appendix C to the Company’s Definitive Proxy Statement, filed on April 14, 2003).
 
   
10.17†
  Amendment to the Amended and Restated Psychiatric Solutions, Inc. Outside Directors’ Stock Option Plan (incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement, filed on April 22, 2005).
 
   
10.18†
  Form of Outside Directors’ Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Annual Report on Form 10-K for the year ended April 30, 1997).
 
   
10.19†
  Summary of Director Compensation (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2006).
 
   
10.20†
  Outside Director Retainer Increase (incorporated by reference to the Company’s Current Report on Form 8-K, filed on October 20, 2008).
 
   
10.21†
  Psychiatric Solutions, Inc. Outside Directors’ Stock Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 9, 2009).

36


Table of Contents

     
Exhibit    
Number   Description
10.22†
  Psychiatric Solutions, Inc. 2009 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on March 6, 2009).
 
   
10.23†
  Psychiatric Solutions, Inc. Amended 2009 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on December 24, 2009).
 
   
10.24†
  Psychiatric Solutions, Inc. 2009 Cash Bonus Plans (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on March 6, 2009).
 
   
10.25†
  Psychiatric Solutions, Inc. 2010 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on December 24, 2009).
 
   
21.1*
  List of Subsidiaries.
 
   
23.1*
  Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
 
   
31.1*
  Certification of the Chief Executive Officer of Psychiatric Solutions, Inc. Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
31.2*
  Certification of the Chief Accounting Officer of Psychiatric Solutions, Inc. Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
   
32.1*
  Certifications of the Chief Executive Officer and Chief Accounting Officer of Psychiatric Solutions, Inc. Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
*   Filed herewith
 
  Management contract or compensatory plan or arrangement

37


Table of Contents


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of Psychiatric Solutions, Inc.
     We have audited the accompanying consolidated balance sheets of Psychiatric Solutions, Inc. as of December 31, 2009 and 2008, and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2009. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
     We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
     In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Psychiatric Solutions, Inc. at December 31, 2009 and 2008, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2009, in conformity with U.S. generally accepted accounting principles.
     We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Psychiatric Solutions, Inc.’s internal control over financial reporting as of December 31, 2009, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 25, 2010 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP
Nashville, Tennessee
February 25, 2010

F-2


Table of Contents

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
     Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Accounting Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2009 based on the framework in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2009.
     Our accompanying consolidated financial statements have been audited by the independent registered public accounting firm of Ernst & Young LLP. Reports of the independent registered public accounting firm, including the independent registered public accounting firm’s report on our internal control over financial reporting, are included in this document.

F-3


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of Psychiatric Solutions, Inc.
     We have audited Psychiatric Solutions, Inc.’s internal control over financial reporting as of December 31, 2009, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Psychiatric Solutions, Inc.’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.
     We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
     A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
     Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
     In our opinion, Psychiatric Solutions, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2009, based on the COSO criteria.
     We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Psychiatric Solutions, Inc. as of December 31, 2009 and 2008, and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2009 of Psychiatric Solutions, Inc. and our report dated February 25, 2010 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP
Nashville, Tennessee
February 25, 2010

F-4


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
                 
    December 31,  
    2009     2008  
ASSETS
Current assets:
               
Cash and cash equivalents
  $ 6,815     $ 51,271  
Accounts receivable, less allowance for doubtful accounts of $51,894 and $48,383, respectively
    249,439       241,459  
Other current assets
    105,166       174,780  
 
           
Total current assets
    361,420       467,510  
Property and equipment:
               
Land
    188,097       172,184  
Buildings
    775,887       662,513  
Equipment
    117,434       95,509  
Less accumulated depreciation
    (149,688 )     (109,753 )
 
           
 
    931,730       820,453  
Cost in excess of net assets acquired
    1,153,111       1,139,242  
Other assets
    60,979       78,785  
 
           
Total assets
  $ 2,507,240     $ 2,505,990  
 
           
 
               

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
Accounts payable
  $ 35,397     $ 34,609  
Salaries and benefits payable
    81,129       83,539  
Other accrued liabilities
    62,036       81,065  
Current portion of long-term debt
    4,940       34,391  
 
           
Total current liabilities
    183,502       233,604  
Long-term debt, less current portion
    1,182,139       1,280,006  
Deferred tax liability
    81,137       69,471  
Other liabilities
    25,790       28,067  
 
           
Total liabilities
    1,472,568       1,611,148  
Redeemable noncontrolling interests
    4,337       4,957  
Stockholders’ equity:
               
Common stock, $0.01 par value, 125,000 shares authorized; 56,226 and 55,934 issued and outstanding, respectively
    562       559  
Additional paid-in capital
    627,476       608,341  
Accumulated other comprehensive loss
          (3,695 )
Retained earnings
    402,297       284,680  
 
           
Total stockholders’ equity
    1,030,335       889,885  
 
           
Total liabilities and stockholders’ equity
  $ 2,507,240     $ 2,505,990  
 
           
See accompanying notes.

F-5


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except for per share amounts)
                         
    Year Ended December 31,  
    2009     2008     2007  
Revenue
  $ 1,805,361     $ 1,696,116     $ 1,414,700  
 
                       
Salaries, wages and employee benefits (including share-based compensation of $17,505, $19,913 and $16,104 for the years ended December 31, 2009, 2008 and 2007, respectively)
    1,005,204       938,363       787,301  
Professional fees
    166,785       162,491       135,803  
Supplies
    92,572       92,393       77,738  
Rentals and leases
    20,131       20,635       18,939  
Other operating expenses
    172,868       162,980       132,778  
Provision for doubtful accounts
    36,414       34,334       27,343  
Depreciation and amortization
    44,778       38,843       30,113  
Interest expense
    71,549       75,982       73,887  
Loss on refinancing long-term debt
                8,179  
 
                 
 
    1,610,301       1,526,021       1,292,081  
 
                 
Income from continuing operations before income taxes
    195,060       170,095       122,619  
Provision for income taxes
    74,889       64,457       46,200  
 
                 
Income from continuing operations
    120,171       105,638       76,419  
(Loss) income from discontinued operations, net of (benefit from) provision for income taxes of $(3,239), $1,528 and $707 for 2009, 2008 and 2007, respectively
    (2,461 )     (81 )     74  
 
                 
Net income
    117,710       105,557       76,493  
Less: Net income attributable to noncontrolling interests
    (93 )     (604 )     (285 )
 
                 
Net income attributable to PSI stockholders
  $ 117,617     $ 104,953     $ 76,208  
 
                 
 
                       
Basic earnings per share:
                       
Income from continuing operations attributable to PSI stockholders
  $ 2.16     $ 1.89     $ 1.40  
(Loss) income from discontinued operations, net of taxes
    (0.04 )            
 
                 
Net income attributable to PSI stockholders
  $ 2.12     $ 1.89     $ 1.40  
 
                 
 
                       
Diluted earnings per share:
                       
Income from continuing operations attributable to PSI stockholders
  $ 2.14     $ 1.87     $ 1.37  
(Loss) income from discontinued operations, net of taxes
    (0.04 )            
 
                 
Net income attributable to PSI stockholders
  $ 2.10     $ 1.87     $ 1.37  
 
                 
 
                       
Shares used in computing per share amounts:
                       
Basic
    55,564       55,408       54,258  
Diluted
    56,116       56,267       55,447  
 
                       
Amounts attributable to PSI stockholders:
                       
Income from continuing operations, net of taxes
  $ 120,078     $ 105,034     $ 76,134  
(Loss) income from discontinued operations, net of taxes
    (2,461 )     (81 )     74  
 
                 
Net income attributable to PSI stockholders
  $ 117,617     $ 104,953     $ 76,208  
 
                 
See accompanying notes.

F-6


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)
                                                 
                            Accumulated              
                    Additional     Other              
    Common Stock     Paid-In     Comprehensive     Retained        
    Shares     Amount     Capital     Loss     Earnings     Total  
Balance at December 31, 2006
    53,421     $ 534     $ 523,193     $     $ 104,052     $ 627,779  
Comprehensive income:
                                               
Net income attributable to PSI stockholders
                            76,208       76,208  
Change in fair value of interest rate swap, net of tax benefit of $308
                      (479 )           (479 )
 
                                             
Total comprehensive income
                                            75,729  
 
                                             
 
                                               
Share-based compensation
                16,104                   16,104  
Common stock issued in acquisition
    243       2       8,998                   9,000  
Exercise of stock options and grants of restricted stock, net of issuance costs
    1,443       15       17,220                   17,235  
Cumulative adjustment for adoption of FIN 48
                            (533 )     (533 )
Income tax benefit of stock option exercises
                9,428                   9,428  
 
                                   
Balance at December 31, 2007
    55,107       551       574,943       (479 )     179,727       754,742  
Comprehensive income:
                                               
Net income attributable to PSI stockholders
                            104,953       104,953  
Change in fair value of interest rate swap, net of tax benefit of $2,154
                      (3,216 )           (3,216 )
 
                                             
Total comprehensive income
                                            101,737  
 
                                             
 
                                               
Share-based compensation
                19,913                   19,913  
Common stock issued in acquisition of discontinued operation
    27             1,000                   1,000  
Exercise of stock options and grants of restricted stock, net of issuance costs
    800       8       9,433                   9,441  
Income tax benefit of stock option exercises
                3,052                   3,052  
 
                                   
Balance at December 31, 2008
    55,934       559       608,341       (3,695 )     284,680       889,885  
Comprehensive income:
                                               
Net income attributable to PSI stockholders
                            117,617       117,617  
Change in fair value of interest rate swap, net of tax provision of $2,466
                      3,695             3,695  
 
                                             
Total comprehensive income
                                            121,312  
 
                                             
 
                                               
Share-based compensation
                17,505                   17,505  
Exercise of stock options and grants of restricted stock, net of issuance costs
    292       3       (48 )                 (45 )
Income tax benefit of stock option exercises
                1,678                   1,678  
 
                                   
Balance at December 31, 2009
    56,226     $ 562     $ 627,476     $     $ 402,297     $ 1,030,335  
 
                                   
See accompanying notes.

F-7


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
                         
    Year Ended December 31,  
    2009     2008     2007  
Operating activities:
                       
Net income
  $ 117,710     $ 105,557     $ 76,493  
Adjustments to reconcile net income to net cash provided by continuing operating activities:
                       
Depreciation and amortization
    44,778       38,843       30,113  
Amortization of loan costs and bond discount/premium
    5,300       2,213       2,151  
Share-based compensation
    17,505       19,913       16,104  
Loss on refinancing long-term debt
                8,179  
Change in income tax assets and liabilities
    20,050       (5,034 )     8,639  
Loss (income) from discontinued operations, net of taxes
    2,461       81       (74 )
Changes in operating assets and liabilities, net of effect of acquisitions:
                       
Accounts receivable
    (3,911 )     (17,755 )     (12,592 )
Other current assets
    8,024       (4,612 )     6,298  
Accounts payable
    (1,391 )     2,891       (7,939 )
Salaries and benefits payable
    (6,219 )     1,731       1,876  
Accrued liabilities and other liabilities
    1,104       (4,567 )     (5,676 )
 
                 
Net cash provided by continuing operating activities
    205,411       139,261       123,572  
Net cash provided by discontinued operating activities
    983       2,522       1,949  
 
                 
Net cash provided by operating activities
    206,394       141,783       125,521  
 
                       
Investing activities:
                       
Cash paid for acquisitions, net of cash acquired
    (32,910 )     (121,156 )     (444,899 )
Cash paid for real estate acquisitions
    (19,341 )            
Capital purchases of leasehold improvements, equipment and software
    (130,674 )     (121,930 )     (71,260 )
Other assets
    1,229       (1,318 )     (2,451 )
 
                 
Net cash used in continuing investing activities
    (181,696 )     (244,404 )     (518,610 )
Net cash provided by (used in) discontinued investing activities
    67,692       (41,811 )     (17,974 )
 
                 
Net cash used in investing activities
    (114,004 )     (286,215 )     (536,584 )
 
                       
(Continued)

F-8


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
                         
    Year Ended December 31,  
    2009     2008     2007  
Financing activities:
                       
Net (decrease) increase in revolving credit facility
  $ (229,333 )   $ 149,333     $ (21,000 )
Borrowings on long-term debt
    106,500             481,875  
Principal payments on long-term debt
    (5,093 )     (6,067 )     (41,281 )
Payment of loan and issuance costs
    (9,903 )     (59 )     (6,661 )
Refinancing of long-term debt
                (7,127 )
Excess tax benefit from share-based payment arrangements
    1,678       3,052       9,428  
Distributions to noncontrolling interests
    (723 )            
Repurchase of common stock upon restricted stock vesting
    (1,057 )     (271 )     (122 )
Proceeds from exercises of common stock options
    1,085       9,745       17,401  
 
                 
Net cash (used in) provided by financing activities
    (136,846 )     155,733       432,513  
 
                 
Net (decrease) increase in cash
    (44,456 )     11,301       21,450  
Cash and cash equivalents at beginning of the year
    51,271       39,970       18,520  
 
                 
Cash and cash equivalents at end of the year
  $ 6,815     $ 51,271     $ 39,970  
 
                 
 
                       
Supplemental Cash Flow Information:
                       
Interest paid
  $ 61,971     $ 79,824     $ 62,864  
 
                 
Income taxes paid
  $ 49,934     $ 68,151     $ 29,924  
 
                 
 
                       
Effect of Acquisitions:
                       
Assets acquired, net of cash acquired
  $ 39,147     $ 124,687     $ 497,354  
Liabilities assumed
    (6,162 )     (3,531 )     (34,753 )
Common stock issued
                (9,000 )
Long-term debt assumed
    (75 )           (8,702 )
 
                 
Cash paid for acquisitions, net of cash acquired
  $ 32,910     $ 121,156     $ 444,899  
 
                 
See accompanying notes.

F-9


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
1. Summary of Significant Accounting Policies
     Description of Business
Psychiatric Solutions, Inc. was incorporated in 1988 as a Delaware corporation and has its corporate office in Franklin, Tennessee. Psychiatric Solutions, Inc. and its subsidiaries (“we,” “us” or “our”) are a leading provider of inpatient behavioral health care services in the United States. Through our owned and leased facilities, we operated 94 owned or leased inpatient behavioral health care facilities with approximately 11,000 beds in 32 states, Puerto Rico and the U.S. Virgin Islands at December 31, 2009. Our other behavioral health care business primarily consists of our contract management and a managed care plan in Puerto Rico. Our contract management business involves the development, organization and management of behavioral health care and rehabilitation programs within medical/surgical hospitals.
     Recent Developments
In January 2009, we opened Rolling Hills Hospital, an 80-bed inpatient facility in Franklin, Tennessee.
In May 2009, we received $106.5 million upon the issuance of $120 million of our 73/4% Senior Subordinated Notes due 2015 (the “73/4% Notes”) and used the proceeds to repay a portion of the outstanding balance of our revolving credit facility. During February 2009, our revolving credit facility was amended to extend the maturity of $200 million capacity to December 31, 2011. During September 2009, the maturity of the remaining $100 million capacity under our revolving credit facility was extended to mature on December 31, 2011. At December 31, 2009, we had no borrowings outstanding under our revolving credit facility.
On September 1, 2009, we completed the acquisition of a 131-bed inpatient behavioral health care facility located in Fargo, North Dakota. On September 30, 2009, we completed the acquisition of a 90-bed inpatient behavioral health care facility located in Panama City, Florida.
On November 2, 2009, we completed the sale of our employee assistance program (“EAP”) business for approximately $68.5 million in cash, net of fees and expenses.
     Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative expenses at our corporate office, excluding share-based compensation expense, were approximately 2.6% of net revenue for the year ended December 31, 2009.
The consolidated financial statements include all wholly-owned subsidiaries and entities controlled by Psychiatric Solutions, Inc. The consolidated financial statements include two inpatient behavioral health care facilities in which we own a controlling interest and account for the ownership interest of the non- controlling partner as redeemable noncontrolling interests. All significant intercompany balances and transactions are eliminated in consolidation.
     Cash and Cash Equivalents
Cash consists of demand deposits held at financial institutions. We place our cash in financial institutions that are federally insured. At December 31, 2009, the majority of our cash is deposited with two financial institutions. Cash equivalents are short-term investments with original maturities of three months or less.
     Accounts Receivable
Accounts receivable vary according to the type of service being provided. Accounts receivable for our owned and leased facilities segment is comprised of patient service revenue and is recorded net of allowances for contractual discounts and estimated doubtful accounts. Such amounts are owed by various governmental agencies, insurance companies and private patients. Medicare comprised approximately 12% and 10% of accounts receivable at December 31, 2009 and 2008, respectively. Medicaid comprised approximately 24% and 26% of accounts receivable at December 31, 2009 and 2008, respectively. Concentration of credit risk from other payors is reduced by the large number of patients and payors.
Accounts receivable for our management contracts is comprised of contractually determined fees for services rendered. Such amounts are recorded net of estimated allowances for doubtful accounts. Concentration of credit risk is reduced by the large number of customers.

F-10


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
     Allowance for Doubtful Accounts
Our ability to collect outstanding patient receivables from third party payors is critical to our operating performance and cash flows.
The primary collection risk with regard to patient receivables relates to uninsured patient accounts or patient accounts for which primary insurance has paid, but the portion owed by the patient remains outstanding. We estimate the allowance for doubtful accounts primarily based upon the age of the accounts since the patient discharge date. We continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts. Significant changes in payor mix or business office operations could have a significant impact on our results of operations and cash flows.
     Allowances for Contractual Discounts
The Medicare and Medicaid regulations are complex and various managed care contracts may include multiple reimbursement mechanisms for different types of services provided in our inpatient facilities and cost settlement provisions requiring complex calculations and assumptions subject to interpretation. We estimate the allowance for contractual discounts on a payor-specific basis given our interpretation of the applicable regulations or contract terms. The services authorized and provided and related reimbursement are often subject to interpretation that could result in payments that differ from our estimates. Additionally, updated regulations and contract renegotiations occur frequently necessitating continual review and assessment of the estimation process by our management.
     Income Taxes
We account for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based upon differences between the financial statement carrying amounts and tax bases of assets and liabilities and are measured using the enacted tax laws that will be in effect when the differences are expected to reverse. A valuation allowance for deferred tax assets is established when we believe that it is more likely than not that the deferred tax asset will not be realized. Significant judgments regarding the recognition and measurement of each tax position are required. Our policy is to classify interest and penalties related to income taxes as a component of our tax provision.
     Long-Lived Assets
     Property and Equipment
Property and equipment are stated at cost and depreciated using the straight-line method over the useful lives of the assets, which range from 25 to 40 years for buildings and improvements and 2 to 7 years for equipment. Leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or estimated useful lives of the assets. Depreciation expense was $41.4 million, $35.4 million and $28.3 million for the years ended December 31, 2009, 2008 and 2007, respectively. Depreciation expense includes the amortization of assets recorded under capital leases.
Cost in Excess of Net Assets Acquired (Goodwill)
We account for acquisitions using the acquisition method of accounting. Goodwill is generally allocated to reporting units based on operating results. Goodwill is reviewed at least annually for impairment. Potential impairment is noted for a reporting unit if its carrying value exceeds the fair value of the reporting unit. For those reporting units that we have identified with potential impairment of goodwill, we determine the implied fair value of goodwill. If the carrying value of goodwill exceeds its implied fair value, an impairment loss is recorded. Our annual impairment tests of goodwill in 2009, 2008 and 2007 resulted in no goodwill impairment.
The following table presents the changes in the carrying amount of goodwill for the years ended December 31, 2009 and 2008 (in thousands):

F-11


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
                         
    Owned and              
    Leased              
    Facilities     Other     Total  
Balance at December 31, 2007
  $ 1,035,606     $ 16,176     $ 1,051,782  
Acquisition of UMC facilities
    85,459             85,459  
Other Acquisitions
    2,001             2,001  
 
                 
Balance at December 31, 2008
    1,123,066       16,176       1,139,242  
Acquisitions
    13,869             13,869  
 
                 
Balance at December 31, 2009
  $ 1,136,935     $ 16,176     $ 1,153,111  
 
                 
     Other Assets
Other assets include contracts that represent the fair value of inpatient management contracts and service contracts purchased and are being amortized using the straight-line method over their estimated life, which is between 4 years and 9 years. At December 31, 2009 and 2008, contracts totaled $22.2 million and $25.5 million and are net of accumulated amortization of $10.7 million and $7.4 million, respectively. Amortization expense related to contracts was $3.3 million, $3.2 million and $1.7 million for the years ended December 31, 2009, 2008 and 2007, respectively. Estimated amortization expense related to contracts for each of the five years ending December 31, 2014 is approximately $3.3 million.
When events, circumstances and operating results indicate that the carrying values of certain long-lived assets and the related identifiable intangible assets might be impaired, we prepare projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate that the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Fair value is estimated based upon projections of discounted cash flows.
Other assets also include loan costs that are deferred and amortized over the term of the related debt. Loan costs at December 31, 2009 and 2008 totaled $18.8 million and $14.0 million, respectively, and are net of accumulated amortization of $9.6 million and $8.1 million, respectively. Amortization expense related to loan costs, which is reported as interest expense, was approximately $5.0 million, $2.9 million and $2.5 million for the years ended December 31, 2009, 2008 and 2007, respectively. Estimated amortization expense of loan costs for the years ending December 31, 2010, 2011, 2012, 2013 and 2014 is $5.4 million, $5.5 million, $2.3 million, $1.8 million and $1.9 million, respectively.
     Other Accrued Liabilities
At December 31, 2009 and 2008, we had approximately $23.1 million and $18.3 million, respectively, of accrued interest expense in other accrued liabilities.
     Share-Based Compensation
We adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (“ASC 718”), under the modified-prospective transition method on January 1, 2006. ASC 718 requires companies to measure and recognize the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value. Share-based compensation recognized under the modified-prospective transition method of ASC 718 includes share-based compensation based on the grant-date fair value determined in accordance with the original provisions, for all share-based payments granted prior to and not yet vested as of January 1, 2006 and share-based compensation based on the grant-date fair-value determined in accordance with ASC 718 for all share-based payments granted on or after January 1, 2006. We use the Black-Scholes valuation model to determine grant-date fair value and use straight-line amortization of share-based compensation expense over the requisite service period of the grant.
     Derivatives
We may periodically enter into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These interest rate swap agreements effectively exchange fixed or variable interest payments between two parties. During 2007, we entered into an agreement to exchange the interest payments associated with a notional amount of $225 million LIBOR indexed variable rate debt related to our senior secured term loan for a fixed interest rate. This interest rate swap agreement expired during the fourth quarter of 2009 and as of December 31, 2009, we were not a party to an interest rate swap agreement.

F-12


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
     Risk Management
We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. Our operations have professional and general liability insurance in umbrella form for claims in excess of a $3.0 million self-insured retention with an insured excess limit of $75.0 million. The self-insured reserves for professional and general liability risks are estimated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates. The reserve for professional and general liability was $19.0 million and $20.0 million as of December 31, 2009 and 2008, respectively.
We carry statutory workers’ compensation insurance from an unrelated commercial insurance carrier. Our statutory workers’ compensation program is fully insured with a $500,000 deductible per accident. The reserve for workers’ compensation liability was $24.2 million and $20.9 million as of December 31, 2009 and 2008, respectively. We believe that adequate provisions have been made for workers’ compensation and professional and general liability risk exposures.
     Fair Value of Financial Instruments
The carrying amounts reported in the accompanying Consolidated Balance Sheets for cash and cash equivalents, accounts receivable and accounts payable approximate their fair value given the short-term maturity of these instruments. The fair value of our $470.0 million 73/4% Senior Subordinated Notes due 2015 (“73/4% Notes”) was $453.6 million and $343.7 million at December 31, 2009 and 2008, respectively. The fair value of our $120.0 million in principal amount of 73/4% Notes issued in May 2009 was $111.6 million as of December 31, 2009. The fair value of our senior secured term loan facility was $536.6 million and $446.4 million as of December 31, 2009 and 2008, respectively. The fair value of our revolving credit facility was $195.5 million as of December 31, 2008.
     Reclassifications
Certain reclassifications have been made to the prior year to conform with current year presentation.
     Recent Accounting Pronouncements
In September 2009, we adopted the FASB ASC. The ASC was established as the source of authoritative accounting principles to be applied to nongovernmental entities in the preparation of financial statements in conformity with GAAP. The ASC did not change GAAP, but was intended to simplify user access to all authoritative GAAP by providing the authoritative literature related to a particular topic in one place. All previously existing accounting standard documents were superseded and all other accounting literature not included in the ASC is considered non-authoritative. New accounting standards issued subsequent to June 30, 2009 are communicated by the FASB through Accounting Standards Updates (ASUs). The ASC did not have an impact on our consolidated results of operation or financial condition. However, throughout the notes to the consolidated financial statements references that were previously made to various former authoritative GAAP pronouncements have been changed to coincide with the appropriate section of the ASC.
In May 2009, the FASB issued guidance codified in ASC 855, Subsequent Events, establishing standards for accounting and disclosure of events that occur after the balance sheet date, but before financial statements are issued. This guidance requires the disclosure of the date through which an entity has evaluated subsequent events and whether that date represents the date the financial statements were issued or were available to be issued. We adopted this guidance in the quarter ended June 30, 2009.
In March 2008, the FASB issued guidance codified in ASC 805, Business Combinations, that requires enhanced disclosures about derivative and hedging activities. We adopted this guidance on January 1, 2009.
In December 2007, the FASB issued guidance codified in ASC 810, Consolidation, requiring the use of the acquisition method of accounting, defining the acquirer, establishing the acquisition date, requiring acquisition-related costs to be expensed as incurred and broadening the scope of a business combination to include transactions and other events in which one entity obtains control over one or more other businesses. We adopted this guidance on January 1, 2009.
In December 2007, the FASB issued guidance establishing accounting and reporting standards for the noncontrolling interest in a subsidiary and for the retained interest and gain or loss when a subsidiary is deconsolidated. We adopted this guidance on January 1, 2009.
     Subsequent Events
We have evaluated subsequent events through February 25, 2010, the date of issuance of these financial statements, and determined that: (i) no subsequent events have occurred that would require recognition in our financial statements for the year ended December 31, 2009; and (ii) no other subsequent events have occurred that would require disclosure in the notes thereto.

F-13


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
2. Revenue
Revenue consists of the following amounts (in thousands):
                         
    December 31,  
    2009     2008     2007  
Patient service revenue
  $ 1,678,449     $ 1,571,141     $ 1,314,203  
Other revenue
    126,912       124,975       100,497  
 
                 
Total revenue
  $ 1,805,361     $ 1,696,116     $ 1,414,700  
 
                 
Patient Service Revenue
Patient service revenue is generated by our inpatient facilities for services provided to patients on an inpatient and outpatient basis within the inpatient behavioral health care facility setting. Patient service revenue is recorded at our established billing rates less contractual adjustments. Contractual adjustments are recorded to state our patient service revenue at the amount we expect to collect for the services provided based on amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas or amounts due from other third-party payors at contractually determined rates. During the years ended December 31, 2009, 2008 and 2007, approximately 29%, 30% and 32%, respectively, of our revenue was obtained from providing services to patients participating in the Medicaid program. During the years ended December 31, 2009, 2008 and 2007, approximately 14%, 13% and 12%, respectively, of our revenue was obtained from providing services to patients participating in the Medicare program.
Settlements under cost reimbursement agreements with third-party payors are estimated and recorded in the period in which the related services are rendered and are adjusted in future periods as final settlements are determined. Final determination of amounts earned under the Medicare and Medicaid programs often occur in subsequent years because of audits by such programs, rights of appeal and the application of numerous technical provisions.
We provide care without charge to patients who are financially unable to pay for the health care services they receive. Because we do not pursue collection of amounts determined to qualify as charity care, these amounts are not reported as revenue.
Other Revenue
Other revenue primarily derives from our contract management business and a managed care plan in Puerto Rico. Our contract management business involves the development, organization and management of behavioral health and rehabilitation programs within medical/surgical hospitals. Services provided are recorded as revenue at contractually determined rates in the period the services are rendered, provided that collectability of such amounts is reasonably assured.
3. Earnings Per Share
ASC 260, Earnings per Share, requires dual presentation of basic and diluted earnings per share by entities with complex capital structures. Basic earnings per share includes no dilution and is computed by dividing net income attributable to PSI stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share also includes the potential dilution of securities that could share in the earnings of the entity. We have calculated earnings per share in accordance with ASC 260 for all periods presented.
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

F-14


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
                         
    Year ended December 31,  
    2009     2008     2007  
Numerator:
                       
Basic and diluted earnings per share:
                       
Income from continuing operations attributable to PSI stockholders
  $ 120,078     $ 105,034     $ 76,134  
(Loss) income from discontinued operations, net of taxes
    (2,461 )     (81 )     74  
 
                 
Net income attributable to PSI stockholders
  $ 117,617     $ 104,953     $ 76,208  
 
                 
 
                       
Denominator:
                       
Weighted average shares outstanding for basic earnings per share
    55,564       55,408       54,258  
Effects of dilutive stock options and restriced stock outstanding
    552       859       1,189  
 
                 
Shares used in computing diluted earnings per common share
    56,116       56,267       55,447  
 
                 
 
                       
Basic earnings per share:
                       
Income from continuing operations attributable to PSI stockholders
  $ 2.16     $ 1.89     $ 1.40  
(Loss) income from discontinued operations, net of taxes
    (0.04 )            
 
                 
Net income attributable to PSI stockholders
  $ 2.12     $ 1.89     $ 1.40  
 
                 
 
                       
Diluted earnings per share:
                       
Income from continuing operations attributable to PSI stockholders
  $ 2.14     $ 1.87     $ 1.37  
(Loss) income from discontinued operations, net of taxes
    (0.04 )            
 
                 
Net income attributable to PSI stockholders
  $ 2.10     $ 1.87     $ 1.37  
 
                 
4. Discontinued Operations
GAAP requires that all components of an entity that have been disposed of (by sale, by abandonment or in a distribution to owners) or are held for sale and whose cash flows can be clearly distinguished from the rest of the entity be presented as discontinued operations. During 2009, we sold our EAP business, elected to close and sell Nashville Rehabilitation Hospital, The Oaks Treatment Center and Cumberland Hall of Chattanooga, and terminated one contract with a South Carolina juvenile justice agency. During 2008, we elected to sell one facility and terminated two contracts with a Puerto Rican juvenile justice agency to manage inpatient facilities. During 2007, we elected to dispose of one facility. Prior to the decision to discontinue these operations, with the exception of our EAP business that was reported in our other segment, their results were reported in our owned and leased facilities segment.
The components of (loss) income from discontinued operations, net of taxes, are as follows (in thousands):
                         
    Year Ended December 31,  
    2009     2008     2007  
Revenue
  $ 61,775     $ 84,660     $ 69,469  
 
                       
Operating expenses
    65,273       81,296       67,921  
Loss on disposal
    2,202       1,917       767  
 
                 
 
    67,475       83,213       68,688  
 
                 
 
                       
(Loss) income from discontinued operations before income taxes
    (5,700 )     1,447       781  
(Benefit from) provision for income taxes
    (3,239 )     1,528       707  
 
                 
(Loss) income from discontinued operations, net of income taxes
  $ (2,461 )   $ (81 )   $ 74  
 
                 
The loss on disposal for the year ended December 31, 2009 is primarily the result of a $3.1 million loss recorded to establish the assets held for sale of The Oaks Treatment Center at the expected net sales price and a $1.3 million gain on the sale of our EAP business. Other current assets include assets held for sale of $21.5 million and $79.1 million as of December 31, 2009 and 2008, respectively. Assets held for sale at December 31, 2008 includes goodwill of $60.9 million from the acquisitions of various EAP businesses.
We have elected to allocate interest expense to discontinued operations based on the ratio of net assets to be sold or discontinued less

F-15


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
debt that is required to be paid as a result of the disposal transaction to the sum of our total net assets plus consolidated debt. Interest allocated to discontinued operations was $2.5 million, $2.8 million and $1.2 million for the years ended December 31, 2009, 2008 and 2007, respectively.
5. Acquisitions
Strategic acquisitions are an important part of our plan to continue to successfully grow our business and increase our profitability.
     2009 Acquisitions
In 2009, we acquired a 131-bed inpatient behavioral health care facility located in Fargo, North Dakota and a 90-bed inpatient behavioral health care facility located in Panama City, Florida, in separate transactions for an aggregate of $32.9 million. Each acquisition was accounted for by the acquisition method and the aggregate purchase prices of these transactions were allocated to the assets acquired and liabilities assumed based upon their respective fair values. The goodwill arising from the acquisitions was allocated to the owned and leased facilities segment.
     2008 Acquisition
On March 1, 2008, we acquired five inpatient behavioral health care facilities with approximately 400 beds from UMC for $120.0 million. The acquisition was accounted for by the purchase method. During 2008, we acquired multiple EAP businesses in separate transactions for approximately $45.0 million, which were subsequently sold in 2009.
     2007 Acquisitions
During 2007, we acquired 16 inpatient behavioral health care facilities with an aggregate of approximately 1,600 beds, including the May 31, 2007 acquisition of Horizon Health, which operated 15 inpatient facilities. Each acquisition was accounted for by the purchase method and the aggregate purchase prices of these transactions were allocated to the assets acquired and liabilities assumed based upon their respective fair values. The consolidated financial statements include the accounts and operations of the acquired entities for the period subsequent to the acquisition date. As the acquisition of Horizon Health involved a merger, the goodwill associated with this acquisition is not deductible for federal income tax purposes.
The following table summarizes the allocation of the aggregate purchase price of Horizon Health (in thousands):
         
    Horizon Health  
Assets acquired:
       
Accounts receivable
  $ 40,590  
Other current assets
    15,102  
Fixed assets
    96,664  
Costs in excess of net assets acquired
    285,068  
Other assets
    24,039  
 
     
 
    461,463  
Liabilities assumed
    35,446  
Long-term debt assumed
    6,998  
 
     
Cash paid, net of cash acquired and discontinued operations
    419,019  
Assets and liabilities of discontinued operations
    10,124  
 
     
Cash paid, net of cash acquired
  $ 429,143  
 
     
Acquisition-related direct costs paid subsequent to closing have been included as a part of the acquisition.

F-16


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
6. Long-term debt
Long-term debt consists of the following (in thousands):
                 
    December 31,  
    2009     2008  
Senior credit facility:
               
Revolving line of credit facility, expiring on December 31, 2011 and bearing interest of 3.4% at December 31, 2008
  $     $ 229,333  
Senior secured term loan facility, expiring on July 1, 2012 and bearing interest of 2.0% and 3.1% at December 31, 2009 and December 31, 2008, respectively
    564,875       568,625  
7 3/4% Notes
    582,666       475,841  
Mortgage loans on facilities, maturing in 2036, 2037 and 2038 bearing fixed interest rates of 5.7% to 7.6%
    32,850       33,273  
Other
    6,688       7,325  
 
           
 
    1,187,079       1,314,397  
Less current portion
    4,940       34,391  
 
           
Long-term debt
  $ 1,182,139     $ 1,280,006  
 
           
Senior Credit Facility
Our Senior Credit Facility (the “Credit Agreement”) includes a $300 million revolving line of credit facility administered by Bank of America, N.A. and a $575 million senior secured term loan facility administered by Citicorp North America, Inc. During February 2009, our revolving credit facility was amended to extend the maturity of $200 million capacity to December 31, 2011. During September 2009, the maturity of the remaining $100 million capacity under our revolving credit facility was extended to December 31, 2011. As a result of the February 2009 extension, $29.3 million of the $229.3 million balance outstanding on our revolving credit facility at December 31, 2008 was classified as current portion of long-term debt. Quarterly principal payments of $0.9 million are due on our senior secured term loan facility and the balance of our senior secured term loan facility is payable in full on July 1, 2012.
Our Credit Agreement is secured by substantially all of the personal property owned by us or our subsidiaries, substantially all real property owned by us or our subsidiaries that has a value in excess of $5.0 million and the stock of substantially all of our operating subsidiaries. In addition, the Credit Agreement is fully and unconditionally guaranteed by substantially all of our operating subsidiaries. The revolving credit facility and senior secured term loan facility accrue interest at our choice of the “Base Rate” or the “Eurodollar Rate” (as defined in the Credit Agreement). The “Base Rate” and “Eurodollar Rate” fluctuate based upon market rates and certain leverage ratios, as defined in the Credit Agreement. At December 31, 2009, we had no borrowings outstanding and $295.7 million available for future borrowings under the revolving credit facility. Until the maturity date, we may borrow, repay and re-borrow an amount not to exceed $300 million on our revolving credit facility. All repayments made under the senior secured term loan facility are a permanent reduction in the amount available for future borrowings. We pay a quarterly commitment fee on the unused portion of our revolving credit facility that fluctuates, based upon certain leverage ratios, between 0.75% and 1.0% per annum. Commitment fees were approximately $1.4 million for the year ended December 31, 2009.
Our Credit Agreement contains customary covenants that include: (1) a limitation on capital expenditures and investments, sales of assets, mergers, changes of ownership, new principal lines of business, indebtedness, transactions with affiliates, dividends and redemptions; (2) various financial covenants; and (3) cross-default covenants triggered by a default of any other indebtedness of at least $5.0 million. As of December 31, 2009, we were in compliance with all debt covenant requirements. If we violate one or more of these covenants, amounts outstanding under the revolving credit facility, senior secured term loan facility and the majority of our other debt arrangements could become immediately payable and additional borrowings could be restricted.
73/4% Notes
The 73/4% Notes mature on July 15, 2015 and are fully and unconditionally guaranteed on a senior subordinated basis by substantially all of our existing operating subsidiaries. In May 2009, we issued $120 million of the 73/4% Notes at a discount of 11.25%. This discount is being amortized over the remaining life of the 73/4% Notes using the effective interest rate method, which results in an effective interest rate of 10.2% per annum on the $120 million issuance. We received a premium of 2.75% plus accrued interest from the issuance of $250 million of 73/4% Notes in 2007. This premium is being amortized over the remaining life of the 73/4% Notes using the effective interest method, which results in an effective interest rate of 7.3% on the $250 million issuance. We also issued $220 million of the 73/4% Notes in 2005. Interest on the 73/4% Notes accrues at the rate of 73/4% per annum and is payable semi-annually in arrears on January 15 and July 15.

F-17


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Mortgage Loans
At December 31, 2009, we had $32.9 million debt outstanding under mortgage loan agreements insured by the U.S. Department of Housing and Urban Development (“HUD”). The mortgage loans insured by HUD are secured by real estate located at Holly Hill Hospital in Raleigh, North Carolina, West Oaks Hospital in Houston, Texas, Riveredge Hospital near Chicago, Illinois, Canyon Ridge Hospital in Chino, California and MeadowWood Behavioral Health in New Castle, Delaware. Interest accrues on the Holly Hill, West Oaks, Riveredge, Canyon Ridge and MeadowWood HUD loans at 6.0%, 5.9%, 5.7%, 7.6% and 7.0% and principal and interest are payable in 420 monthly installments through December 2037, September 2038, December 2038, January 2036 and October 2036, respectively. The carrying amount of assets held as collateral approximated $59.5 million at December 31, 2009.
Interest Rate Swap Agreements
We periodically enter into interest rate swap agreements to manage our exposure to fluctuations in interest rates. During 2007, we entered into an agreement with Merrill Lynch Capital Services, Inc. to exchange the interest payments associated with a notional amount of $225 million of LIBOR indexed variable rate debt related to our senior secured term loan for a fixed interest rate of 3.8%. The agreement matured on November 30, 2009. The fair value of our interest rate swap of $6.2 million at December 31, 2008 is included in other accrued liabilities.
Other
The aggregate maturities of long-term debt, including capital lease obligations, are as follows (in thousands):
         
2010
  $ 4,940  
2011
    4,915  
2012
    558,494  
2013
    1,106  
2014
    1,148  
Thereafter
    616,476  
 
     
Total
  $ 1,187,079  
 
     
7. Leases
Our operating leases consist primarily of the leases of seven inpatient behavioral health care facilities, our corporate office and the office for our contract management business. At December 31, 2009, future minimum lease payments under operating leases having an initial or remaining non-cancelable lease term in excess of one year are as follows (in thousands):
         
2010
  $ 14,089  
2011
    11,410  
2012
    8,223  
2013
    6,949  
2014
    6,323  
Thereafter
    33,001  
 
     
Total
  $ 79,995  
 
     
8. Income Taxes
Total provision for income taxes for the years ended December 31, 2009, 2008 and 2007 was allocated as follows (in thousands):
                         
    2009     2008     2007  
Provision for income taxes attributable to income from continuing operations
  $ 74,889     $ 64,457     $ 46,200  
(Benefit from) provision for income taxes attributable to (loss) income from discontinued operations
    (3,239 )     1,528       707  
 
                 
Total provision for income taxes
  $ 71,650     $ 65,985     $ 46,907  
 
                 

F-18


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
The provision for income taxes attributable to income from continuing operations consists of the following (in thousands):
                         
    2009     2008     2007  
Current:
                       
Federal
  $ 54,580     $ 45,202     $ 31,153  
State
    6,388       5,568       4,838  
Foreign
    2,547       2,338       3,505  
 
                 
 
    63,515       53,108       39,496  
 
                       
Deferred:
                       
Federal
    11,200       9,819       8,086  
State
    638       1,487       (457 )
Foreign
    (464 )     43       (925 )
 
                 
 
    11,374       11,349       6,704  
 
                 
Provision for income taxes
  $ 74,889     $ 64,457     $ 46,200  
 
                 
The tax benefits associated with exercises of nonqualified stock options decreased the current tax liability by $0.1 million, $3.1 million and $9.4 million in 2009, 2008 and 2007, respectively. Such benefits were recorded as increases to stockholders’ equity.
The reconciliation of income tax computed by applying the U.S. federal statutory rate to the actual income tax expense attributable to income from continuing operations is as follows (in thousands):
                         
    2009     2008     2007  
Federal tax
  $ 68,239     $ 59,322     $ 42,817  
State income taxes (net of federal)
    4,567       4,586       2,848  
Other
    2,083       549       535  
 
                 
Provision for income taxes
  $ 74,889     $ 64,457     $ 46,200  
 
                 
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The tax effects of significant items comprising temporary differences at December 31, 2009 and 2008 are as follows (in thousands):
                 
    2009     2008  
Deferred tax assets:
               
Net operating loss carryforwards
  $ 9,038     $ 9,146  
Allowance for doubtful accounts
    18,474       13,488  
Alternative minimum tax credit carryovers
          794  
Accrued liabilities
    42,349       39,293  
 
           
Total gross deferred tax assets
    69,861       62,721  
Less: Valuation allowance
    (4,272 )     (4,748 )
 
           
Total deferred tax assets
    65,589       57,973  
Deferred tax liabilities:
               
Intangible assets
    (52,938 )     (37,567 )
Property and equipment
    (66,537 )     (57,415 )
Other
    (1,985 )     (2,658 )
 
           
Net deferred tax liability
  $ (55,871 )   $ (39,667 )
 
           
Deferred income taxes of $25.3 million and $29.8 million at December 31, 2009 and 2008, respectively, are included in other current assets. Noncurrent deferred income tax liabilities totaled $81.1 million and $69.5 million at December 31, 2009 and 2008, respectively.
GAAP requires that deferred income taxes reflect the tax consequences of differences between the tax basis of assets and liabilities and their carrying values for GAAP. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not. A valuation allowance is established for those benefits that do not meet the more likely than not criteria. We have evaluated the need for a valuation allowance against deferred tax assets and have recorded valuation allowances of $4.3 million, $4.7 million and $5.6 million at December 31, 2009, 2008 and 2007, respectively. The net change in valuation allowance was a decrease of $0.4

F-19


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
million and $0.9 million for the years ended December 31, 2009 and December 31, 2008, respectively. Changes to the valuation allowance affect income tax expense.
As of December 31, 2009, we had an unrecognized deferred tax liability for temporary differences of $3.4 million related to investments in our Puerto Rico subsidiaries that are essentially permanent in duration.
As of December 31, 2009, we had federal net operating loss carryforwards of $4.0 million expiring in the year 2021, state net operating loss carryforwards of $80.9 million expiring in various years through 2029 and foreign net operating loss carryforwards of $11.2 million expiring through 2016.
Our policy is to classify interest and penalties related to income taxes as a component of our tax provision. We had gross unrecognized tax benefits of $1.7 million as of December 31, 2009 and 2008. The total amount of interest and penalties recognized in our consolidated balance sheet was $0.1 million and $0.2 million as of December 31, 2009 and 2008, respectively. The net impact on provision for income tax of unrecognized tax benefits, if recognized, would have been $0.5 million for each of the years ended December 31, 2009 and 2008.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):
         
Balance as of January 1, 2009
  $ 1,724  
Increases for tax positions taken in the current year
    408  
Reductions due to lapse of statute of limitations
    (383 )
 
     
Balance as of December 31, 2009
  $ 1,749  
 
     
Our tax years 2006 through 2009 remain open to examination by federal and state taxing authorities. In addition, our 2005 tax year remains open to examination in certain states.
In addition, ABS, an entity acquired in 2006, has pre-acquisition federal income tax returns which remain open to examination back to the year 2006. Certain pre-acquisition state income tax returns of acquired ABS subsidiaries also remain open to examination for the years 2002 through 2006. We are fully indemnified under the ABS stock purchase agreement for any liabilities resulting from examinations of pre-acquisition tax returns.
Horizon Health has federal and state tax years which remain open to examination going back to 2006 and in certain states going back to 2005. We have no indemnification for any pre-acquisition liabilities that may result from examinations of Horizon Health income tax returns for pre-acquisition periods.
In the next twelve months we anticipate increases in unrecognized tax benefits of approximately $0.4 million related to certain state tax issues, and we anticipate potential reductions in unrecognized tax benefits of approximately $0.5 million related to certain state tax expired statutes of limitation.
9. Stock Option Plans
A maximum of 13,116,666 shares of our common stock are authorized for grant as stock options, restricted stock or other share-based compensation under the Psychiatric Solutions, Inc. Equity Incentive Plan (the “Equity Incentive Plan”). Under the Equity Incentive Plan, stock options may be granted for terms of up to ten years. Grants to employees generally vest in annual increments of 25% each year, commencing one year after the date of grant. The exercise prices of stock options are equal to the closing sales prices of our common stock on the date of grant or the trading day immediately preceding the date of grant.
A maximum of 683,334 shares of our common stock are authorized for grant as stock options or restricted stock under the Psychiatric Solutions, Inc. Outside Directors’ Stock Incentive Plan (the “Directors’ Plan”). The Director’s Plan provides for a grant of 3,200 shares of restricted stock at each annual meeting of stockholders to each outside director. The Directors’ Plan also provides for an initial grant of 4,800 shares of restricted stock to each new outside director on the date of the director’s initial election or appointment to the board of directors. The grants of restricted stock vest in annual increments of 25% each year, commencing one year after the date of grant and generally have terms of ten years.

F-20


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Stock option activity during 2009 is as follows (number of options and aggregate intrinsic value in thousands):
                                 
                    Weighted    
            Weighted   Average    
            Average   Remaining   Aggregate
    Number of   Exercise   Contractual   Intrinsic
    Options   Price   Term (in years)   Value
Outstanding at December 31, 2008
    6,512     $ 28.98       7.5     $ 24,448  
Granted
    396     $ 18.65       n/a       n/a  
Canceled
    (823 )   $ 33.17       n/a       n/a  
Exercised
    (86 )   $ 12.66       n/a       n/a  
 
                               
Outstanding at December 31, 2009
    5,999     $ 27.84       6.6     $ 12,667  
 
                               
Exercisable at December 31, 2009
    4,095     $ 26.17       5.9     $ 11,586  
 
                               
Restricted stock activity is as follows (number of restricted shares in thousands):
                 
            Weighted
            Average
    Number of   Grant-
    Restricted   Date Fair
    Shares   Value
Unvested at December 31, 2008
    498     $ 33.23  
Granted
    327     $ 17.14  
Canceled
    (82 )   $ 24.64  
Vested
    (142 )   $ 33.97  
 
               
Unvested at December 31, 2009
    601     $ 25.47  
 
               
We recognized $17.5 million, $19.9 million and $16.1 million in share-based compensation expense and approximately $6.7 million, $7.6 million and $6.1 million of related income tax benefit for the years ended December 31, 2009, 2008 and 2007, respectively. The impact of share-based compensation expense, net of tax, on our basic and diluted earnings per share was approximately $0.19, $0.22 and $0.18 per share for the years ended December 31, 2009, 2008 and 2007, respectively. We classified $1.7 million, $3.1 million and $9.4 million in income tax benefits in excess of share-based compensation expense on stock options exercised and restricted stock vested as a cash flow from financing activities in our Condensed Consolidated Statement of Cash Flows for the years ended December 31, 2009, 2008 and 2007, respectively. The fair value of our stock options was estimated using the Black-Scholes option pricing model. We recognize expense on all share-based awards on a straight-line basis over the requisite service period of the entire award.
The following table summarizes the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for options granted in the years ended December 31, 2009, 2008 and 2007:
                         
    2009   2008   2007
Weighted average grant-date fair value of options
  $ 6.20     $ 11.02     $ 14.25  
Risk-free interest rate
    2 %     3 %     5 %
Expected volatility
    36 %     34 %     35 %
Expected life (in years)
    5       5       5  
Dividend yield
    0 %     0 %     0 %
Our estimate of expected volatility for stock options granted in 2009, 2008 and 2007 is based upon the historical volatility of our common stock. Our estimate of expected term is based upon our historical stock option exercise experience.
Based on our stock option and restricted stock grants outstanding at December 31, 2009, we estimate remaining unrecognized share-based compensation expense to be approximately $31.3 million with a weighted average remaining amortization period of 2.1 years.
The total intrinsic value, which represents the difference between the underlying stock’s market price and the option’s exercise price, of options exercised during the years ended December 31, 2009, 2008 and 2007 was $5.0 million, $10.9 million and $31.2 million, respectively.

F-21


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
10. Employee Benefit Plan
We sponsor the Psychiatric Solutions, Inc. Retirement Savings Plan (the “Plan”). The Plan is a tax-qualified profit sharing plan with a cash or deferred arrangement whereby employees who have completed three months of service and are age 21 or older are eligible to participate. The Plan allows eligible employees to make contributions of 1% to 85% of their annual compensation, subject to annual limitations. The Plan enables us to make discretionary contributions into each participants’ account that fully vest over a four year period based upon years of service.
11. Contingencies and Health Care Regulation
Contingencies
We are subject to various claims and legal actions which arise in the ordinary course of business. We have professional and general liability insurance in umbrella form for claims in excess of a $3.0 million self-insured retention with an insured excess limit of $75.0 million.
A stockholder lawsuit alleging violation of federal securities law was filed in 2009. We believe the lawsuit is without merit and intend to defend it vigorously.
In the opinion of management, we are not currently a party to any legal proceeding, the negative outcome of which would have a material adverse effect on our financial condition or results of operations.
Employment Agreement
We entered into an employment agreement with Joey A. Jacobs, our Chairman, President and Chief Executive Officer, on May 10, 2007. The initial term of employment was through December 31, 2008. After the initial term, the agreement renews automatically for successive terms of 12 months each unless either party provides written notice to the other of its intent not to renew the employment agreement. On December 31, 2009, the employment agreement was automatically renewed through December 31, 2010. Pursuant to the employment agreement, Mr. Jacobs’ base salary, cash bonuses and incentive compensation are subject to adjustment from time to time at the discretion of the Compensation Committee.
If we terminate Mr. Jacobs’ employment “without cause” or if Mr. Jacobs resigns as a result of a “constructive discharge,” as those terms are defined in the employment agreement: (a) Mr. Jacobs will receive a lump sum severance payment equal to two times the sum of his base salary on the date of termination and the most recent annual bonus paid to Mr. Jacobs during the immediately previous 12-month period; (b) Mr. Jacobs will receive any earned but unpaid base salary, which shall be paid in accordance with our normal payroll practices; (c) Mr. Jacobs will receive bonus compensation payable on a prorated basis for the year of termination, which shall be paid at the same time our executive officers receive their bonuses for the year in which the termination occurred; (d) to the extent that Mr. Jacobs is eligible for and has elected continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), we agree to waive all premiums for elected continuation coverage during such COBRA period but not to exceed 18 months; (e) to the extent that Mr. Jacobs is covered by an individual health policy, we will pay all reasonable premiums under such policy for 24 months following the termination date; and (f) all shares of restricted stock and unvested stock options held by Mr. Jacobs and scheduled to vest during the succeeding 24-month period will immediately vest and any such options will remain exercisable for 12 months from the date of termination. Termination, whether voluntary or involuntary, of Mr. Jacobs’ employment within 12 months following a “change in control,” as defined in the employment agreement, shall be treated as a termination without cause.
If Mr. Jacobs’ employment terminates as a result of his disability or death, Mr. Jacobs or his beneficiaries will be entitled to receive any earned but unpaid base salary, which shall be paid in accordance with the normal payroll practices of the Company. In addition, Mr. Jacobs or his beneficiaries will also receive any bonus compensation, which is payable on a prorated basis for the year of termination, and which shall be paid at the same time our executive officers receive their bonuses for the year in which the termination occurred. Finally, all shares of restricted stock and unvested stock options held by Mr. Jacobs will immediately vest upon his death or termination for disability.
If Mr. Jacobs’ employment is terminated for cause, as defined in the employment agreement, or he resigns other than pursuant to a triggering event described above, any earned but unpaid base salary shall be paid in accordance with our normal payroll practices, but we will not make any other payments or provide any benefits to Mr. Jacobs.
Current Operations
Final determination of amounts earned under prospective payment and cost-reimbursement arrangements is subject to review by appropriate governmental authorities or their agents. We believe adequate provision has been made for any adjustments that may result from such reviews.

F-22


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. We believe that we are in substantial compliance with all applicable laws and regulations and are not aware of any material pending or threatened investigations involving allegations of potential wrongdoing. While no material regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare and Medicaid programs.
We have acquired and may continue to acquire corporations and other entities with prior operating histories. Acquired entities may have unknown or contingent liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement regulations, fraud and abuse or similar laws. Although we exercise reasonable diligence to assure ourselves that no such liabilities exist and obtain indemnification rights for such matters from prospective sellers, there can be no assurance that we will be indemnified for any such liabilities or, if we are indemnified, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
12. Related Party Transactions
William M. Petrie, M.D., a member of our Board of Directors owns a partnership interest in and serves as President of Psychiatric Consultants, P.C. (“PCPC”), a physician practice group that leases office space from and is managed by Rolling Hills Hospital, our facility in Franklin, TN. The initial term of Rolling Hills’ Management Services Agreement with PCPC expires on December 31, 2011 and automatically renews for successive terms of one year each unless either party provides notice of its intent not to renew at least 60 days prior to any expiration date. Rolling Hills’ management fee and rental income for PCPC is less than $0.3 million annually. Dr. Petrie is also the Medical Director of Rolling Hills Hospital. The initial term of Dr. Petrie’s Medical Director Services Agreement with Rolling Hills Hospital expires December 31, 2011 and automatically renews for successive terms of one year each unless either party provides prior written notice of its intent not to renew.
13. Disclosures About Reportable Segments
In accordance with GAAP, our owned and leased behavioral health care facilities segment is our only reportable segment. Our chief operating decision maker regularly reviews the operating results of our inpatient facilities on a combined basis, which represent more than 90% of our consolidated revenue. As of December 31, 2009, the owned and leased facilities segment provides mental health and behavioral health services to patients in its 86 owned and 8 leased inpatient facilities in 32 states, Puerto Rico and the U.S. Virgin Islands. The column entitled “Other” in the schedules below includes management contracts to provide inpatient psychiatric management and development services to inpatient behavioral health units in hospitals and clinics and a managed care plan in Puerto Rico. The operations included in the “Other” column do not qualify as reportable segments. Activities classified as “Corporate” in the following schedules relate primarily to unallocated home office expenses and discontinued operations.
Adjusted EBITDA is a non-GAAP financial measure and is defined as income from continuing operations before interest expense (net of interest income), income taxes, depreciation, amortization, stock compensation and other items included in the caption labeled “Other expenses.” These other expenses may occur in future periods, but the amounts recognized can vary significantly from period to period and do not directly relate to ongoing operations of our health care facilities. Our management relies on adjusted EBITDA as the primary measure to review and assess the operating performance of our inpatient facilities and their management teams. We believe it is useful to investors to provide disclosures of our operating results on the same basis as that used by management. Management and investors also review adjusted EBITDA to evaluate our overall performance and to compare our current operating results with corresponding periods and with other companies in the health care industry. You should not consider adjusted EBITDA in isolation or as a substitute for net income, operating cash flows or other cash flow statement data determined in accordance with U. S. generally accepted accounting principles. Because adjusted EBITDA is not a measure of financial performance under U. S. generally accepted accounting principles and is susceptible to varying calculations, it may not be comparable to similarly titled measures of other companies. The following is a financial summary by reportable segment for the periods indicated (dollars in thousands):

F-23


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Year Ended December 31, 2009
                                 
    Owned and                    
    Leased                    
    Facilities     Other     Corporate     Consolidated  
Revenue
  $ 1,678,449     $ 126,912     $     $ 1,805,361  
 
                               
Adjusted EBITDA
  $ 361,078     $ 14,945     $ (47,131 )   $ 328,892  
Interest expense, net
    28,494       (788 )     43,843       71,549  
Provision for income taxes
                74,889       74,889  
Depreciation and amortization
    38,894       4,288       1,596       44,778  
Inter-segment expenses
    57,538       5,117       (62,655 )      
Other expenses:
                               
Share-based compensation
                17,505       17,505  
 
                       
Total other expenses
                17,505       17,505  
 
                       
Income (loss) from continuing operations
    236,152       6,328       (122,309 )     120,171  
Less: Income attributable to noncontrolling interest
    (93 )                 (93 )
 
                       
Income (loss) from continuing operations attributable to PSI stockholders
  $ 236,059     $ 6,328     $ (122,309 )   $ 120,078  
 
                       
Total assets
  $ 2,341,778     $ 58,438     $ 107,024     $ 2,507,240  
 
                       
Capital expenditures
  $ 127,285     $ 339     $ 3,050     $ 130,674  
 
                       
Cost in excess of net assets acquired
  $ 1,136,935     $ 16,176     $     $ 1,153,111  
 
                       
Year Ended December 31, 2008
                                 
    Owned and                    
    Leased                    
    Facilities     Other     Corporate     Consolidated  
Revenue
  $ 1,571,141     $ 124,975     $     $ 1,696,116  
 
                               
Adjusted EBITDA
  $ 327,124     $ 22,866     $ (45,157 )   $ 304,833  
Interest expense, net
    27,920       (1,391 )     49,453       75,982  
Provision for income taxes
                64,457       64,457  
Depreciation and amortization
    32,668       4,633       1,542       38,843  
Inter-segment expenses
    63,054       5,840       (68,894 )      
Other expenses:
                               
Share-based compensation
                19,913       19,913  
 
                       
Total other expenses
                19,913       19,913  
 
                       
Income (loss) from continuing operations
    203,482       13,784       (111,628 )     105,638  
Less: Income attributable to noncontrolling interest
    (604 )                 (604 )
 
                       
Income (loss) from continuing operations attributable to PSI stockholders
  $ 202,878     $ 13,784     $ (111,628 )   $ 105,034  
 
                       
Total assets
  $ 2,213,462     $ 62,965     $ 229,563     $ 2,505,990  
 
                       
Capital expenditures
  $ 116,719     $ 876     $ 4,335     $ 121,930  
 
                       
Cost in excess of net assets acquired
  $ 1,123,066     $ 16,176     $     $ 1,139,242  
 
                       

F-24


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Year Ended December 31, 2007
                                 
    Owned and                    
    Leased                    
    Facilities     Other     Corporate     Consolidated  
Revenue
  $ 1,314,203     $ 100,497     $     $ 1,414,700  
 
                               
Adjusted EBITDA
  $ 272,672     $ 16,862     $ (38,632 )   $ 250,902  
Interest expense, net
    29,670       100       44,117       73,887  
Provision for income taxes
                46,200       46,200  
Depreciation and amortization
    26,240       2,413       1,460       30,113  
Inter-segment expenses
    54,578       4,503       (59,081 )      
Other expenses:
                               
Share-based compensation
                16,104       16,104  
Loss on refinancing long-term debt
                8,179       8,179  
 
                       
Total other expenses
                24,283       24,283  
 
                       
Income (loss) from continuing operations
    162,184       9,846       (95,611 )     76,419  
Less: Income attributable to noncontrolling interest
    (285 )                 (285 )
 
                       
Income (loss) from continuing operations attributable to PSI stockholders
  $ 161,899     $ 9,846     $ (95,611 )   $ 76,134  
 
                       
Total assets
  $ 1,950,999     $ 69,333     $ 159,173     $ 2,179,505  
 
                       
Capital expenditures
  $ 66,828     $ 354     $ 4,078     $ 71,260  
 
                       
Cost in excess of net assets acquired
  $ 1,035,606     $ 16,176     $     $ 1,051,782  
 
                       
14. Other Information
A summary of activity in allowance for doubtful accounts follows (in thousands):
                                         
    Balances   Additions   Additions   Accounts written   Balances
    at beginning   charged to costs   charged to   off, net of   at end
    of period   and expenses   other accounts (1)   recoveries   of period
Allowance for doubtful accounts:
                                       
Year ended December 31, 2007
  $ 18,468       27,343       12,982       23,827     $ 34,966  
Year ended December 31, 2008
  $ 34,966       34,334             20,917     $ 48,383  
Year ended December 31, 2009
  $ 48,383       36,414             32,903     $ 51,894  
 
(1)   Allowances as a result of acquisitions.

F-25


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
15. Quarterly Information (Unaudited)
Summarized results for each quarter in the years ended December 31, 2009 and 2008 are as follows (in thousands, except per share data):
                                         
    1st   2nd   3rd   4th    
    Quarter   Quarter   Quarter   Quarter   Total Year
2009
                                       
Revenue
  $ 433,930     $ 455,287     $ 453,187     $ 462,957     $ 1,805,361  
Income from continuing operations attributable to PSI stockholders
  $ 27,521     $ 34,580     $ 28,305     $ 29,672     $ 120,078  
Net income attributable to PSI stockholders
  $ 27,382     $ 34,408     $ 28,152     $ 27,675     $ 117,617  
 
                                       
Earnings per share:
                                       
Basic
  $ 0.49     $ 0.62     $ 0.51     $ 0.50     $ 2.12  
Diluted
  $ 0.49     $ 0.62     $ 0.50     $ 0.49     $ 2.10  
 
                                       
2008
                                       
Revenue
  $ 408,602     $ 429,200     $ 429,878     $ 428,436     $ 1,696,116  
Income from continuing operations attributable to PSI stockholders
  $ 24,566     $ 28,338     $ 27,977     $ 24,153     $ 105,034  
Net income attributable to PSI stockholders
  $ 25,496     $ 29,059     $ 26,377     $ 24,021     $ 104,953  
 
                                       
Earnings per share:
                                       
Basic
  $ 0.46     $ 0.53     $ 0.48     $ 0.43     $ 1.89  
Diluted
  $ 0.46     $ 0.52     $ 0.47     $ 0.43     $ 1.87  
As discussed in Note 4, we sold our EAP business, closed and elected to make Nashville Rehabilitation Hospital, The Oaks Treatment Center and Cumberland Hall of Chattanooga available for sale and terminated one contract with a South Carolina juvenile justice agency during 2009. During 2008, we elected to sell one inpatient behavioral health care facility and two contracts with a Puerto Rican juvenile justice agency to manage inpatient facilities were terminated. Accordingly, these operations, net of income taxes, have been presented as discontinued operations and all prior quarterly data has been reclassified.
16. Financial Information for the Company and Its Subsidiaries
We conduct substantially all of our business through our subsidiaries. Presented below is consolidated financial information for Psychiatric Solutions, Inc. and its subsidiaries as of December 31, 2009 and 2008, and for the years ended December 31, 2009, 2008 and 2007. The information segregates the parent company (Psychiatric Solutions, Inc.), the combined wholly-owned subsidiary guarantors, the combined non-guarantors, and eliminations. All of the subsidiary guarantees are both full and unconditional and joint and several.

F-26


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Condensed Consolidating Balance Sheet
As of December 31, 2009
(in thousands)
                                         
            Combined                    
            Subsidiary     Combined Non-     Consolidating     Total Consolidated  
    Parent     Guarantors     Guarantors     Adjustments     Amounts  
Current Assets:
                                       
Cash and cash equivalents
  $     $ 2,111     $ 4,704     $     $ 6,815  
Accounts receivable, net
          241,211       8,296       (68 )     249,439  
Other Current Assets
          90,259       16,284       (1,377 )     105,166  
 
                             
Total current assets
          333,581       29,284       (1,445 )     361,420  
Property and equipment, net of accumulated depreciation
          879,453       61,491       (9,214 )     931,730  
Cost in excess of net assets acquired
          1,153,111                   1,153,111  
Investment in subsidiaries
    1,486,852       (368,332 )     (16,964 )     (1,101,556 )      
Other assets
    17,536       37,420       25,372       (19,349 )     60,979  
 
                             
Total assets
  $ 1,504,388     $ 2,035,233     $ 99,183     $ (1,131,564 )   $ 2,507,240  
 
                             
 
                                       
Current Liabilities:
                                       
Accounts payable
  $     $ 34,467     $ 998     $ (68 )   $ 35,397  
Salaries and benefits payable
          80,255       874             81,129  
Other accrued liabilities
    28,901       32,783       1,610       (1,258 )     62,036  
Current portion of long-term debt
    4,490             450             4,940  
 
                             
Total current liabilities
    33,391       147,505       3,932       (1,326 )     183,502  
Long-term debt, less current portion
    1,149,738             32,401             1,182,139  
Deferred tax liability
          81,137                   81,137  
Other liabilities
    127       (6,324 )     36,069       (4,082 )     25,790  
 
                             
Total liabilities
    1,183,256       222,318       72,402       (5,408 )     1,472,568  
Redeemable noncontrolling interest
                      4,337       4,337  
Total stockholders’ equity (deficit)
    321,132       1,812,915       26,781       (1,130,493 )     1,030,335  
 
                             
Total liabilities and stockholders’ equity (deficit)
  $ 1,504,388     $ 2,035,233     $ 99,183     $ (1,131,564 )   $ 2,507,240  
 
                             
Condensed Consolidating Balance Sheet
As of December 31, 2008
(in thousands)
                                         
            Combined                    
            Subsidiary     Combined Non-     Consolidating     Total Consolidated  
    Parent     Guarantors     Guarantors     Adjustments     Amounts  
Current Assets:
                                       
Cash and cash equivalents
  $     $ 39,881     $ 11,390     $     $ 51,271  
Accounts receivable, net
          234,197       7,331       (69 )     241,459  
Other Current Assets
          158,305       16,910       (435 )     174,780  
 
                             
Total current assets
          432,383       35,631       (504 )     467,510  
Property and equipment, net of accumulated depreciation
          772,377       57,600       (9,524 )     820,453  
Cost in excess of net assets acquired
          1,139,242                   1,139,242  
Investment in subsidiaries
    1,668,515       (547,165 )     (23,521 )     (1,097,829 )      
Other assets
    12,633       15,923       27,164       23,065       78,785  
 
                             
Total assets
  $ 1,681,148     $ 1,812,760     $ 96,874     $ (1,084,792 )   $ 2,505,990  
 
                             
 
                                       
Current Liabilities:
                                       
Accounts payable
  $     $ 33,853     $ 825     $ (69 )   $ 34,609  
Salaries and benefits payable
          81,970       1,569             83,539  
Other accrued liabilities
    28,786       51,475       4,335       (3,531 )     81,065  
Current portion of long-term debt
    33,968             423             34,391  
 
                             
Total current liabilities
    62,754       167,298       7,152       (3,600 )     233,604  
Long-term debt, less current portion
    1,247,156             32,850             1,280,006  
Deferred tax liability
          69,471                   69,471  
Other liabilities
    12,433       (61,717 )     31,349       46,002       28,067  
 
                             
Total liabilities
    1,322,343       175,052       71,351       42,402       1,611,148  
Redeemable noncontrolling interest
                      4,957       4,957  
Total stockholders’ equity (deficit)
    358,805       1,637,708       25,523       (1,132,151 )     889,885  
 
                             
Total liabilities and stockholders’ equity (deficit)
  $ 1,681,148     $ 1,812,760     $ 96,874     $ (1,084,792 )   $ 2,505,990  
 
                             

F-27


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Condensed Consolidating Statement of Income
For the Twelve Months Ended December 31, 2009
(in thousands)
                                         
            Combined                    
            Subsidiary     Combined Non-     Consolidating     Total Consolidated  
    Parent     Guarantors     Guarantors     Adjustments     Amounts  
Revenue
  $     $ 1,764,827     $ 56,180     $ (15,646 )   $ 1,805,361  
Salaries, wages and employee benefits
          979,106       26,098             1,005,204  
Professional fees
          162,862       6,840       (2,917 )     166,785  
Supplies
          90,222       2,350             92,572  
Rentals and leases
          24,234       257       (4,360 )     20,131  
Other operating expenses
          168,965       14,804       (10,901 )     172,868  
Provision for doubtful accounts
          35,303       1,111             36,414  
Depreciation and amortization
          42,831       2,257       (310 )     44,778  
Interest expense
    69,799             1,750             71,549  
 
                             
 
    69,799       1,503,523       55,467       (18,488 )     1,610,301  
(Loss) income from continuing operations before income taxes
    (69,799 )     261,304       713       2,842       195,060  
(Benefit from) provision for income taxes
    (26,798 )     100,322       274       1,091       74,889  
 
                             
(Loss) income from continuing operations
    (43,001 )     160,982       439       1,751       120,171  
(Loss) income from discontinued operations, net of tax
          (3,280 )     819             (2,461 )
 
                             
Net (loss) income
    (43,001 )     157,702       1,258       1,751       117,710  
Less: Net income attributable to noncontrolling interest
                      (93 )     (93 )
 
                             
Net (loss) income attributable to PSI stockholders
  $ (43,001 )   $ 157,702     $ 1,258     $ 1,658     $ 117,617  
 
                             
Condensed Consolidating Statement of Income
For the Twelve Months Ended December 31, 2008
(in thousands)
                                         
            Combined Subsidiary     Combined     Consolidating     Total Consolidated  
    Parent     Guarantors     Non-Guarantors     Adjustments     Amounts  
Revenue
  $     $ 1,651,496     $ 56,499     $ (11,879 )   $ 1,696,116  
Salaries, wages and employee benefits
          911,145       27,238       (20 )     938,363  
Professional fees
          158,005       4,586       (100 )     162,491  
Supplies
          90,069       2,324             92,393  
Rentals and leases
          24,768       97       (4,230 )     20,635  
Other operating expenses
          158,046       13,116       (8,182 )     162,980  
Provision for doubtful accounts
          33,496       838             34,334  
Depreciation and amortization
          36,898       2,252       (307 )     38,843  
Interest expense
    74,663             1,319             75,982  
 
                             
 
    74,663       1,412,427       51,770       (12,839 )     1,526,021  
(Loss) income from continuing operations before income taxes
    (74,663 )     239,069       4,729       960       170,095  
(Benefit from) provision for income taxes
    (28,293 )     90,635       1,751       364       64,457  
 
                             
(Loss) income from continuing operations
    (46,370 )     148,434       2,978       596       105,638  
(Loss) income from discontinued operations, net of tax
          (992 )     911             (81 )
 
                             
Net (loss) income
    (46,370 )     147,442       3,889       596       105,557  
Less: Net income attributable to noncontrolling interest
                      (604 )     (604 )
 
                             
Net (loss) income attributable to PSI stockholders
  $ (46,370 )   $ 147,442     $ 3,889     $ (8 )   $ 104,953  
 
                             

F-28


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Condensed Consolidating Statement of Income
For the Twelve Months Ended December 31, 2007
(in thousands)
                                         
            Combined                    
            Subsidiary     Combined Non-     Consolidating     Total Consolidated  
    Parent     Guarantors     Guarantors     Adjustments     Amounts  
Revenue
  $     $ 1,390,521     $ 37,257     $ (13,078 )   $ 1,414,700  
Salaries, wages and employee benefits
          772,765       14,533       3       787,301  
Professional fees
          132,757       4,178       (1,132 )     135,803  
Supplies
          76,563       1,192       (17 )     77,738  
Rentals and leases
          22,890       55       (4,006 )     18,939  
Other operating expenses
          130,185       12,292       (9,699 )     132,778  
Provision for doubtful accounts
          26,633       710             27,343  
Depreciation and amortization
          28,517       1,872       (276 )     30,113  
Interest expense
    72,642             1,245             73,887  
Loss on refinancing long-term debt
    8,179                         8,179  
 
                             
 
    80,821       1,190,310       36,077       (15,127 )     1,292,081  
(Loss) income from continuing operations before income taxes
    (80,821 )     200,211       1,180       2,049       122,619  
 
                                       
(Benefit from) provision for income taxes
    (30,451 )     75,432       446       773       46,200  
 
                             
(Loss) income from continuing operations
    (50,370 )     124,779       734       1,276       76,419  
(Loss) income from discontinued operations, net of taxes
          (222 )     296             74  
 
                             
Net (loss) income
    (50,370 )     124,557       1,030       1,276       76,493  
Less: Net income attributable to noncontrolling interest
                      (285 )     (285 )
 
                             
Net (loss) income attributable to PSI stockholders
  $ (50,370 )   $ 124,557     $ 1,030     $ 991     $ 76,208  
 
                             

F-29


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Condensed Consolidating Statement of Cash Flows
For the Twelve Months Ended December 31, 2009
(in thousands)
                                         
            Combined                    
            Subsidiary     Combined Non-     Consolidating     Total Consolidated  
    Parent     Guarantors     Guarantors     Adjustments     Amounts  
Operating activities:
                                       
Net (loss) income
  $ (43,001 )   $ 157,702     $ 1,258     $ 1,751     $ 117,710  
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
                                       
Depreciation and amortization
          42,831       2,257       (310 )     44,778  
Amortization of loan costs and bond premium
    5,255             45             5,300  
Share-based compensation
          17,505                   17,505  
Change in income tax assets and liabilities
          20,050                   20,050  
Loss (income) from discontinued operations, net of taxes
          3,280       (819 )           2,461  
Changes in operating assets and liabilities, net of effect of acquisitions:
                                       
Accounts receivable
          (2,946 )     (965 )           (3,911 )
Other current assets
          7,398       626             8,024  
Accounts payable
          (1,564 )     173             (1,391 )
Salaries and benefits payable
          (5,524 )     (695 )           (6,219 )
Accrued liabilities and other liabilities
    4,773       4,008       (7,677 )           1,104  
 
                             
Net cash (used in) provided by continuing operating activities
    (32,973 )     242,740       (5,797 )     1,441       205,411  
Net cash (used in) provided by discontinued operating activities
          (602 )     1,585             983  
 
                             
Net cash (used in) provided by operating activities
    (32,973 )     242,138       (4,212 )     1,441       206,394  
Investing activities:
                                       
Cash paid for acquisitions, net of cash acquired
    (32,910 )                       (32,910 )
Cash paid for real estate acquisitions
          (19,341 )                 (19,341 )
Capital purchases of leasehold improvements, equipment and software
          (130,167 )     (507 )           (130,674 )
Other assets
          2,008       (779 )           1,229  
 
                             
Net cash (used in) provided by continuing investing activities
    (32,910 )     (147,500 )     (1,286 )           (181,696 )
Net cash provided by discontinued investing activities
          67,692                   67,692  
 
                             
Net cash (used in) provided by investing activities
    (32,910 )     (79,808 )     (1,286 )           (114,004 )
Financing activities:
                                       
Net increase in revolving credit facility, less acquisitions
    (229,333 )                       (229,333 )
Borrowings on long-term debt
    106,500                         106,500  
Principal payments on long-term debt
    (4,671 )           (422 )           (5,093 )
Payment of loan and issuance costs
    (9,903 )                       (9,903 )
Excess tax benefits from share-based payment arrangements
    1,678                         1,678  
Distributions to noncontrolling interests
    (723 )                       (723 )
Repurchase of common stock upon restricted stock vesting
    (1,057 )                       (1,057 )
Net transfers to and from members
    202,307       (200,100 )     (766 )     (1,441 )      
Proceeds from exercises of common stock options
    1,085                         1,085  
 
                             
Net cash provided by (used in) financing activities
    65,883       (200,100 )     (1,188 )     (1,441 )     (136,846 )
 
                             
Net decrease in cash
          (37,770 )     (6,686 )           (44,456 )
Cash and cash equivalents at beginning of the year
          39,881       11,390             51,271  
 
                             
Cash and cash equivalents at end of the year
  $     $ 2,111     $ 4,704     $     $ 6,815  
 
                             

F-30


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Condensed Consolidating Statement of Cash Flows
For the Twelve Months Ended December 31, 2008
(in thousands)
                                         
            Combined     Combined              
            Subsidiary     Non-     Consolidating     Total Consolidated  
      Parent   Guarantors     Guarantors     Adjustments     Amounts  
Operating activities:
                                       
Net (loss) income
  $ (46,370 )   $ 147,442     $ 3,889     $ 596     $ 105,557  
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
                                       
Depreciation and amortization
          36,898       2,252       (307 )     38,843  
Amortization of loan costs and bond premium
    2,168             45             2,213  
Share-based compensation
          19,913                   19,913  
Change in income tax assets and liabilities
          (5,034 )                 (5,034 )
Loss from discontinued operations, net of taxes
          992       (911 )           81  
Changes in operating assets and liabilities, net of effect of acquisitions:
                                       
Accounts receivable
          (17,649 )     (106 )           (17,755 )
Other current assets
          10,523       (15,135 )           (4,612 )
Accounts payable
          3,098       (207 )           2,891  
Salaries and benefits payable
          1,679       52             1,731  
Accrued liabilities and other liabilities
    (3,599 )     861       (1,829 )           (4,567 )
 
                             
Net cash (used in) provided by continuing operating activities
    (47,801 )     198,723       (11,950 )     289       139,261  
Net cash provided by discontinued operating activities
          739       1,783             2,522  
 
                             
Net cash (used in) provided by operating activities
    (47,801 )     199,462       (10,167 )     289       141,783  
Investing activities:
                                       
Cash paid for acquisitions, net of cash acquired
    (121,156 )                       (121,156 )
Capital purchases of leasehold improvements, equipment and software
          (119,540 )     (2,390 )           (121,930 )
Other assets
          (1,668 )     350             (1,318 )
 
                             
Net cash used in continuing investing activities
    (121,156 )     (121,208 )     (2,040 )           (244,404 )
Net cash (used in) provided by discontinued investing activities
    (45,000 )     3,189                   (41,811 )
 
                             
Net cash used in investing activities
    (166,156 )     (118,019 )     (2,040 )           (286,215 )
Financing activities:
                                       
Net increase in revolving credit facility, less acquisitions
    149,333                         149,333  
Principal payments on long-term debt
    (5,669 )           (398 )           (6,067 )
Payment of loan and issuance costs
    (59 )                       (59 )
Excess tax benefits from share-based payment arrangements
    3,052                         3,052  
Repurchase of common stock upon restricted stock vesting
    (271 )                       (271 )
Net transfers to and from members
    57,826       (60,716 )     3,179       (289 )      
Proceeds from exercises of common stock options
    9,745                         9,745  
 
                             
Net cash provided by (used in) financing activities
    213,957       (60,716 )     2,781       (289 )     155,733  
 
                             
Net increase (decrease) in cash
          20,727       (9,426 )           11,301  
Cash and cash equivalents at beginning of the year
          19,154       20,816             39,970  
 
                             
Cash and cash equivalents at end of the year
  $     $ 39,881     $ 11,390     $     $ 51,271  
 
                             

F-31


Table of Contents

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2009
Condensed Consolidating Statement of Cash Flows
For the Twelve Months Ended December 31, 2007
(in thousands)
                                         
            Combined                    
            Subsidiary     Combined Non-     Consolidating     Total Consolidated  
      Parent   Guarantors     Guarantors     Adjustments     Amounts  
Operating activities:
                                       
Net (loss) income
  $ (50,370 )   $ 124,557     $ 1,030     $ 1,276     $ 76,493  
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
                                       
Depreciation and amortization
          28,517       1,872       (276 )     30,113  
Amortization of loan costs and bond premium
    2,106             45             2,151  
Share-based compensation
          16,104                   16,104  
Loss on refinancing long-term debt
    8,179                         8,179  
Change in income tax assets and liabilities
          8,193       446             8,639  
Loss from discontinued operations, net of taxes
          222       (296 )           (74 )
Changes in operating assets and liabilities, net of effect of acquisitions:
                                       
Accounts receivable
          (13,158 )     566             (12,592 )
Other current assets
          6,626       (328 )           6,298  
Accounts payable
          (7,499 )     (440 )           (7,939 )
Salaries and benefits payable
          1,633       243             1,876  
Accrued liabilities and other liabilities
    10,965       (20,307 )     3,666             (5,676 )
 
                             
Net cash (used in) provided by continuing operating activities
    (29,120 )     144,888       6,804       1,000       123,572  
Net cash provided by discontinued operating activities
          3,185       (1,236 )           1,949  
 
                             
Net cash (used in) provided by operating activities
    (29,120 )     148,073       5,568       1,000       125,521  
Investing activities:
                                       
Cash paid for acquisitions, net of cash acquired
    (444,899 )                       (444,899 )
Capital purchases of leasehold improvements, equipment and software
          (70,693 )     (567 )           (71,260 )
Other assets
          (2,866 )     415             (2,451 )
 
                             
Net cash used in continuing investing activites
    (444,899 )     (73,559 )     (152 )           (518,610 )
Net cash used in discontinued investing activities
    (17,921 )     (53 )                 (17,974 )
 
                             
Net cash used in investing activities
    (462,820 )     (73,612 )     (152 )           (536,584 )
Financing activities:
                                       
Net decrease in revolving credit facility, less acquisitions
    (21,000 )                       (21,000 )
Borrowings on long-term debt
    481,875                         481,875  
Principal payments on long-term debt
    (40,936 )           (345 )           (41,281 )
Payment of loan and issuance costs
    (6,661 )                       (6,661 )
Refinancing of long-term debt
    (7,127 )                       (7,127 )
Excess tax benefits from share-based payment arrangements
    9,428                         9,428  
Repurchase of common stock upon restricted stock vesting
    (122 )                       (122 )
Net transfers to and from members
    59,082       (58,471 )     389       (1,000 )      
Proceeds from exercises of common stock options
    17,401                         17,401  
 
                             
Net cash provided by (used in) financing activities
    491,940       (58,471 )     44       (1,000 )     432,513  
 
                             
Net increase in cash
          15,990       5,460             21,450  
Cash and cash equivalents at beginning of the year
          3,164       15,356             18,520  
 
                             
Cash and cash equivalents at end of the year
  $     $ 19,154     $ 20,816     $     $ 39,970  
 
                             

F-32


Table of Contents

Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  Psychiatric Solutions, Inc.
 
 
  By:   /s/ Joey A. Jacobs    
    Joey A. Jacobs   
    Chief Executive Officer   
 
Dated: February 25, 2010
     Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
         
Signature   Title   Date
/s/ Joey A. Jacobs
 
Joey A. Jacobs
  Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)   February 25, 2010
 
       
/s/ Jack E. Polson
 
Jack E. Polson
  Executive Vice President, Chief Accounting Officer (Principal Financial and Accounting Officer)   February 25, 2010
 
       
/s/ Mark P. Clein
  Director   February 25, 2010
         
Mark P. Clein
       
 
       
/s/ David M. Dill
  Director   February 25, 2010
         
David M. Dill
       
 
       
/s/ Richard D. Gore
  Director   February 25, 2010
         
Richard D. Gore
       
 
       
/s/ Christopher Grant, Jr.
  Director   February 25, 2010
         
Christopher Grant, Jr.
       
 
       
/s/ William M. Petrie, M.D.
  Director   February 25, 2010
         
William M. Petrie, M.D.
       
 
       
/s/ Edward K. Wissing
  Director   February 25, 2010
         
Edward K. Wissing